fluorodeoxyglucose f18 has been researched along with Lymph Node Metastasis in 1949 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.05) | 18.7374 |
| 1990's | 140 (7.18) | 18.2507 |
| 2000's | 696 (35.71) | 29.6817 |
| 2010's | 915 (46.95) | 24.3611 |
| 2020's | 197 (10.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, EN; Chen, WC; Liu, ZQ; OuYang, PY; Wu, YS; Xiao, SM; Xie, FY; Yang, SS; Zhang, BY; Zhang, J; Zhang, X | 1 |
| Chen-Yoshikawa, TF; Fukui, T; Goto, M; Iwano, S; Kadomatsu, Y; Nakamura, S; Nakanishi, K; Ozeki, N; Sugiyama, T; Ueno, H | 1 |
| Asano, M; Fuwa, M; Ikeda, T; Kanayama, T; Kato, A; Mori, I; Morita, H; Shizui, N; Taguchi, K; Tateyama, S | 1 |
| Akl, P; Buvat, I; Duboucher, C; Lacroix, M; Soussan, M; Wallis, D | 1 |
| Aigner, C; Darwiche, K; Eberhardt, WEE; Gauler, T; Guberina, M; Guberina, N; Hautzel, H; Herrmann, K; Karpf-Wissel, R; Metzenmacher, M; Ploenes, T; Pöttgen, C; Schuler, M; Stuschke, M; Theegarten, D; Umutlu, L; Wiesweg, M | 1 |
| Durgun, B; Guney, IB; Kucuker, KA; Kucuker, M | 1 |
| Li, G; Wang, Z; Wu, Y; Zhang, B; Zhou, Z | 1 |
| Bai, T; Huang, Q; Yao, L; Zhang, N; Zuo, M | 1 |
| Cai, Q; Flores, R; Henschke, CI; Lee, DS; Taioli, E; Wang, Y; Yankelevitz, DF; Yip, R; You, N; Zhu, Y | 1 |
| Ahmed, MM; Baker, A; Fagiry, R; Ibrahim, N; Mahmood, S; Mair, M; Menon, I; Vaidhyanath, R | 1 |
| Antonoff, MB; Betancourt Cuellar, SL; Erasmus, JJ; Feldman, HA; Hofstetter, WL; Mehran, RJ; Rajaram, R; Rice, DC; Sepesi, B; Swisher, SG; Vaporciyan, AA; Walsh, GL; Zhou, N | 1 |
| Gao, C; Liu, H; Zou, Q | 1 |
| Albersen, M; Berghen, C; De Maeseneer, D; De Man, K; De Meerleer, G; De Visschere, P; Decaestecker, K; Dirix, P; Fonteyne, V; Ost, P; Poppe, L; Rottey, S; Van Praet, C; Verbeke, S; Verghote, F; Villeirs, G | 1 |
| Park, YM; Seo, HI | 1 |
| Dubroff, JG; O'Brien, SR; Pantel, AR; Rosenspire, KC; Weeks, JK | 1 |
| Broglie, MA; Hüllner, MW; Lekanne Dit Deprez, LW; Morand, GB; Pazahr, S; Thüring, C | 1 |
| Duarte, LH; Gouveia, P; Nunes, S; Petiz, A; Sá Pinto, A; Teixeira, R; Violante, L | 1 |
| Aikou, S; Fukayama, M; Momose, T; Okumura, Y; Seto, Y; Takahashi, M; Takyu, S; Yagi, K; Yamaya, T; Yoshimura, S | 1 |
| Akaihata, M; Asakura, K; Ishida, Y; Takahashi, I; Takahashi, Y; Tsumura, Y | 1 |
| Aokage, K; Ishii, G; Kojima, M; Miyazaki, S; Miyoshi, T; Nakai, T; Nishina, Y; Nomura, K; Sakamoto, N; Sakashita, S; Samejima, J; Suzuki, K; Taki, T; Tane, K; Tsuboi, M; Watanabe, R | 1 |
| Bergamini, A; Bettinardi, V; Bezzi, C; Bocciolone, L; Candiani, M; Candotti, G; De Cobelli, F; Fallanca, F; Gianolli, L; Gnasso, C; Ironi, G; Mangili, G; Mapelli, P; Picchio, M; Rancoita, PMV; Sant'Angelo, M; Scifo, P; Taccagni, GL | 1 |
| Çağlar, HB; Canoğlu, MD; Küçük, N; Küçükmorkoç, E; Rzazade, R; Turna, M | 1 |
| Hirosue, A; Kawahara, K; Kitajima, M; Minamitake, A; Murakami, R; Nakayama, H; Sakamoto, F; Sakata, J; Shiraishi, S; Yamana, K; Yoshida, R | 1 |
| Bertolaso, P; Bladou, F; Brouste, V; Cabart, M; Cazeau, AL; de Clermont-Gallerande, H; Gross-Goupil, M; Lefort, F | 1 |
| Borm, KJ; Buschner, G; Combs, SE; Duma, MN; Düsberg, M; Ernst, L; Oechsner, M; Voppichler, J; Weber, W | 1 |
| Li, L; Li, Y; Xiao, L | 1 |
| Haga, A; Ikushima, H; Kudo, Y; Kudoh, K; Kudoh, T; Miyamoto, Y; Sasaki, M; Takahashi, A | 1 |
| Brambs, CE; Combs, SE; Hugo, C; Knorr, K; Scharl, S; Schüttrumpf, L; Weidenbaecher, CB | 1 |
| Alhoubani, Y; Catalano, OA; Davidson, T; Domachevsky, L; Eifer, M; Eshet, Y; Kanana, N; Klang, E; Konen, E; Pinian, H; Tau, N | 1 |
| Dong, A; Ji, X | 2 |
| Donswijk, ML; Haarsma, R; Scholten, AN; van Duijnhoven, FH; van Loevezijn, AA; Vrancken Peeters, MTFD | 1 |
| Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Oshikiri, T; Suzuki, S; Urakawa, N; Yamada, K; Yamamoto, M; Yamashita, K | 1 |
| Dasgupta, P; Ghose, A; Hayes, JDB; Kandala, A; Omorphos, NP; Sharma, A; Vasdev, N | 1 |
| Beets-Tan, RGH; de Mooij, CM; Heuts, EM; Kooreman, LFS; Lobbes, MBI; Mitea, C; Samiei, S; Smidt, ML; van Nijnatten, TJA | 1 |
| Bouchelouche, K; Fledelius, J; Jakobsen, JK; Stilling, C; Szumniak, J | 1 |
| Chen, D; Chen, W; Chen, Y; Lin, Z; Lou, Y; Song, L; Sun, J; Zhang, M | 1 |
| Doki, Y; Eguchi, H; Furuyashiki, M; Hata, T; Kida, A; Miyoshi, N; Ogino, T; Sekido, Y; Takahashi, H; Tsuboyama, T; Uemura, M; Yukimoto, R | 1 |
| Chen, X; Hua, J; Liu, L; Liu, Y; Xu, S; Zhang, W | 1 |
| Afzal, Z; Ashcroft, J; Cheow, H; Davies, J; De Paepe, KN; Joshi, H; Meyer, J; Powar, M; Rooney, S; Simillis, C; Wheeler, J | 1 |
| Amthauer, H; Baur, ADJ; Becker, PH; Furth, C; Gorodetski, B; Hamm, B; Hartenstein, A; Makowski, M; Penzkofer, T; Rogasch, JMM | 1 |
| Ma, D; Shao, X; Wu, C; Wu, J; Zhang, Y | 1 |
| Annema, J; Crombag, L; Fielding, D; Hardcastle, N; Irving, LB; Jennings, BR; Kothari, G; Lee, P; Nguyen, P; Ost, DE; Rangamuwa, K; Siva, S; Steinfort, DP; Yasufuku, K; Yo, S | 1 |
| Gerke, O; Hildebrandt, MG; Holm, J; Jensen, PT; Jochumsen, KM; Spasojevic, D; Sponholtz, SE; Thomassen, A; Vilstrup, MH | 1 |
| Cheng, G; Huang, Y; Jiang, X; Liu, LN; Shi, YH; Wu, HJ; Xia, YX; Xu, DK; Xu, H; Zhang, D | 1 |
| Akdemir, ÜÖ; Atay, LÖ; Aydos, U; Dursun, A; Gülbahar Ateş, S; Üner, A; Yüksel, O | 1 |
| Aloglu, M; Atikcan, Ş; Çimen, F; Düzgün, S; Özmen, Ö; Şentürk, A | 1 |
| Bang, S; Han, K; Hwang, HK; Hwang, SH; Kim, MJ; Kim, SS; Lee, HS; Park, MS; Yoon, JK; Yun, M | 1 |
| Araz, M; Bakırarar, B; Ortaç, UF; Soydal, Ç; Taşkın, S; Varlı, B | 1 |
| Hanaoka, K; Hattori, S; Ishii, K; Kaida, H; Kato, H; Kimura, Y; Kitajima, K; Matsukubo, Y; Shiraishi, O; Tsurusaki, M; Yamada, M; Yasuda, T | 1 |
| Dai, Q; Huang, G; Jin, M; Liu, L; Wang, M | 1 |
| Goto, H; Harada, H; Hasegawa, H; Kakeji, Y; Kanaji, S; Matsuda, T; Oshikiri, T; Sawada, R; Urakawa, N; Yamashita, K | 1 |
| Chorti, E; Klode, J; Mertens, D; Placke, JM; Roesch, A; Schadendorf, D; Stoffels, I; Tasdogan, A; Ugurel, S | 1 |
| Hod, N; Lantsberg, S; Nalbandyan, K; Porges, T | 1 |
| Arikan, AE; Capkinoglu, E; Dulgeroglu, O; Kara, H; Uras, C | 1 |
| Dupin, C; Fitoussi, O; Galland, S; Gordien, P; Henriques, B; Kuratle, T; Poulain, JE; Ramos-Pascual, S; Riviere, J; Roche, JB; Saffarini, M; Vincent, M; Wallerand, H | 1 |
| Baixeras, N; Pudis, M; Suárez-Piñera, M; Torró, CM; Vilariño, N | 1 |
| Akovali, B; Bese, T; Bicer, E; Demirkiran, F; Kabasakal, L; Tetikli Kosuk, A; Turan, H | 1 |
| Fujii, H; Fujiwara, Y; Ishido, N; Kadowaki, Y; Komoto, S; Kubota, T; Matano, T; Okino, T; Okubo, Y; Shirasaka, D; Watanabe, A | 1 |
| Nakahira, S; Oi, K; Saito, Y; Tamagawa, H; Taniguchi, E; Tsujimura, N | 1 |
| Akbas, S; Arslan, E; Battal Havare, S; Beyhan, E; Can Trabulus, FD; Cin, M; Ergül, N; Erol Fenercioglu, Ö; Fikret Çermik, T; Mermut, Ö; Sahin, R | 1 |
| Amthauer, H; Baumgärtner, GL; Frost, N; Furth, C; Gerhold, M; Michaels, L; Neudecker, J; Ochsenreither, S; Penzkofer, T; Rogasch, JMM; Rückert, JC; Schmidt, B; Schneider, P | 1 |
| Berberich, C; Gaa, J; Krackhardt, A; Mustafa, M; Nekolla, SG; Zhuwu, Y | 1 |
| Boellaard, TN; de Reijke, TM; Greidanus, J; Mertens, LS; Oosterbaan, L; van Gennep, EJ; van Ginkel, N; van Rhijn, BWG; Vis, AN; Wondergem, M | 1 |
| Feng, J; Gao, X; He, Y; Hu, Y; Ma, Y; Pan, Y; Peng, L; Xu, F; Zhu, X | 1 |
| Fan, Y; Guo, C; Huang, W; Li, S; Liao, X; Liu, J; Liu, M; Wang, R; Xiong, Y; Zhang, J | 1 |
| Bahig, H; Bélair, M; De-Meric-de-Bellefon, M; Filion, E; Landry, D; Lavigne, D; Létourneau-Guillon, L; Nguyen-Tan, FP; O'Sullivan, B | 1 |
| Fujimori, S; Ishihara, M; Kawabata, H; Kawaguchi, S; Kinowaki, K; Kobayashi, Y; Nishikawa, A; Ogura, T; Sato, J; Shibata, A; Shiiba, M; Suzuki, S; Tamura, N; Tanaka, K | 1 |
| Albert, NL; Belka, C; Cegla, P; Cholewinski, W; Ferentinos, K; Furth, C; Hajiyianni, M; Hofheinz, F; Holzgreve, A; Kaźmierska, J; Kotzerke, J; Landry, G; Lombardo, E; Marschner, SN; Maus, J; Nikulin, P; Rogasch, JMM; Strouthos, I; van den Hoff, J; Zschaeck, S | 1 |
| Coskun, G; Hasbek, Z; Karabacak, U; Karadayi, K; Mollaoglu, MC; Turkan, H | 1 |
| Atay, LO; Aydos, U; Cebeci, S; Duzlu, M; Pula, D; Yeniceri, A; Yilmaz, M | 1 |
| Wang, X; Xue, B | 1 |
| Adileh, M; Asher, N; Ben-Betzalel, G; Ben-Yaacov, A; Grynberg, S; Lahat, G; Laks, S; Miodovnik, M; Mor, E; Nissan, A; Nizri, E; Schachter, J; Schtrechman, G; Shapira, R; Shimonovitz, M; Steinberg, Y; Stoff, R; Zippel, D | 1 |
| Iijima, Y; Ishikawa, M; Iwai, S; Mizoguchi, T; Motono, N; Uramoto, H | 1 |
| Gao, Y; Gauci, CM; Kim, TJ; Perera, DS | 1 |
| Betsuno, H; Imasato, N; Kamai, T; Kijima, T; Kokubun, H; Nakamura, G; Nishihara, D; Shimoda, H; Suzuki, I; Takei, K; Yashi, M | 1 |
| Fukugawa, Y; Hirai, T; Matsuyama, T; Murakami, D; Orita, Y; Oya, N; Saito, T; Shiraishi, S; Toya, R; Watakabe, T | 1 |
| Deng, Y; Wang, H; Xie, H; Zhang, W | 1 |
| Cheng, W; Huo, L; Liu, M; Zhou, J; Zhu, W | 1 |
| Kuribayashi, A; Miura, M; Nakamura, S; Wamasing, N; Watanabe, H | 1 |
| Chang, BS; Chen, YC; Chen, YH; Chu, SC; Lin, CB; Lin, HH; Liu, SH; Lue, KH | 1 |
| Chen, KC; Chiu, YJ; Chu, PY; Li, CY; Wang, TH | 1 |
| Akamine, T; Ito, K; Kusumoto, M; Nakagawa, K; Watanabe, H; Watanabe, SI; Yatabe, Y; Yoshida, Y; Yotsukura, M | 1 |
| Cai, L; Chen, X; Chen, Y; He, X; Liu, M; Shu, Q | 1 |
| He, Y; Li, P; Li, Y; Yang, J; Zhao, W | 1 |
| Duvernay, J; Majoufre, C; Schlund, M | 1 |
| Isaji, Y; Okazawa, H; Orisaka, M; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
| Avsar, G; Bayar, S; Cetindag, Ö; Deryol, R; Eroglu, A; Ertekin, SÇ; Hakseven, M; Karasoy, D | 1 |
| Asel, C; Bauer, B; Gabriel, M; Poier-Fabian, N; Rubicz, N; Zwittag, P | 1 |
| Cheng, J; Ren, C; Song, S; Sun, Y; Zhang, F; Zhang, J | 1 |
| Bao, W; Gu, S; Pan, YQ; Wang, M; Yang, Y | 1 |
| Sauvanet, A; Wartski, M | 1 |
| Çermik, TF; Dağ, S; Ergul, N; Yilmaz, B | 2 |
| Dehdashti, F; Grigsby, PW; Lin, AJ; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J; Siegel, BA; Thaker, PH; Wright, JD | 1 |
| Cho, YS; Chung, IK; Lee, JW; Lee, MS; Lee, SM; Son, MW | 1 |
| Du, S; Gao, S; Lu, Z; Sun, H; Xin, J | 1 |
| Hata, M; Kunisaki, C; Misumi, T; Ogino, I; Watanabe, S | 1 |
| Borm, KJ; Buschner, G; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Weber, W | 1 |
| Jiang, B; Shi, H; Teng, X; Wang, S; Yang, F | 1 |
| Cheng, MH; Li, J; Li, X; Liu, DD; Peng, F; Qin, L; Xie, L | 1 |
| Azawi, NH; Azizi, M; Bandini, M; Bouchelouche, K; Briganti, A; Foerster, B; Goffin, K; Hendricksen, K; Jensen, JB; Joniau, S; Ku, JH; Muilwijk, T; Necchi, A; Nielsen, AM; Schweitzer, D; Shariat, SF; Spiess, PE; van Rhijn, BWG; van Werkhoven, E; Vegt, E; Voskuilen, CS; Xylinas, E | 1 |
| Benedetti Panici, P; Di Donato, V; Di Pinto, A; Musella, A; Palaia, I; Petriglia, G; Santangelo, G | 1 |
| Gluskin, JS; Montane, G; Nanni, G; Perez, R | 1 |
| Budak, E; Yanarateş, A | 1 |
| Mimae, T; Okada, M | 1 |
| Carella, C; Ferrari, C; Naglieri, E; Nappi, AG; Niccoli Asabella, A; Rubini, G | 1 |
| Fujiwara, N; Hirano, Y; Koyama, I; Miyawaki, Y; Okamoto, K; Oya, S; Sakuramoto, S; Sato, H; Sugita, H; Yamaguchi, S; Yamane, T | 1 |
| Chen, H; Chen, X; He, H; Hu, H; Li, B; Li, N; Li, Y; Liu, S; Qian, B; Sun, Y; Xiang, J; Zhang, Y | 1 |
| Welz, S; Zips, D | 1 |
| Altin, D; Ersöz, CC; Ortaç, F; Soydal, Ç; Taşkin, S; Varli, B | 1 |
| Cho, YS; Choi, JY; Hyun, SH; Lee, KH; Lim, CH; Park, YJ; Shin, M | 1 |
| Dybvik, JA; Fasmer, KE; Gulati, A; Haldorsen, IS; Krakstad, C; Salvesen, Ø; Trovik, J; Ytre-Hauge, S | 1 |
| Fei, J; Guo, C; Niu, L; Wang, D; Zhang, J; Zheng, D | 1 |
| Hirai, T; Itoh, T; Kichikawa, K; Kobayashi, H; Marugami, N; Matsubara, S; Obayashi, C; Okada, H; Takahama, J; Uchiyama, T; Wakita, Y; Yamauchi, S | 1 |
| Bonacina, M; Buda, A; Crivellaro, C; De Bernardi, E; Delle Marchette, M; Di Martino, G; Elisei, F; Fruscio, R; Giuliani, D; Gotuzzo, I; Grassi, T; Guerra, L; Landoni, C; Landoni, F; Magni, S; Messa, C; Monaco, L | 1 |
| Baek, S; Hong, JH; Kim, ES; Kim, HJ; Kwon, KH; Park, MW; Yoon, DY; Yun, EJ | 1 |
| Bangiyev, L; Bernstein, C; Cattell, R; Cohen, J; Duanmu, H; Duong, TQ; Ha, R; Huang, P; Jambawalikar, S; Li, H; Liu, MZ; Ren, T; Vanguri, R; Wang, F | 1 |
| Altun, E; Basch, EM; Bjurlin, MA; Chen, RC; David, GU; Deal, AM; Eulitt, PJ; Godley, PA; Kim, WY; Lee, JK; Lin, W; Milowsky, MI; Nielsen, ME; Pruthi, RS; Ramirez, J; Rathmell, WK; Rose, TL; Sheikh, A; Smith, AB; Wallen, EM; Whang, YE; Wong, TZ; Woods, ME | 1 |
| Akashi, H; Imamura, T; Ishibashi, Y; Kodama, M; Matsumura, M; Morimitsu, Y; Muroya, D; Nishimura, T; Sato, H; Shimokobe, T; So, H; Taketani, S; Taniwaki, S; Wada, Y; Yoshimoto, Y | 1 |
| Arpacı, E; Olguner, AA; Orhan, E; Şahin, E; Yılmaz, H | 1 |
| Hirose, M; Ishibashi, H; Ohta, S | 1 |
| Liu, B; Niu, R; Shao, XL; Shao, XN; Shi, YM; Wang, JF; Wang, XS; Wang, YT; Yu, WJ; Zhang, FF | 1 |
| Cebryk, R; Chaber, R; Koptiuk, O; Kuczyński, K; Kwaśnicka, J; Olchowy, A; Olchowy, C; Pogodajny, Z; Popecki, P; Zaleska-Dorobisz, U; Łach, K; Łasecki, M | 1 |
| Dalci, K; Guney, IB; Kucuker, KA; Teke, ZT | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Arimura, H; Kai, Y; Matsuyama, T; Murakami, D; Nakayama, H; Orita, Y; Oya, N; Saito, T; Sakamoto, F; Shiraishi, S; Toya, R; Tsuda, N; Watakabe, T; Yoshida, R | 1 |
| Arioka, T; Fukuhara, R; Fukuma, S; Hiraki, T; Kaji, M; Kanazawa, S; Marunaka, H; Masaoka, Y; Ogawa, N; Shinya, T; Tanaka, T | 1 |
| Baynosa, J; Cheng, D; De Guzman, MD; Doyle, GM; Jones, MS; Kirgan, D; McNicoll, CF; Rivera, MR; St Hill, CR | 1 |
| Chen, X; Fu, Z; Li, Q; Yang, X | 1 |
| Dorgelo, B; Fazzi, M; Hanemaaijer, SH; Oosting, SF; Plaat, BEC; Steenbakkers, RJHM; Stormezand, GN; van der Laan, BFAM; van der Vegt, B; Witjes, MJH | 1 |
| Kim, DH; Kim, SJ | 1 |
| Atun, R; Hricak, H; Scott, AM; Vargas, HA; Ward, ZJ; Woo, S | 1 |
| Guo, Y; Qian, X; Zhai, X | 1 |
| Boura, J; LeRose, CC; Ramirez, CA | 1 |
| Akatli, A; Akyol, H; Asik, M; Balci, TA; Comak, A; Elmali, F; Kekilli, E; Koroglu, R; Kuslu, D; Simsek, FS; Ulutas, H; Yalcin, NC | 1 |
| Liu, Y; Luo, H; Zhang, J; Zhang, X | 1 |
| Flores, RM; Henschke, CI; Kaufman, A; Lee, DS; Wang, Y; Yankelevitz, DF; Yip, R; Zhu, Y | 1 |
| Chen, Y; Hou, Y; Hu, S; Hu, X; Li, W; Liu, X; Luo, Z; Shao, Y; Wang, Q; Wang, Y; Zhang, Y; Zhou, X | 1 |
| Endoh, H; Ichikawa, A; Nishizawa, N; Oriuchi, N; Satoh, Y; Shiozawa, S; Yamamoto, R | 1 |
| Handa, Y; Ito, H; Mimae, T; Miyata, Y; Nakayama, H; Okada, M; Tsutani, Y | 1 |
| Khalil, FK; Mohamed, AZ; Tanvetyanon, T; Toloza, EM | 1 |
| Donswijk, ML; Einerhand, SMH; Hendricksen, K; Mertens, LS; van der Poel, HG; van Gennep, EJ; van Rhijn, BWG | 1 |
| Akazawa, K; Asai, J; Katoh, N; Komori, S; Kotani, T; Maeno, M; Maruyama, A; Ohshita, A | 1 |
| Kim, HJ; Kim, NH; Kim, YH; Lee, SR | 1 |
| Abe, H; Aikou, S; Fukayama, M; Jinbo, K; Kawasaki, K; Koyama, K; Momose, T; Mori, K; Nishida, M; Nomura, S; Okumura, Y; Onoyama, H; Seto, Y; Takahashi, M; Urabe, M; Ushiku, T; Yagi, K; Yamashita, H; Yoshimura, S | 1 |
| Arai, Y; Bando, Y; Harada, M; Kubo, M; Otomi, Y; Otsuka, H; Shinya, T; Toba, H; Yamanaka, M | 1 |
| Davis, MR; Del Carmen, MG; Feltmate, CM; Goodman, A; Growdon, WB; Horowitz, NE; Lee, SI; St Laurent, JD | 1 |
| Aragaki, M; Fujiwara-Kuroda, A; Hida, Y; Kaga, K; Kato, T; Wakasa, S | 1 |
| Huang, X; Li, J; Xiong, Y; Yang, J | 1 |
| Asenov, YN; Dineva, SE; Grudeva, VV; Hadzhiyska, VH; Ilcheva, MG; Mladenov, KB; Nikolova, PN; Veneva, S | 1 |
| Dong, A; Dong, H; Ji, X | 2 |
| Ge, H; Liu, S; Pan, H; Song, S; Wang, C; Xia, L; Yang, Z; Zhou, Z | 1 |
| Adam, JA; Bipat, S; Mom, CH; Stoker, J; van Diepen, PR; van Eck-Smit, BLF | 1 |
| Holzmann, D; Hüllner, MW; Maurer, A; Meerwein, CM; Soyka, MB; Stadler, TM; Stolzmann, P | 1 |
| Can, C; Güzel, Y; Komek, H; Tasdemir, B | 1 |
| Kim, SJ; Kim, YS; Seol, HY | 1 |
| Arnold, C; Dejaco, D; Kofler, B; Moser, P; Riechelmann, H; Riedl, D; Schartinger, VH; Steinbichler, TB; Uprimny, C; Virgolini, I; Widmann, G | 1 |
| Iizuka, H; Ishiwata, Y; Kaneta, T; Nawata, S; Utsunomiya, D | 1 |
| Alessi, A; Bandini, M; Bianchi, M; Briganti, A; Capitanio, U; Capozza, A; Colecchia, M; Farè, E; Fossati, N; Gallina, A; Gandaglia, G; Giannatempo, P; Marandino, L; Montorsi, F; Necchi, A; Padovano, B; Pederzoli, F; Raggi, D; Salonia, A; Serafini, G | 1 |
| Alberto Vargas, H; Bajorin, DF; Bochner, BH; Capeanu, M; Dalbagni, G; Dason, S; Dean, LW; Di Paolo, PL; Donahue, TF; Mannelli, L; McPherson, VA; Meier, A; Rosenberg, JE; Wong, NC; Zheng, J | 2 |
| Findikcioglu, A; Guler, OC; Onal, C; Reyhan, M | 1 |
| González, E; Martí, A; Morón, S; Rojas, J | 1 |
| Bassett, RL; Le, VT; Whitman, GJ; Wong, FC | 1 |
| Bai, C; Cheng, Y; Guan, M; Jia, N; Xing, J; Ying, H | 1 |
| Cheon, M; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Park, YJ; Um, SW; Won, HH; Yoo, J; Zo, JI | 1 |
| Flavell, RR; Ha, PK; Strohl, MP; Yom, SS | 1 |
| Albenda, DG; Buchpiguel, CA; Cecconello, I; Duarte, PS; Junior, UR; Sallum, RAA; Takeda, FR; Tustumi, F | 1 |
| Berg, HF; Bozickovic, O; Engerud, H; Forsse, D; Haldorsen, IS; Halle, MK; Hoivik, EA; Krakstad, C; Trovik, J; Werner, HMJ; Woie, K | 1 |
| Allende Riera, AJ; Cabello García, D; Díaz Silván, A; Lara Martínez, MF; Vilahomat Hernández, O | 1 |
| Albrecht-Beste, E; Alslev, L; Bjerggaard Jensen, J; Bouchelouche, K; Cardoso Costa, J; Frahm Nielsen, T; Grønkaer Toft, B; Høyer, S; Ipsen, P; Jakobsen, JK; Predbjørn Krarup, K | 1 |
| Song, BI | 1 |
| Carré, A; Coutant, C; Dabakuyo, S; Kamga, AM; Rouffiac, M; Sellier, J | 1 |
| Beets-Tan, R; Castelijns, J; de Koekkoek-Doll, PK; Maas, M; Smit, L; van den Brekel, M; Vogel, W; Zavrakidis, I | 1 |
| Chen, J; He, Y; Li, C; Tian, Y; Wen, B | 1 |
| Dehdashti, F; Grigsby, PW; Lin, AJ; Markovina, S; Massad, LS; Mutch, DG; Powell, MA; Schwarz, JK; Siegel, BA; Thaker, PH | 1 |
| Bove, S; Collarino, A; Fragomeni, S; Garganese, G; Gentileschi, S; Moro, F; Rufini, V; Scambia, G; Sperduti, I; Testa, AC; Triumbari, EKA; Verri, D | 1 |
| Kim, K; Kim, SJ; Lee, SW; Shim, SR | 1 |
| Bom, HS; Cho, SG; Jeon, S; Kang, SR; Kim, DY; Kim, GJ; Kim, J; Kwon, SY; Lee, C; Min, JJ; Pyo, A; Song, HC; Yoo, SW | 1 |
| Abrahamsson, J; Almquist, H; Bläckberg, M; Brändstedt, J; Kollberg, P; Liedberg, F; Lyttkens, K; Simoulis, A; Sjödahl, G; Sörenby, A; Trägårdh, E | 1 |
| Akcay, MC; Dincer, M; Entok, E; Etiz, D; Saylisoy, S; Tepe, M; Toprak, U | 1 |
| Benjamin, J; Hephzibah, J; Mathew, D; Oommen, R; Pavamani, S; Rajnikanth, J; Shanthly, N | 1 |
| Brouwer, OR; Djajadiningrat, RS; Donswijk, ML; Graafland, NM; Horenblas, S; Ottenhof, SR; van der Noort, V; Vegt, E; Versleijen, MWJ | 1 |
| De Ridder, M; Everaert, H; Farid, K; Fontaine, C; Gorobets, O; Lamote, J; Nguyen, NP; Perrin, J; Storme, G; Van Parijs, H; Vanhoeij, M; Verfaillie, G; Verschraegen, C; Vinh-Hung, V | 1 |
| Garg, R; Jain, TK; Krishnaraju, VS; Kumar, R; Kumar, S; Mittal, BR; Sood, A | 1 |
| Gao, YJ; Li, N; Wang, XJ; Yang, Z; Yu, JY; Zhou, NN | 1 |
| Choi, KH; Hong, JH; Kim, MS; Kim, YS; Lee, YS; Park, EY; Song, JH; Sun, DI; Yoo, IR | 1 |
| Dercle, L; Girard, A; Rouanne, M; Vila Reyes, H | 1 |
| Aleman, BMP; Bartels-Rutten, A; Grootscholten, C; Sonke, JJ; Takken, SL; van de Kamer, JB; van Dieren, JM; van Sandick, JW; Vegt, E; Voncken, FEM | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Barshack, I; Ben-Haim, S; Chikman, B; Davidson, T; Halevy, A; Nissan, E; Shehade, N; Sklair-Levy, M; Zippel, D | 1 |
| Bley, TA; Brands, RC; Brumberg, J; Buck, AK; Dierks, A; Hartmann, S; Haug, L; Herterich, T; Kertels, O; Kübler, AC; Lapa, C; Linz, C; Müller-Richter, U | 1 |
| Buchwald, P; Frennered, A; Johnsson, A; Nilsson, MP; Sartor, H; Scherman, J; Trägårdh, E; Zackrisson, S | 1 |
| Gao, J; Gong, R; Gong, Y; Li, Z; Ma, Y; Yang, J; Zhu, J | 1 |
| Alizadeh, H; Balogh, P; Dezső, D; Hegedűs, N; Horváth, I; Jia, X; Máthé, D; Ritter, Z; Schmidt, E; Szöllősi, D; Tuch, D; Vyas, K; Zámbó, K | 1 |
| Araki, K; Harimoto, N; Higuchi, T; Hirai, K; Igarashi, T; Ishii, N; Kogure, N; Kubo, N; Mochida, Y; Shirabe, K; Tanaka, H; Tsukagoshi, M; Watanabe, A | 1 |
| Abe, K; Fujii, T; Kanamura, R; Kitamura, Y; Okamoto, H; Otozai, S; Suzuki, M; Takeda, N; Yoshii, T | 1 |
| Kave, M; Parooie, F; Sadegi, K; Salarzaei, M | 1 |
| Deveci, EK; Irkorucu, O; Kulahci, O; Tas, ZA | 1 |
| Ichinose, J; Kawaguchi, Y; Kondo, Y; Matsuura, Y; Mun, M; Nakao, M; Okumura, S | 1 |
| Hamada, K; Hashimoto, K; Honda, M; Kawamura, H; Nakayama, Y; Saginoya, T; Takada, T; Takano, Y; Todate, Y; Yamaguchi, H | 1 |
| Chen, X; Hua, J; Li, L; Liu, L; Liu, Q; Liu, Y | 1 |
| Guo, Y; Li, X; Sun, H; Xu, C; Yu, Y | 1 |
| Afshar-Oromieh, A; Alberts, I; Fischlin, C; Mingels, C; Rominger, A; Wartenberg, J | 1 |
| Choi, EK; Chong, A; Ha, JM; Jung, CK; Kim, SH; O, JH | 1 |
| Grigsby, PW; Hagemann, AR; Ioffe, YJ; Massad, LS; Mutch, DG; Powell, MA; Schwarz, JK; Thaker, PH | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Liang, JA; Shen, WC; Yen, KY | 1 |
| Cerny, T; Fehr, M; Fornaro, J; Güller, U; Horber, D; Knitel, M; Koeberle, D; Müller, J | 1 |
| Alongi, P; Broggi, S; Dell Oca, I; Di Muzio, NG; Fallanca, F; Fiorino, C; Gianolli, L; Incerti, E; Kirienko, M; Mapelli, P; Picchio, M; Vanoli, EG | 1 |
| Donker, M; Koolen, BB; Rutgers, EJT; Straver, ME; Valdés Olmos, RA; van der Noordaa, MEM; Vrancken Peeters, MJTFD | 1 |
| Alchawaf, A; Germetaki, T; Khoja, L; Kordatou, Z; Mansoor, W; Owen-Holt, V; Papaxoinis, G; Patrao, A; Stamatopoulou, S; Weaver, JMJ | 1 |
| Dettmer, MS; Giger, R; Sachpekidis, C; Wartenberg, J; Weidner, S | 1 |
| Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
| Athanasian, EA; Healey, JH; Ulaner, GA | 1 |
| Kim, JH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY | 1 |
| Gilhuijs, KG; Koolen, BB; Pengel, KE; Rodenhuis, S; Rutgers, EJ; Sonke, GS; Teixeira, SC; Valdés Olmos, RA; van Ramshorst, MS; Vogel, WV; Vrancken Peeters, MT; Wesseling, J | 1 |
| Chae, SY; Choi, HJ; Kim, HO; Kim, YT; Lee, JJ; Nam, JH; Park, JY; Song, IH; Sung, CO | 1 |
| Abraham, T; Bello, JA; Cho, JK; Gulko, E; Lee, AY; Lin, J; Moadel, RM; Neimark, M; Ow, TJ; Schiff, BA; Schlecht, NF; Shifteh, K; Smith, RV; Tassler, AB; Ustun, B; Valdivia, A | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, YI; Kim, YJ; Lee, DS; Paeng, JC | 1 |
| Hattori, A; Matsunaga, T; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Aktas, Z; Demirag, F; Ozturk, A; Tari, P; Yilmaz, A | 1 |
| Goldring, J; Lim, E; Mallorie, A; Patel, A; Wagner, T | 1 |
| Bernd, K; Gasparri, ML; Genoud, S; Mueller, MD; Papadia, A | 1 |
| Bruining, A; Hendricksen, K; Horenblas, S; Mertens, LS; van de Putte, EEF; van der Heijden, MS; van Rhijn, BWG; Vegt, E | 1 |
| Aaltonen, K; Abrahamsson, J; Engilbertsson, H; Gudjonsson, S; Liedberg, F; Patschan, O; Rydén, L; Sjödahl, G | 1 |
| Bhasin, DK; Das, A; Gupta, R; Mittal, BR; Nada, R; Rana, SS; Santhosh, S | 1 |
| Fu, Z; Han, A; Jin, F; Kong, L; Qu, B; Yu, J; Zhang, Y | 1 |
| Colella, S; Frost Clementsen, P; Konge, L; Naur, TMH; Richter Larsen, K; Sivapalan, P | 1 |
| An, YS; Han, SU; Lee, D; Lee, JH; Lee, KM; Lee, SJ; Park, S; Yoon, JK | 1 |
| Kan, Y; Wang, W; Yang, J; Yuan, L | 1 |
| Agha Hossein, F; Bakhshayesh Karam, M; Doroudinia, A; Kaghazchi, F; Mehrian, P; Safavi Nainee, A; Yousefi Koma, A | 1 |
| Bove, S; Collarino, A; Evangelista, MT; Fragomeni, SM; Garganese, G; Gentileschi, S; Giordano, A; Ieria, FP; Perotti, G; Rufini, V; Scambia, G; Zagaria, L | 1 |
| Bell, C; Bjerggaard Jensen, J; Bouchelouche, K; Høyer, S; Ipsen, P; Vind-Kezunovic, S | 1 |
| Falcoz, PE; Filosso, PL; Guerrera, F; Massard, G; Nigra, V; Oliaro, A; Renaud, S; Ruffini, E; Santelmo, N; Schaeffer, M; Solidoro, P | 1 |
| Chung, J; Kim, BS; Yoo, J; Yoon, HJ | 1 |
| Alongi, F; Alongi, P; Fersino, S; Fiorentino, A; Giaj-Levra, N; Mazzola, R; Ricchetti, F; Salgarello, M | 1 |
| Basturk, O; Corrias, G; Mannelli, L; Ragucci, M; Saba, L | 1 |
| Chan, ACY; Cheung, TT; Chiu, WH; Chok, KSH; Dai, WC; Lo, CM; Ma, KW; She, WH | 1 |
| Chu, YY; Hu, JH; Lin, CH; Liu, NJ; Tang, JH | 1 |
| Gvetadze, SR; Ilkaev, KD; Li, J; Lv, M; Sun, J; Xiong, P; Yang, X | 1 |
| Buda, A; Crivellaro, C; De Ponti, E; Di Martino, G; Elisei, F; Guerra, L; Guglielmo, P; La Manna, M; Landoni, C; Magni, S | 1 |
| Horenblas, S; Leone, AR; Ottenhof, SR; Spiess, PE; Vegt, E | 1 |
| Choi, YJ; Jang, JY; Ki, YK; Kim, H; Kim, IJ; Kim, SJ; Kim, WT; Pak, KJ; Seol, YM; Wang, SG; Yi, KI | 1 |
| Kang, BJ; Kim, H; Kim, SH; O, JH; Park, HL; Yoo, IR | 1 |
| Alifano, M; Charpentier, MC; Cusumano, G; Damotte, D; Fournel, L; Galia, A; Nicolosi, M; Regnard, JF; Strano, S; Terminella, A | 1 |
| Capurso, G; Delle Fave, G; Falconi, M; Iannicelli, E; Merola, E; Muffatti, F; Panzuto, F; Partelli, S; Pizzichini, P; Prosperi, D; Rinzivillo, M; Salgarello, M; Schillaci, O; Scopinaro, F | 1 |
| An, YS; Jung, Y; Kang, DK; Kim, TH | 1 |
| Chen, M; Chen, X; Rong, L; Sun, Q; Sun, Y; Wu, Q; Xu, H; Zhu, D | 1 |
| Atri, M; Bandos, AI; Gee, MS; Gold, MA; Lee, SI; Mannel, RS | 1 |
| Chen, L; Guo, R; Guo, Y; Li, WF; Lin, XP; Liu, LZ; Ma, J; Mao, YP; Peng, H; Sun, Y; Tang, LL; Tian, L; Zhang, X; Zhang, Y | 1 |
| Bockisch, A; Herrmann, K; Hoffmann, TK; Nagarajah, J; Poeppel, TD; Ruhlmann, V; Sauerwein, W; Umutlu, L; Veit, J | 1 |
| Guler, OC; Onal, C; Torun, N; Yildirim, BA | 1 |
| Cayci, Z; Khaja, S; Li, F; Ozturk, K; Rischall, M; Ustun, C | 1 |
| Brunotte, F; Chardin, D; Cochet, A; Desmoulins, I; Humbert, O; Riedinger, JM | 1 |
| Buwenge, M; Cammelli, S; Castellucci, P; Cilla, S; Cima, S; De Iaco, P; Fanti, S; Ferioli, M; Ferrandina, G; Galuppi, A; Macchia, G; Morganti, AG; Perrone, AM; Rubino, D; Salizzoni, E | 1 |
| Jiang, C; Jiang, S; Lyu, W; Ma, X; Wang, M; Xia, F; Zhang, Y | 1 |
| Emi, A; Goda, N; Kadoya, T; Kajitani, K; Masumoto, N; Okada, M; Sasada, S | 1 |
| Coca-Pelaz, A; de Bree, R; Ferlito, A; Kowalski, L; Leemans, CR; Lopez, F; Mendenhall, W; Quer, M; Rinaldo, A; Senft, A; Shaha, AR; Silver, CE; Strojan, P; Takes, RP | 1 |
| Luo, R; Shi, H; Xiu, Y; Yin, H; Zhang, H | 1 |
| Coolen, J; De Leyn, P; De Ruysscher, D; De Wever, W; Decaluwé, H; Depypere, L; Deroose, C; Dooms, C; Fieuws, S; Lambrecht, M; Moons, J; Nackaerts, K; Stanzi, A; Van Raemdonck, D; Vansteenkiste, J; Verbeken, E | 1 |
| Chae, YS; Jeong, SY; Jung, JH; Kim, HJ; Kim, WH; Lee, SW; Lee, WK; Park, HY | 1 |
| Hasumi, H; Hayashi, N; Ikeda, I; Inoue, T; Izumi, K; Kaneta, T; Kawahara, T; Kishida, T; Kobayashi, K; Kondo, K; Makiyama, K; Minamimoto, R; Miyoshi, Y; Muraoka, K; Nakaigawa, N; Namura, K; Osaka, K; Tateishi, U; Teranishi, JI; Uemura, H; Ueno, D; Yao, M; Yumura, Y | 1 |
| Aguloglu, N; Altindag, S; Can, C; Karaoglan, H; Kepenek, F; Komek, H; Morcali, H | 1 |
| Alharbi, AA; Aljared, A; Huellner, MW | 1 |
| Cho, JS; Eom, JS; Kim, BS; Kim, IJ; Kim, K; Kim, MH; Kim, SJ; Kim, YS; Lee, MK; Pak, K | 1 |
| Bussink, J; Carvalho, S; de Geus-Oei, LF; Lambin, P; Leijenaar, RTH; Oberije, C; Troost, EGC; van Elmpt, W; van Timmeren, JE | 1 |
| Bradbury, P; Cho, J; de Perrot, M; Elliott, HS; Hussey, D; Metser, U; Noam, T; Veit-Haibach, P | 1 |
| Elkhuizen, PHM; Groen, EJ; Loo, CE; Russell, NS; Stokkel, M; Straver, ME; van der Noordaa, MEM; van Duijnhoven, FH; Vrancken Peeters, MTFD | 1 |
| Alavi, A; Emamzadehfard, S; Gholami, S; Paydary, K; Seraj, SM; Shamchi, SP; Werner, TJ; Zadeh, MZ | 1 |
| Azmi, A; Gillham, C; Keenan, LG; McArdle, O; Rock, K; Salib, O | 1 |
| Hu, Y; Liu, Y; Shi, H | 1 |
| Carter, BW; Goense, L; Ho, L; Hofstetter, WL; Lin, SH; Maru, DM; Meijer, GJ; van Hillegersberg, R; van Rossum, PSN; Xi, M | 1 |
| Choi, S; Kim, S; Pahk, K | 1 |
| Beauregard, JM; Bergeron, M; Blouin, AC; Buteau, FA; Duchesnay, N; Dujardin, T; Fradet, V; Fradet, Y; Lacombe, L; Lavallée, E; Makao-Nguile, M; Pouliot, F; Tiguert, R | 1 |
| Hata, K; Ishihara, S; Kawai, K; Kiyomatsu, T; Morikawa, T; Nozawa, H; Tanaka, T; Watanabe, T | 1 |
| Arita, T; Fujiwara, H; Ikoma, H; Komatsu, S; Konishi, H; Kosuga, T; Kubota, T; Kudou, M; Kuriu, Y; Morimura, R; Murayama, Y; Nakanishi, M; Okamoto, K; Otsuji, E; Shiozaki, A; Shoda, K | 1 |
| Andree, C; Buck, AK; Gorin, MA; Higuchi, T; Javadi, MS; Lapa, C; Pienta, KJ; Pomper, MG; Rowe, SP; Werner, RA | 1 |
| Bechter, O; De Keyzer, F; De Paepe, KN; Dierickx, D; Janssens, A; Oyen, R; Vandecaveye, V; Verhoef, G; Wolter, P | 1 |
| Hamerla, G; Meyer, HJ; Purz, S; Surov, A | 1 |
| Ohmichi, M; Sasaki, S; Tanaka, T; Terai, Y; Tsuchihashi, H; Yamada, T; Yamamoto, K | 1 |
| Goense, L; Lam, MGEH; Meijer, GJ; Meziani, J; Ruurda, JP; van Hillegersberg, R; van Rossum, PSN; Wessels, FJ | 1 |
| Appetecchia, M; Barnabei, A; Giovanella, L; Lauretta, R; Romanelli, F; Trimboli, P; Valabrega, S | 1 |
| Duan, D; Jing, X; Li, H; Li, S; Pang, H; You, J | 1 |
| Asai, S; Fujioka, T; Harada, H; Michi, Y; Nakamura, S; Tateishi, U; Toriihara, A; Yamaga, E; Yoshimura, R | 1 |
| Al-Mamgani, A; Dijkema, T; Kaanders, JHAM; Raaijmakers, CP; Terhaard, CHJ; van den Bosch, S; Vogel, WV | 1 |
| Baek, S; Han, YM; Kim, ES; Moon, JY; Seo, YL; Yoon, DY; Yun, EJ | 1 |
| Cho, H; Choi, EC; Kim, H; Kim, SH; Koh, YW; Yun, M | 1 |
| Choi, JW; Han, M; Kim, SY; Lee, D; Lee, SJ | 1 |
| Ha, HK; Kim, SJ; Koo, PJ | 1 |
| Fang, Y; Liu, T; Ma, PQ; Sun, C; Xu, LB; Xu, SF; Yu, SJ; Zhang, WJ; Zhang, XX; Zhao, ZG | 1 |
| Adam, JA; Arkies, H; Hinnen, K; Laan, JJ; Mom, CH; Stalpers, LJ; Stoker, J; van Eck-Smit, BL; van Os, R; van Waesberghe, JH | 1 |
| Antoch, G; Grueneisen, J; Heusch, P; Klode, J; Pöppel, TD; Schaarschmidt, BM; Schadendorf, D; Stebner, V; Stoffels, I; Umutlu, L | 1 |
| Kim, HR; Nah, YW; Park, HW; Park, SH; Seo, M | 1 |
| Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S | 1 |
| Ishigame, T; Kofunato, Y; Murakami, Y; Nakano, K; Okada, R; Shimura, T; Suzuki, S; Takenoshita, S; Yashima, R | 1 |
| Kina, S; Miura, K; Nagano, N; Nagasaka, S; Sato, T; Sugiyama, H; Takeda, Y; Tsujimoto, Y | 1 |
| Dika, E; Diodato, S; Fanti, S; Gardini, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Veronesi, G; Zannetti, G | 1 |
| Bjerring, OS; Fristrup, CW; Hess, S; Høilund-Carlsen, PF; Mortensen, MB | 1 |
| Been, LB; Faut, M; Hoekstra, HJ; Kruijff, S; van Ginkel, RJ; van Leeuwen, BL | 1 |
| Fujii, T; Hirakata, T; Kurozumi, S; Nakazawa, Y; Obayashi, S; Shirabe, K; Tokuda, S; Yajima, R; Yanai, K | 1 |
| Date, H; Hamaji, M; Koyasu, S; Yamaguchi, K | 1 |
| Li, TC; Lin, J; Ouyang, ML; Tang, K; Xu, MM; Zheng, XW | 1 |
| Borm, KJ; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Vag, T; Voppichler, J; Weber, W | 1 |
| Chung, JH; Kim, S; Lee, SH; Pahk, K; Yi, E | 1 |
| Bonyadlou, S; Brunette, LL; Groshen, S; Ji, L; Lin, YG; Matsuo, K; Mehta, A; Roman, LD; Shuster, D; Sposto, R | 1 |
| Aktas, GE; Balta, C; Karamustafaoğlu, YA; Sarikaya, A; Sarikaya, İ; Süt, N | 1 |
| Cho, JY; Cho, YJ; Kim, ES; Kim, Y; Lee, CT; Lee, JH; Lee, SH; Lee, YJ; Leem, CS; Park, JS; Yoon, HI | 1 |
| Bae, SU; Baek, SK; Jeong, WK; Kim, HW; Song, BI; Won, KS | 1 |
| Ohmichi, M; Tanaka, T; Terai, Y; Yamada, T; Yamamoto, K | 1 |
| Shao, M; Wen, G; Zi, J | 1 |
| Bagetakos, I; Becker, M; Botsikas, D; Boudabbous, S; Da Cunha Afonso Barisits, AC; Kalovidouri, A; Lam, GT; Mainta, I; Montet, X; Picarra, M | 1 |
| Axelrod, D; Kim, E; Melsaether, AN; Pujara, AC | 1 |
| Kong, MC; Nadel, HR | 1 |
| Mahadevan, P; Pratap, T; Ramesh, H; Senthil, R; Visakh R, A | 1 |
| Fujino, H; Kajiura, K; Kondo, K; Miyoshi, H; Otani, T; Otsuka, H; Takizawa, H | 1 |
| Jeong, HJ; Joo, J; Jung, SY; Kang, HS; Kim, SK; Kim, TS; Kong, SY; Kwon, YM; Lee, DE; Lee, ES; Lee, H; Lee, KS; Lee, S; Park, IH; Park, S; Sim, SH | 1 |
| Kidd, EA; Koenig, JL; Kozak, MM; von Eyben, R | 1 |
| Choi, YY; Chung, MS; Lee, SJ; Shin, SJ | 1 |
| Gorin, MA; Joice, GA; Pierorazio, PM; Rowe, SP | 1 |
| Kang, WJ; Kim, HJ; Kim, S; Kim, SW; Kim, YT; Lee, CY; Lee, IO; Lee, JY; Nam, EJ | 1 |
| Dankbaar, JW; de Boer, M; de Bree, R; de Keizer, B; Peltenburg, B; Philippens, MEP; Terhaard, CHJ; Willems, SM | 1 |
| Anemona, L; Buonomo, OC; Caredda, E; Chiaravalloti, A; Marchese, PV; Orsaria, P; Palombi, L; Petrella, G; Portarena, I; Schillaci, O; Titka, B | 1 |
| Dong, C; Jiang, Y; Lü, X; Wang, Y; Xiao, Z; Xu, P | 1 |
| Ahmed, F; Chang, P; Makkar, J; Mutasa, S; Schwartz, L; Shaish, H | 1 |
| Cho, H; Kim, D; Kim, JH; Kim, SH; Lee, SH; Park, HS; Yun, M | 1 |
| Hu, J; Yang, Y; Zhu, D | 1 |
| Hwang, HK; Kang, CM; Lee, SH; Lee, WJ; Yun, M | 1 |
| Bernard, A; Brown, E; Foote, M; Gandhi, M; Liu, HY; Lock, G; McGrath, M; Milne, R; Panizza, BJ; Porceddu, SV | 1 |
| Antonowicz, S; Bradley, KM; El Kafsi, J; Findlay, JM; Gillies, RS; Maynard, ND; Middleton, MR; Segaran, A; Zhang, A | 1 |
| Barthe, N; Cazeau, AL; Fernandez, P; Hindié, E; Macgrogan, G; Morgat, C; Schollhammer, R; Vélasco, V; Vimont, D | 1 |
| Kawamura, M; Matsutani, N; Suzuki, S; Takahashi, Y | 1 |
| Berkowitz, AS; Eliashar, R; Frenkel, S; Hirshoren, N; Neuman, T; Weinberger, JM | 1 |
| Aubard, Y; Ceuca, A; Deluche, E; Gauthier, T; Lacorre, A; Legros, M; Margueritte, F; Mbou, VB; Monteil, J; Sallee, C; Tardieu, A | 1 |
| Abd Alkhalik Basha, M; Al-Molla, RM; Awad, NM; Elkholy, E; Hussein, RS; Refaat, R; Sobhi Hassan, M | 1 |
| Chantalat, E; Courbon, F; Ducassou, A; Ferron, G; Gabiache, E; Lusque, A; Martinez, A; Motton, S; Querleu, D; Voglimacci, M | 1 |
| Dehdashti, F; Grigsby, P; Lin, A; Ma, S; Markovina, S; Powell, M; Schwarz, J; Siegel, B | 1 |
| Burchardt, E; Cegla, P; Cholewinski, W; Roszak, A; Urbanski, B | 1 |
| Guren, MG; Hernes, E; Klotz, D; Malinen, E; Rekstad, BL; Rusten, E; Undseth, C | 1 |
| Ishikawa, Y; Jingu, K; Kadoya, N; Matsushita, H; Takahashi, N; Takeda, K; Umezawa, R; Yamamoto, T | 1 |
| Krombach, GA; Litzlbauer, D; Wörner, JM | 1 |
| Grigsby, PW; Lin, AJ; Ma, S; Markovina, S; Mutch, DG; Powell, MA; Schwarz, J | 1 |
| Bando, Y; Harada, M; Kinoshita, M; Kubo, M; Otomi, Y; Otsuka, H; Shinya, T; Takechi, K; Terazawa, K; Toba, H; Uyama, N; Yamanaka, M | 1 |
| Appold, S; Bandurska-Luque, A; Hoberück, S; Kohler, A; Kotzerke, J; Löck, S; Schreiber, A; Zips, D; Zöphel, K | 1 |
| Acar, E; Kaya, G; Turgut, B; Yiğit, S | 1 |
| Guo, Q; Li, K; Sun, H | 1 |
| Ahrweiller, F; Castelli, J; Cuvilliers, C; Palard-Novello, X; Vauléon, E | 1 |
| Bun, A; Fujimoto, Y; Fukui, R; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Ozawa, H; Yamakado, K | 1 |
| de Greef, BTA; Jansen, FH; Maaskant-Braat, AJG; Nieuwenhuijzen, GAP; Poodt, IGM; Schipper, RJ; Voogd, AC; Vugts, G; Wyndaele, DNJ | 1 |
| Ichinose, S; Ikeda, N; Uchida, O; Yamaguchi, G | 1 |
| Cho, DH; Cho, SG; Kang, SR; Kim, J; Kwon, SY; Na, MH; Song, HC; Yoo, SW | 1 |
| Beddell, G; Ivanov, N; Vaiciunaite, D | 1 |
| Eo, JS; Kim, WY; Lee, JB; Lee, S; Woo, SU | 1 |
| Canevari, C; De Nardi, P; Guarneri, G; Passoni, P; Rosati, R; Slim, N; Tamburini, A | 1 |
| Beets-Tan, RGH; Donswijk, ML; Jóźwiak, K; Kusters, M; Lahaye, MJ; Lambregts, DMJ; Maas, M; Min, LA; Roberti, S; Vegt, E; Vogel, WV; Zijlmans, HJ | 1 |
| Fangliang, L; Miao, H; Nan, L; Shanyuan, Z; Shaolei, L; Yue, Y; Yumei, L | 1 |
| Nguyen, BD; Ocal, TI; Seetharam, M | 1 |
| Auranen, A; Grénman, S; Hietanen, S; Hynninen, J; Kemppainen, J; Laasik, M; Seppänen, M | 1 |
| Cui, R; Wang, J; Wang, W; Zhao, Y | 1 |
| Hu, J; Wang, Y; Xue, F; Yan, Y; Zang, Y; Zhang, K | 1 |
| Li, Y; Wen, G; Zhang, J; Zhong, K | 1 |
| Lin, J; Ouyang, ML; Tang, K; Wang, LL; Xia, HW; Xu, MM; Zheng, XW | 1 |
| Hope, TA; Kassam, Z; Loening, A; McNamara, MM; Paspulati, R | 1 |
| Burzyńska-Śliwowska, J; Gugnacki, P; Jurgilewicz, DH; Mojsak, M; Samołyk-Kogaczewska, N; Sierko, E; Szczecina, K; Szumowski, P; Wojtukiewicz, MZ; Zuzda, K | 1 |
| Liu, Y; Lyu, L; Tao, XL; Wang, XY; Wu, N; Yang, L; Zhang, ZK | 1 |
| Aloia, TA; Chasen, B; Dioun, S; Erwin, W; Fleming, N; Frumovitz, M; Lu, KH; Ramirez, PT; Soliman, PT; Stewart, KI; Westin, SN; Wong, F | 1 |
| Croteau, E; Levasseur, MA; Marcotte, ME; Panet, F; Pavic, M; Richard, MA | 1 |
| Choi, EK; Kim, SJ; Kim, YK; Park, HL; Yoo, IR | 1 |
| Armani, M; Cadiot, G; Couvelard, A; Cros, J; de Mestier, L; Hentic, O; Lebtahi, R; Rebours, V; Ruszniewski, P; Sauvanet, A | 1 |
| Asai, S; Fujikura, M; Kurabayashi, T; Nakamura, S | 1 |
| Can, C; Komek, H | 1 |
| Adjei, A; Bogner, P; Cheney, R; Demmy, TL; Dexter, E; Hennon, M; Hutson, A; Kannisto, E; Morrison, C; Nwogu, CE; Picone, A; Reid, M; Tan, W; Yendamuri, S | 1 |
| Ahmad, N; Haerle, SK; Hany, TF; Huber, GF; Kastrinidis, N; Kuhn, FP | 1 |
| Gilhuijs, KG; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Chan, JY; Chow, VL; Wei, WI; Wong, ST | 1 |
| Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakabeppu, Y; Nakajo, M; Tanabe, H; Tani, A | 1 |
| Adachi, S; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Tsutani, Y; Yoshimura, M | 2 |
| Cheng, H; Huo, X; Shi, W; Wang, J; Wang, W | 1 |
| Cheng, CY; Ho, CL; Huang, WS; Lin, YH; Su, TF | 1 |
| Cintolo, JA; Pryma, DA; Tchou, J | 1 |
| Bal, A; Bhattacharya, A; Dahyia, D; Kaman, L; Raj, P; Singh, R | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 3 |
| Hattori, N; Hirata, K; Hosokawa, M; Itoh, K; Manabe, O; Oyama-Manabe, N; Takahashi, H; Tamaki, N | 1 |
| Enoki, Y; Fujimoto, S; Fukui, A; Morishita, H; Okuyama, Y; Yoshida, N | 1 |
| Jian, L; Jingui, L; Yongkui, L | 1 |
| Bender, K; Grünberg, K; Haberkorn, U; Kauczor, HU; Ott, K; Stange, A; von Gall, CC; Weber, MA; Zechmann, C | 1 |
| An, YS; Kim, BS; Kim, Y; Seok, JW | 1 |
| Hendel, HW; Jensen, BV; Nielsen, D; Skougaard, K | 1 |
| Hu, JW; Li, Y; Qi, L; Yang, ZQ; Ye, H | 1 |
| Apisarnthanarax, S; Christodouleas, JP; Corradetti, MN; Evans, TL; Fernandes, AT; Grover, S; Kim, M; Langer, CJ; Lee, TT; Lin, LL; Mitra, N; Pryma, DA; Rengan, R; Simone, CB; Stevenson, JP; Xanthopoulos, EP | 1 |
| Bastiaannet, E; Bonenkamp, JJ; Hoekstra, HJ; Hoekstra, OS; Koelemij, R; Niebling, MG | 1 |
| Aravkin, AY; Beatty, JD; Eissa, MJ; Porter, BA; Rogers, JV; Wang, CL | 1 |
| Aridome, K; Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakajo, M; Nihara, T; Nishimata, N; Shimaoka, S; Tanaka, S; Tani, A | 1 |
| Elkhuizen, PH; Koolen, BB; Rutgers, EJ; Valdés Olmos, RA; van der Leij, F; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Bae, JS; Baek, KH; Cha, BY; Jung, CK; Kang, MI; Kim, MH; Kim, SH; Ko, SH; Lee, JM; Lee, SH; Lim, DJ | 1 |
| Chen, L; Cui, JX; Li, T; Wei, B; Xi, HQ | 1 |
| Agarwal, R; Akin, EA; Ionita, JA; Sadeghi, N; Taheri, MR | 1 |
| Buda, A; Crivellaro, C; De Ponti, E; Elisei, F; Fruscio, R; Guerra, L; Messa, C; Montanelli, L; Pirovano, C; Signorelli, M | 1 |
| Corral, C; de Guevara, DL; Fariña, C; Fuentes, A; Pefaur, R | 1 |
| Beadle, BM; Debnam, JM; Frank, SJ; Fuller, CD; Garden, AS; Glisson, BS; Gunn, GB; Morrison, WH; Phan, J; Rosenthal, DI; Sturgis, EM | 1 |
| Akkas, BE; Demirel, BB; Vural, GU | 2 |
| Ahronowitz, I; Hernandez Pampaloni, M; Ibrahim, SF; McCalmont, TH; Ryan, JL; Yu, SS | 1 |
| Agrawal, A; Karapinar, U; Naiboglu, B; Ozer, E; Ozer, HG; Schuller, DE | 1 |
| Guler, OC; Onal, C; Oymak, E; Parlak, C; Reyhan, M | 1 |
| Balci, TA; Cengiz, E; Karyagar, S; Karyagar, SS; Koc, ZP; Öztürk, I; Sayc, Y | 1 |
| Chen, L; Chen, M; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Zhang, H; Zhang, L | 1 |
| Wang, N; Zhu, L | 1 |
| Beriwal, S; Fulay, S; Kabolizadeh, P | 1 |
| Cao, G; Lan, X; Liao, S; Yuan, H; Zhang, Y | 1 |
| Shim, KN; Yun, HW | 1 |
| Hanazaki, K; Kobayashi, M; Namikawa, T; Nogami, M; Ogawa, Y; Okabayshi, T | 1 |
| Blake, MA; Gervais, DA; Hahn, PF; Mueller, PR; Nguyen, ML; Sahani, DV; Uppot, RN | 1 |
| Kruse, M; Mercier, G; Paidpally, V; Sherry, SJ; Subramaniam, RM | 1 |
| Antke, C; Antoch, G; Boeck, I; Buchbender, C; Handschel, J; Heusch, P; Heusner, TA; Macht, S; Rieser, E; Scherer, A; Sproll, C; Terjung, J | 1 |
| Adams, G; Burmeister, B; Foote, M; Panizza, B; Porceddu, SV; Pryor, DI; Rowan, A | 1 |
| Bashir, MR; Jaffe, TA; Neville, AM; Thacker, JM; Uronis, HE | 1 |
| Heegaard, S; Prause, JU; Pryds, A; Toft, PB; Venzo, A | 1 |
| Ganeshan, D; Hanlon, R; Lewis-Jones, H; Prowse, PM; Prowse, SJ; Shaw, R; Wieshmann, H | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Lee, J; Lee, SW | 1 |
| Kumagai, K; Ohmichi, M; Okamura, T; Senzaki, H; Toyoda, M; Watanabe, C | 1 |
| Kaanders, JH; Merkx, MA; Oyen, WJ; Schinagl, DA; Slootweg, PJ; Span, PN; van den Hoogen, FJ | 1 |
| Farjah, F; Lou, F; Rizk, NP; Rusch, VW; Sima, C | 1 |
| Lupinacci, RM; Menegaux, F; Simon, JM; Spano, JP | 1 |
| Feldmann, HJ; Nestle, U; Schanne, D | 1 |
| Dai, Q; Jiang, YX; Lai, XJ; Zhang, B; Zhao, RN | 1 |
| Buda, A; Ceppi, L; Crivellaro, C; Cuzzucrea, M; Elisei, F; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M | 1 |
| Amant, F; Berteloot, P; Dauwen, H; Deroose, CM; Leunen, K; Neven, P; Op de Beeck, K; Timmerman, D; Van Calster, B; Vergote, I | 1 |
| Castiglioni, I; Dell'Oca, I; Gallivanone, F; Gianolli, L; Kirienko, M; Mapelli, P; Messa, C; Picchio, M; Villa, E | 1 |
| Henzler, T; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Wasser, K | 1 |
| Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vogel, WV; Vrancken Peeters, MJ | 2 |
| Abe, K; Akamatsu, G; Baba, S; Honda, H; Isoda, T; Kitamura, Y; Maruoka, Y; Mizoguchi, N; Sasaki, M | 1 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Embry, S; Hudson, K; Warren, LA | 1 |
| Peller, PJ | 1 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Fish, LM | 1 |
| Dubray, B; Lazarescu, I; Nkhali, L; Pradier, O; Thureau, S | 1 |
| Aogi, K; Kadoya, T; Kiyoto, S; Masumoto, N; Okada, M; Sugawara, Y | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Park, JO; Yoo, IeR | 2 |
| Doki, Y; Kurokawa, Y; Miyata, H; Mori, M; Murakami, K; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M | 1 |
| Kataoka, M; Kiyoto, S; Mochizuki, T; Nakajima, N; Ochi, T; Ohsumi, S; Sugawara, Y | 1 |
| d'Amico, A; Przeorek, C; Turska-d'Amico, M | 1 |
| Hosokawa, M; Itoh, K; Kikkawa, T; Kinoshita, Y; Kusumi, T; Nishida, Y; Sakashita, K; Sasaki, S; Takenouchi, T; Uemura, S; Yamada, H | 1 |
| Booth, K; Hanna, GG; Lynch, T; McAleese, J; McGonigle, N; McGuigan, J; McManus, KG; O'Sullivan, J | 1 |
| Kim, EK; Park, JH; Park, WJ | 1 |
| Akamatsu, G; Baba, S; Mitsumoto, K; Sasaki, M; Taniguchi, T; Tsutsui, Y | 1 |
| Byun, BH; Choi, CW; Kim, EK; Kim, HA; Lee, SS; Lim, SM; Noh, WC; Park, J | 1 |
| Chen, Z; Shi, X; Wang, X; Yi, C; Zhang, B; Zhang, X | 1 |
| Ceriani, L; Giovanella, L; Paone, G; Perriard, U; Treglia, G | 1 |
| Hasanzadeh, M; Kadkhodayan, S; Kakhki, VR; Sadeghi, R; Shahriari, S; Treglia, G; Yousefi, Z; Zakavi, SR | 1 |
| Ahn, SH; Chae, SY; Gong, GY; Kim, HO; Lee, JJ; Lee, JW; Moon, DH; Park, SH; Ryu, JS; Seo, MJ; Son, BH | 1 |
| Feng, Y; Li, S; Ma, Y; Wang, Y; Yang, Y; Zhao, B; Zheng, Q | 1 |
| Chung, SK; Chung, YA; Jeon, HM; Kim, SH; Kim, YS; Oh, JK; Park, YH | 1 |
| An, YS; Jung, YS; Kang, DK; Kim, KS; Kim, TH; Lee, DH; Lee, SJ; Yim, H; Yoon, JK | 1 |
| Ho, TY; Lee, LY; Liao, CT; Lin, CY; Tseng, JR; Wang, HM; Yen, TC | 1 |
| Chung, JK; Im, HJ; Kim, JY; Kim, SK; Kim, TS; Lee, ES; Park, SY; Yoon, HJ | 1 |
| Bernsdorf, M; Graff, J | 2 |
| Kosaka, T; Kuwano, H; Mogi, A; Tanaka, S; Yamaki, E | 1 |
| Chen, ZF; Li, ZP; Rao, LJ; Shi, XC; Wang, XY; Yi, C; Yi, QQ; Zhang, XS | 1 |
| Dong, A; Wang, Y; Zhai, Z; Zhang, J; Zuo, C | 1 |
| Cheon, GJ; Choe, JG; Kim, DS; Oh, SY; Park, BJ; Park, TG; Yu, YD | 1 |
| Dasgupta, P; Evison, F; Goodfellow, H; Hughes, P; Hughes, S; Khan, MS; O'Brien, T; Rankin, S; Rottenberg, G; Viney, Z | 1 |
| Aguiló, R; Arriola, E; Belda-Sanchis, J; Curull, V; Pijuan, L; Rodríguez de Dios, N; Rodríguez-Fuster, A; Sánchez-Font, A; Suárez-Piñera, M; Taus, Á; Vollmer, I; Zuccarino, F | 1 |
| Brooks, FJ; Grigsby, PW | 1 |
| Balm, AJ; Hamming-Vrieze, O; Lange, CA; Lodder, WL; Pameijer, FA; Van Den Brekel, MW; Van Velthuysen, ML; Vogel, WV | 1 |
| Akutsu, Y; Fujishiro, T; Gunji, H; Hanaoka, T; Hoshino, I; Imanishi, S; Kono, T; Matsubara, H; Murakami, K; Narushima, K; Ohira, G; Okazumi, S; Shiratori, T; Shuto, K; Tochigi, T; Tohma, T; Uesato, M | 1 |
| Eaton, A; Fazio, M; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; Lilienstein, J; Morris, PG; Patil, S; Ulaner, GA | 1 |
| Ayez, N; de Ridder, J; de Wilt, JH; Oyen, WJ; Verhoef, C; Wiering, B | 1 |
| Cho, A; Choi, YJ; Hwang, HS; Jeong, YH; Kang, WJ; Kim, HJ; Lee, JD; Lee, JH; Yun, M | 1 |
| Bodell, MA; Kraus, ES; Lipson, EJ; Sharfman, WH | 1 |
| Hida, Y; Hirano, S; Kaga, K; Matsui, Y; Muto, J; Nakada-Kubota, R; Ohtaka, K; Okamoto, S; Tamaki, N | 1 |
| Ansaloni, L; Baiocchi, GL; Capponi, MG; Coniglio, A; D'Ugo, D; De Manzoni, G; Di Leo, A; Giacopuzzi, S; Giulini, SM; Marchet, A; Marrelli, D; Morgagni, P; Nitti, D; Pacelli, F; Rosa, F; Roviello, F; Saragoni, L; Tiberio, GA; Verlato, G | 1 |
| Jo, HJ; Kim, IJ; Kim, S; Kim, SJ | 1 |
| Cheng, MH; Duan, XB; Fan, W; Xie, LJ; Xu, ZQ | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Derlin, T; Hofheinz, F; Köhler, C; Marnitz, S; Michel, R; Prasad, V; Rosner, C; Steffen, IG | 1 |
| Ela Bella, AJ; Fan, W; Fu, JH; Lin, P; Luo, KJ; Rong, TH; Yang, H; Zhang, YR | 1 |
| Barizzi, J; Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
| Aide, N; Allouache, D; Bellevre, D; Blanc Fournier, C; Crouet, H; Desmonts, C; Dugué, AE; Grellard, JM; Guilloit, JM; Levy, C; Switsers, O | 1 |
| Burke, L; Henry, MT; Hinchion, J; Kennedy, MP; Maher, MM; McCarthy, J; McCarthy, L; McSweeney, S; Moloney, F; O'Regan, K; Ryan, D | 1 |
| Banfalvi, G; Kahlik, B; Kertai, P; Kiss, A; Nagy, G; Nemeth, E; Trencsenyi, G | 1 |
| Aebersold, DM; Cihoric, N; Klaeser, B; Krüger, K; Lössl, K; Tapia, C | 1 |
| Hashimoto, J; Ichikawa, T; Imai, Y; Kikuchi, T; Yabe, M | 1 |
| Annunziata, S; Ayati, N; Caldarella, C; Giovanella, L; Sadeghi, R; Treglia, G | 1 |
| Campbell, A; McCarthy, M; McIvor, J; Siew, T | 1 |
| Choi, JY; Choi, YS; Hyun, SH; Kim, BT; Kim, HS; Lee, KH; Moon, SH; Shim, YM; Zo, JI | 1 |
| Ciancia, G; Cirillo, M; Cozzolino, I; Pane, F; Pettinato, G; Picardi, M; Pugliese, N; Quintarelli, C; Salvatore, C; Zeppa, P | 1 |
| Chan, WW; Choy, TS; Ho, PP; Khong, PL; Kwong, DL; Lam, KO; Lee, EY; Lee, VH; Leung, DK; Leung, TW | 1 |
| Borbély, K; Kásler, M; Németh, Z | 1 |
| Castelli, P; Crippa, S; Falconi, M; Laiti, S; Partelli, S; Salgarello, M; Spinelli, AE; Tamburrino, D; Zamboni, G | 1 |
| Benedetti Panici, P; Fischetti, M; Lio, S; Pecorella, I; Perniola, G; Tomao, F | 1 |
| Beuthien-Baumann, B; Gudziol, V; Kitzler, HH; Kotzerke, J; Laniado, M; Maus, J; Platzek, I; Popp, M; Schneider, M; Schramm, G; van den Hoff, J | 1 |
| Wu, CX; Zhu, ZH | 1 |
| Cortot, A; Hossein-Foucher, C; Olivier, A; Petyt, G; Scherpereel, A | 1 |
| Lu, P; Sun, Y; Yu, L | 1 |
| Blake, P; Chan, D; Fielding, P; Foley, KG; Karran, A; Lewis, WG; Roberts, SA | 1 |
| Cervino, AR; Evangelista, L | 1 |
| Coolen, J; De Wever, W; Verschakelen, J | 1 |
| Kim, C; Kim, J; Kim, YT; Paeng, JC; Ryu, JK | 1 |
| Arya, S; Deshmukh, A; Rane, P | 1 |
| Deng, H; Hu, S; Jia, Z; Shen, G | 2 |
| Groen, H; Hollema, H; Pavlov, K; Plukker, JT; Pruim, J; Pultrum, BB; Schreurs, LM; Smit, JK | 1 |
| Cheng, W; Fu, H; Liang, S; Tang, Y; Wang, H; Wu, S; Wu, Z; Ye, Z | 1 |
| Doki, Y; Fujiwara, Y; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Baba, H; Baba, Y; Ida, S; Imamura, Y; Iwagami, S; Karashima, R; Miyamoto, Y; Sakamoto, Y; Watanabe, M; Yoshida, N | 1 |
| Hoermann, K; Klohr, S; Li, CY; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| An, YS; Jo, KS; Kim, CH; Kwon, SH; Lee, DH; Lee, SJ; Shin, YS; Yoon, JK | 1 |
| Ding, L; Dong, L; Liu, B; Liu, M; Song, Y | 1 |
| Gleeson, N; Kamran, MW; Meghen, K; O'Toole, F; Saadeh, FA; Wahab, AN | 1 |
| Ahn, BC; Hong, CM; Jeong, SY; Kim, DH; Lee, J; Lee, SW; Song, BI | 1 |
| Byun, BH; Choi, CW; Kim, BI; Lim, I; Lim, SM; Moon, SM; Shin, US | 1 |
| Driscoll, DO; Halpenny, D; Johnston, C; Keogan, M; Sheehy, N | 1 |
| Batstone, M; Krishnamoorthy, R; Ravi Kumar, AS | 1 |
| Isomoto, I; Kojima, Y; Kubota, K; Kuroki, Y; Mukai, H; Ohnuki, K; Ohsumi, S; Tozaki, M | 1 |
| Cho, KJ; Joo, YH; Kim, CS; Kim, MS; Kim, SY; Nam, IC; Park, JO; Yoo, IR | 1 |
| Beiderwellen, K; Buchbender, C; Gomez, B; Heusch, P; Köhler, J; Nensa, F; Reis, H; Ruhlmann, V; Schaarschmidt, B; Sivanesapillai, R | 1 |
| Ariyaratnam, P; Beddow, E; Darr, A; Dusmet, M; Granato, F; Greenwood, A; Iyer, S; Kirk, A; Leung, M; Lim, E; Loubani, M; Marchbank, A; Mohamed, S; Naidu, B; Nicholson, AG; Pattenden, HA; Shackcloth, M; West, D | 1 |
| Anelli, V; Covello, R; Kayal, R; Manciocco, V; Marucci, L; Mercante, G; Pellini, R; Pichi, B; Sanguineti, G; Sciuto, R; Sperduti, I; Spriano, G; Turri-Zanoni, M; Vidiri, A | 1 |
| Ajani, JA; Carter, BW; Correa, AM; Cuellar, SL; Erasmus, JJ; Hofstetter, WL; Komaki, R; Lee, JH; Macapinlac, HA; Swisher, SG; Welsh, JW | 1 |
| Di Perri, D; Geets, X; Lee, J; Sterpin, E; Wanet, M | 1 |
| Brunotte, F; Cochet, A; Cormier, L; Créhange, G; Humbert, O; Kanoun, S; Walker, PM | 1 |
| Chen, MK; Hong, SF; Lai, YS; Lee, KW | 1 |
| Guo, HM; Han, JK; Lu, YJ; Lv, K; Wu, ZX; Zhang, K | 1 |
| Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Grueneisen, J; Heusch, P; Kraff, O; Lauenstein, TC; Ruhlmann, V; Umutlu, L | 1 |
| Choi, WH; Chung, SK; Kim, YK; Lee, KY; Park, HL; Wang, YP; Yoo, IeR | 1 |
| Botto, H; Girma, A; Hervé, JM; Le Stanc, E; Lebret, T; Letang, N; Neuzillet, Y; Radulescu, C; Rouanne, M; Vilain, D; Yonneau, L | 1 |
| Bashirzadeh, F; Bhatt, M; Fielding, D; Hundloe, J; Nguyen, P; Ravi Kumar, AS; Ware, R | 1 |
| Cheze Le Rest, C; Fayad, H; Fernandez, P; Lamare, F; Le Pogam, A; Pradier, O; Valette, G; Visvikis, D | 1 |
| Dong, M; Li, W; Li, Y; Sun, X; Xing, L | 1 |
| Borms, M; Cocquyt, V; Kruse, V; Maes, A; Pottel, H; VAN Belle, S; VAN DE Wiele, C | 1 |
| Huang, ZQ; Li, J; Li, X; Liu, QW; Tan, HH; Tan, R; Yao, SZ | 1 |
| Doudouh, A; El Hammoumi, M; El Marjany, M; Kabiri, el H; Mansouri, H; Moussaoui, D | 1 |
| Bae, YT; Kang, T; Kim, JY; Kim, S; Lee, SH | 1 |
| Asao, T; Fujii, T; Kuwano, H; Morita, H; Tsutsumi, S; Yajima, R; Yamaguchi, S | 1 |
| Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R | 1 |
| De Ruysscher, D; Eriksson, J; Even, AJ; Hoebers, FJ; Houben, RM; Lambin, P; Mottaghy, FM; Ollers, MC; Reymen, B; Troost, EG; van Elmpt, W; Windhorst, AD; Zegers, CM | 1 |
| Cho, JH; Cho, KJ; Chun, BJ; Joo, YH; Kim, CS; Kim, MS; Nam, IC; Yoo, IeR | 1 |
| Cho, YL; Chong, GO; Hong, DG; Jeong, SY; Lee, DW; Lee, YH; Lee, YS; Park, JY | 1 |
| Elliott, JA; Halpenny, D; Johnston, C; King, S; Malik, V; Muldoon, C; O'Farrell, NJ; Reynolds, JV | 1 |
| Aoki, D; Banno, K; Iida, M; Irie, H; Kisu, I; Masugi, Y; Murakami, K; Nogami, Y; Okuda, S; Tanaka, K; Tominaga, E | 1 |
| Cheon, GJ; Chung, JK; Kang, KW; Kim, EE; Lee, DS; Pak, K | 1 |
| Arnould, L; Bachelot, T; Berriolo-Riedinger, A; Bougnoux, P; Coeffic, D; Coudert, B; Coudert, M; Dupré, PF; Ferrero, JM; Gabelle, P; Giard, S; Hernandez, J; Kerbrat, P; Kerrou, K; Mouret-Reynier, MA; Paintaud, G; Petit, T; Pierga, JY; Prevost, JB; Thibault, G | 1 |
| Beets-Tan, RGH; Lobbes, MBI; Moossdorff, M; Schipper, RJ; Smidt, ML | 1 |
| Chu, C; Gao, X; Li, Y; Liu, W; Lu, P; Wang, W; Yu, L | 1 |
| Chang, HT; Chiu, YL; Hu, C; Liu, RS; Peng, NJ | 1 |
| Boonya-ussadorn, T; Choi, WH; Chung, SK; Hyun, J; Kim, SH; Yoo, IeR | 1 |
| Doki, Y; Fujiwara, Y; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Dunleavy, K; Redman, M; Smith, SD | 1 |
| Choi, JY; Jung, HK; Jung, SA; Kim, SE; Shim, KN; Yoo, K | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Ko, SF; Liao, CT; Lin, CY; Lin, YC; Ng, SH; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Jeon, TY; Kim, HJ; Kim, YW; Lee, BJ; Lee, JC | 1 |
| Harada, H; Kikuchi, M; Kishimoto, I; Shinohara, S; Suehiro, A | 1 |
| Chen, Y; Guo, L; Hu, X; Huang, J; Ji, C; Ling, C; Xu, H; Zhang, B; Zhu, W | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Peters, TT; Senft, A; Witte, BI | 1 |
| Burmeister, BH; Burmeister, E; Chua, B; Foote, MC; Panizza, B; Porceddu, SV; Pryor, D; Sjövall, J | 1 |
| Buchbender, C; Gomez, B; Grueneien, J; Grueneisen, J; Heusch, P; Köhler, J; Nensa, F; Reis, H; Ruhlmann, V; Schaarschmidt, BM; Umutlu, L | 1 |
| Chen, SW; Hsieh, TC; Kao, CH; Lin, YC; Wang, YC; Yang, SN; Yen, KY | 1 |
| Sun, R; Tang, X; Yang, Y; Zhang, C | 1 |
| Groen, HJM; Klinkenberg, TJ; van den Berg, LL; Widder, J | 1 |
| Frey, S; Hoermann, K; Piniol, R; Sadick, H; Sadick, M; Schoenberg, SO; Weiss, C | 1 |
| Ahn, H; Hong, JH; Hong, S; Jeong, IG; Kim, CS; You, D | 1 |
| Kang, WJ; Kim, J; Koh, YW; Lee, HJ; Lee, JH; Woo, HY | 1 |
| Baumann, S; Browning, CM; Craft, JF; Renker, M; Schoepf, UJ | 1 |
| Hruby, G; Jones, M; Martin, J; Rutherford, N; Solomon, M | 1 |
| Cheng, JC; Cheng, MF; Lee, JM; Liu, CJ; Tzen, KY; Yen, RF | 1 |
| Brade, J; Buesing, KA; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Sperk, E; Suetterlin, M; Sutton, EJ; Wasgindt, S; Wasser, K | 1 |
| Abe, M; Cong, Y; Kato, Y; Nomori, H; Sugimura, H | 1 |
| Fu, DL; Guan, YH; Jin, C; Wang, XY; Yang, F; Zhang, HW | 1 |
| Alberts, FM; Bloemena, E; Castelijns, JA; Comans, EF; de Bree, R; de Graaf, P; Hoekstra, OS; Leemans, CR; Sanchez, E; Schouten, CS; Witte, BI | 1 |
| Adachi, S; Akagi, K; Dono, K; Hatano, H; Imamura, H; Iwazawa, T; Komori, T; Masuike, Y; Morita, S; Noda, T; Oshima, K; Tanida, T; Yasumoto, T | 1 |
| Chikamatsu, K; Kaira, K; Sakakura, K; Toyoda, M; Tsushima, Y; Yokobori, Y | 1 |
| Asayama, Y; Baba, S; Fujita, N; Honda, H; Kitamura, Y; Kubo, Y; Morita, K; Nishie, A; Shirabe, K; Takayama, Y; Ushijima, Y | 1 |
| Hagiwara, N; Matsutani, T; Miyashita, M; Nomura, T; Uchida, E; Wachi, E; Yamashita, N | 1 |
| Ang, KK; Foote, R; Garden, AS; Harari, P; Harris, J; Holland, J; Jones, CU; Le, QT; Levering, A; Opanowski, A; Rosenthal, DI; Schwartz, DL; Trotti, AM; Yao, M; Zhang, Q | 1 |
| Emri, G; Erdei, I; Fedinecz, N; Galuska, L; Gellén, E; Janka, E; Juhász, I; Lukács, R; Péter, Z; Remenyik, É; Sántha, O | 1 |
| Chen, M; Li, Y; Shao, T; Yu, L | 1 |
| He, X; Huo, Y; Ma, C; Shao, M; Sun, L | 1 |
| Clavero R, JM; Furnaro L, F; Ladrón de Guevara H, D; Lazo P, D; Pardo B, C; Pefaur D, R; Piottante B, A; Rodríguez D, P; Yévenes A, S | 1 |
| Aoki, D; Banno, K; Iida, M; Irie, H; Masugi, Y; Murakami, K; Nogami, Y | 1 |
| Abramson, RG; Abramson, VG; Arlinghaus, LR; Chakravarthy, AB; Jones-Jackson, LB; Lambert, KF; Williams, J; Yankeelov, TE | 1 |
| Carlson, ER; Heidel, RE; Schaefferkoetter, JD | 1 |
| Cho, SH; Chung, HW; Hong, S; Kim, SN; Kim, WY; Lee, SJ; Lim, JY; So, Y | 1 |
| Dong, M; Liu, K; Ma, S; Wang, Y; Yao, Y; Zhou, J | 1 |
| Asano, T; Futamura, M; Kanematsu, M; Kobayashi, K; Mori, R; Morikawa, A; Morimitsu, K; Nawa, M; Yoshida, K | 1 |
| Burger, IA; Haerle, SK; Huber, GF; Hüllner, M; Müller, J; Strobel, K | 1 |
| Iyamu, I; Mathews, D; Peng, F; Truelson, J; Wachsmann, J | 1 |
| Hoshikawa, M; Kimura, H; Kurimoto, N; Marushima, H; Nakamura, H; Saji, H; Tagaya, R; Takagi, M | 1 |
| Bristow, RE; Eskander, RN; Grove, N; Zheng, M | 1 |
| Biersack, HJ; Buermann, J; Essler, M; Gärtner, FC; Skowasch, D | 1 |
| Bernstine, H; Domachevsky, L; Galili, R; Groshar, D; Saute, M | 1 |
| Chang, TC; Chang, YC; Hong, JH; Kao, WH; Lai, CH; Lin, SY; Ng, KK; Tsai, CS | 1 |
| Hall, NC; Martin, EW; Murrey, DA; Povoski, SP; Wright, CL | 1 |
| Ahn, BC; Ahn, D; Choi, JH; Kim, H; Na, KJ; Sohn, JH | 1 |
| Lin, R; Su, M; Wei, H; Zhang, X; Zhao, L; Zou, C | 1 |
| Katano, A; Nakagawa, K; Okuma, K; Takenaka, R; Yamashita, H | 1 |
| Altini, C; Di Palo, A; Fanelli, M; Ferrari, C; Moschetta, M; Niccoli Asabella, A; Rubini, G | 1 |
| Fakhry, C; Kang, H; Kiess, AP; Marcus, C; Pasha, MA; Subramaniam, RM | 1 |
| Kang, WJ; Kim, J; Koh, YW; Lee, JH; Shin, NY; Sohn, B | 1 |
| Freiwald-Chilla, B; Froehlich, JM; Hauser, N; Kubik-Huch, RA; Queiroz, MA; Veit-Haibach, P; von Schulthess, G | 1 |
| Bertagna, F; Bertoli, M; Evangelista, L; Giubbini, R; Saladini, G; Stela, T | 1 |
| Choi, EK; Chung, YA; Oh, JK | 1 |
| Fujii, Y; Fukui, I; Kihara, K; Kohno, A; Koizumi, M; Komai, Y; Masuda, H; Sakai, Y; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yoshida, S; Yuasa, T | 1 |
| Biermann, M; Bjørge, L; Haldorsen, IS; Husby, JA; Magnussen, IJ; Reitan, BC; Salvesen, HB; Salvesen, ØO; Trovik, J | 1 |
| Arlandini, A; Bandelloni, R; Foppiani, L; Massollo, M; Piccardo, A | 1 |
| Ito, H; Mimae, T; Mimura, T; Miyata, Y; Nakayama, H; Okada, M; Okumura, S; Yoshimura, M | 1 |
| Eigentler, T; Pfannenberg, C; Schüle, SC | 1 |
| Chisin, R; Freedman, N; Klein, M; Orevi, M; Peretz, T; Tahover, E; Uziely, B | 1 |
| Jeon, YK; Kim, BH; Kim, H; Kim, IJ; Kim, K; Kim, SJ; Kim, SS; Kim, WJ; Kim, YK | 1 |
| An, YS; Jeon, GS; Jung, YS; Kang, DK; Kim, TH; You, S | 1 |
| Baek, JH; Cho, SH; Choi, YJ; Kim, DY; Kim, HO; Kim, N; Kim, SY; Koh, MJ; Lee, JH; Yoon, RG | 1 |
| Berriolo-Riedinger, A; Brunotte, F; Charon-Barra, C; Cochet, A; Coutant, C; Desmoulins, I; Fumoleau, P; Humbert, O; Kanoun, S; Lorgis, V; Riedinger, JM | 1 |
| Chen, F; Date, H; Hasegawa, S; Hatano, E; Iwamoto, M; Kawada, K; Nakamoto, Y; Sakai, Y; Toda, K; Togashi, K; Uemoto, S | 1 |
| Hata, H; Hirata, K; Imafuku, K; Inamura, Y; Kitamura, S; Sakashita, T; Shimizu, H | 1 |
| Ahsanuddin, S; Ashamalla, H; Foster, A; Mattes, MD; Moshchinsky, AB; Rimner, A; Rizk, NP; Weber, WA; Wu, AJ | 1 |
| Bom, HS; Chong, A; Jung, SH; Kim, J; Kwon, SY; Min, JJ; Song, HC | 1 |
| Cho, H; Choi, JY; Kim, HK; Kim, J; Lee, HY; Lee, KS; Um, SW | 1 |
| Baek, JH; Choe, J; Choi, CM; Kim, HJ; Kim, MY | 1 |
| Ban, MJ; Chang, JW; Choi, EC; Hong, HJ; Kim, WS; Koh, YW; Shin, YS | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Son, SH; Song, BI | 1 |
| Alslev, L; Bouchelouche, K; Costa, JC; Høyer, S; Ipsen, P; Jakobsen, JK; Jensen, JB; Krarup, KP; Nerstrøm, H; Sommer, P; Toft, BG | 1 |
| Chung, MH; Jung, NY; Kang, BJ; Kim, SH; Park, SY | 1 |
| Cho, A; Jo, K; Lee, JD; Lee, JW; Noh, SH; Yun, M | 1 |
| Fisker, RV; Gade, M; Kubik, M; Petersen, LJ; Thorlacius-Ussing, O | 1 |
| De Leeuw, AA; Fokdal, LU; Gormsen, LC; Jürgenliemk-Schulz, IM; Kroon, PS; Lindegaard, JC; Ramlov, A; Tanderup, K | 1 |
| Basu, S; Thapa, P | 1 |
| Arai, Y; Chiba, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K | 2 |
| Chu, YH; Hsu, CC; Huang, WY; Lee, JC; Lin, CK; Shu, YC; Tsai, MC | 1 |
| Damhuis, RA; Derks, JL; Dingemans, AM; Hendriks, LE; Hochstenbag, MM; Houben, RM; Postmus, PE; Smit, EF; Troost, EG | 1 |
| Jung, HS; Kim, DJ; Lee, JW; Park, CK; Park, SY; Yun, MJ | 1 |
| Bao, X; Cheng, J; Geng, D; Liu, G; Mo, M; Wang, Y; Zhang, J; Zhang, Y | 1 |
| Bao, M; Chen, Q; Han, Y; Li, J; Li, Z; Lin, Q; Lin, Z; Liu, S; Peng, M; Xiong, L; Xu, B; Ye, B; Zhu, W | 1 |
| Arslan, N; Aydin, E; Dadali, Y; Gokcek, A; Okuyucu, K; Ozmen, O; Tatci, E; Yilmaz, U | 1 |
| Alongi, P; Caobelli, F; Castello, A; Cocciolillo, F; Crivellaro, C; De Biasi, V; Dolci, C; Evangelista, L; Geatti, O; Kirienko, M; Laghai, I; Picchio, M; Popescu, CE; Quartuccio, N; Rensi, M; Saladini, G; Seghezzi, S | 1 |
| Dershaw, DD; Jacobs, SS; Jochelson, MS; Lebron, L; Morris, EA; Moskowitz, CS; Powell, SN; Sacchini, V; Ulaner, GA; Zheng, J | 1 |
| de Geus-Oei, LF; Grootjans, W; Hermsen, R; Oyen, WJ; Schuurbiers-Siebers, OC; van der Heijden, EH; Visser, EP | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motono, N; Sagawa, M; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K; Watanabe, N | 1 |
| Howle, J; Larcos, G; Liu, J; Veness, M | 1 |
| Galloway, S; Mirza, A | 1 |
| Abdulrezzak, U; Dolanbay, M; Kutuk, MS; Ozcelik, B; Serin, IS; Uludag, S | 1 |
| Cheon, GJ; Chung, HH; Chung, JK; Im, HJ; Kang, KW; Kim, EE; Lee, DS; Sarker, A | 1 |
| Doki, Y; Kurokawa, Y; Makino, T; Miyata, H; Miyazaki, Y; Mori, M; Takahashi, T; Takiguchi, S; Tatsumi, M; Yamasaki, M | 1 |
| Chang, JS; Keum, KC; Kim, HJ; Kim, KH; Kim, SI; Kim, YB; Lee, J; Suh, CO; Yun, M | 1 |
| Cao, KJ; Chen, QY; Chen, WH; Fan, W; Guo, L; Guo, SS; Guo, X; Liu, LT; Mai, HQ; Qian, CN; Tang, LQ; Xie, D; Zeng, MS; Zhang, L; Zhang, X; Zhao, C | 1 |
| Cho, A; Kang, WJ; Kim, HJ; Kim, YT; Yun, M | 1 |
| Higashi, M; Jinguji, M; Nakabeppu, Y; Nakajo, M; Nakamura, Y; Nakayama, H; Sato, M; Yoshiura, T | 1 |
| Adams, S; Paryani, B; Subbiah, V; Takalkar, A | 1 |
| He, Q; Luo, G; Shi, X; Yi, C; Yu, D; Zhang, X | 1 |
| Chang, S; Kim, SJ; Pak, K | 1 |
| Bar-Shalom, R; Dan, LF; Guralnik, L; Kagna, O; Kremer, R; Nir, RR; Peysakhovich, Y | 1 |
| Abe, H; Aikou, S; Fukayama, M; Jinbo, K; Koyama, K; Matsusaka, K; Momose, T; Mori, K; Nomura, S; Okumura, Y; Onoyama, H; Seto, Y; Takahashi, M; Ushiku, T; Yamagata, Y; Yamashita, H | 1 |
| Ahn, BC; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
| Ahn, SG; Jeon, TJ; Jeong, J; Lee, JH; Ryu, YH; Seok, JW | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Park, JT; Roh, JL | 1 |
| Itoh, T; Kanda, T; Kitajima, K; Nibu, K; Otsuki, N; Sasaki, R; Suenaga, Y; Sugimura, K | 1 |
| Lee, SJ; Park, KJ; Park, SY; Yoon, JK | 1 |
| Koolen, BB; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Bishop, JA; Bradley, PJ; Ferlito, A; Haigentz, M; Hamoir, M; Hartl, DM; López, F; Mendenhall, WM; Rinaldo, A; Robbins, KT; Rodrigo, JP; Shaha, AR; Silver, CE; Strojan, P; Suárez, C; Takes, RP; Werner, JA | 1 |
| Doi, H; Fukushima, K; Hirota, S; Igarashi, Y; Katsuura, T; Kawanaka, Y; Kitajima, K; Maruyama, K; Miyoshi, Y; Mouri, M; Yamakado, K; Yamano, T | 1 |
| Fujii, T; Kuwano, H; Oosone, K; Tatsuki, H; Yajima, R | 1 |
| Li, BS; Shi, H; Wang, J; Wen, M; Xiao, MY | 1 |
| Abdelhafez, YG; El Refaei, S; Hamada, E; Osama, A; Tawakol, A | 1 |
| Artiko, V; Grozdic-Milojevic, I; Obradovic, V; Odalovic, S; Pavlovic, S; Sobic Saranovic, D; Stojiljkovic, M; Susnjar, S | 1 |
| Alaerts, H; Beels, L; D'hulst, L; Gheysens, O; Maes, A; Nicolaij, D; Van de Wiele, C | 1 |
| Kim, DY; Kim, JH; Kim, MH; Kim, YM; Kim, YT; Lee, HJ; Lee, JJ; Nam, JH; Park, JY; Suh, DS | 1 |
| Igai, H; Kaira, K; Kakegawa, S; Kamiyoshihara, M; Nagashima, T; Nakazawa, S; Nishiyama, M; Obayashi, K; Ohtaki, Y; Shimizu, K; Takeyoshi, I | 1 |
| Dolak, W; Giraudo, C; Karanikas, G; Kiesewetter, B; Mayerhoefer, ME; Raderer, M; Simonitsch-Klupp, I; Weber, M | 1 |
| Abu-Rustum, NR; Benz, M; Hricak, H; Lyons, G; Robertson, NL; Sala, E; Sonoda, Y; Sosa, RE; Vargas, HA | 1 |
| Chang, S; Kim, SJ | 1 |
| Dahm, P; Froehlich, J; Goldfarb, R; Hayward, D; Jha, G; Konety, BR; Soubra, A | 1 |
| Choe, JG; Kim, S; Pahk, K; Rhee, S | 1 |
| Chen, L; Li, WF; Liu, Q; Ma, J; Mao, YP; Peng, H; Sun, Y; Zhang, Y; Zhou, GQ | 1 |
| Belderbos, JS; Chen, C; Sonke, JJ; van den Heuvel, MM; van Diessen, JN | 1 |
| Belcher, E; Black, E; Bradley, KM; Gleeson, FV; McGowan, DR; Moore, A; Sykes, A; Teoh, EJ | 1 |
| Chen, FL; Chung, YL; Horng, CF; Lee, PI | 1 |
| Eo, JS; Hong, JH; Jung, US; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
| Chen, R; Huang, G; Liu, J; Zhou, X | 1 |
| Chiba, T; Haga, H; Hatano, E; Isoda, H; Kodama, Y; Kurita, A; Kuriyama, K; Minamiguchi, S; Nakamoto, Y; Sawai, Y; Togashi, K; Uemoto, S; Uza, N; Yoshimura, K | 1 |
| Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Wray, R; Wright, JL | 1 |
| Hotta, K; Kaji, M; Kiura, K; Kubo, T; Minami, D; Ninomiya, T; Oda, N; Ohashi, K; Sato, A; Tabata, M; Takigawa, N; Tanimoto, M | 1 |
| Matsunaga, N; Shigemoto, Y; Suga, K | 1 |
| Habu, M; Kito, S; Kodama, M; Koga, H; Kokuryo, S; Matsumoto-Takeda, S; Matsuo, K; Miyamoto, I; Morimoto, Y; Nishimura, S; Nishino, T; Oda, M; Sasaguri, M; Tanaka, T; Tominaga, K; Uehara, M; Yoshiga, D; Yoshioka, I | 1 |
| Arnulfo, A; Brambilla, M; Buemi, F; Carriero, A; Cassarà, A; Matheoud, R; Sacchetti, GM; Stecco, A | 1 |
| Fujiwara, M; Fukamizu, H; Suzuki, T; Takiguchi, T; Tokura, Y | 1 |
| Fujii, T; Kuwano, H; Tatsuki, H; Yajima, R | 1 |
| Doi, H; Fukushima, K; Hirota, S; Kaibe, N; Kawanaka, Y; Kitajima, K; Miwa, H; Mouri, M; Niwa, H; Oshima, T; Sasako, M; Tomita, T | 1 |
| Ehara, S; Ishida, K; Kato, K; Kawashima, K; Matsuo, M; Nakamura, R; Otsuka, K; Tomabechi, M | 1 |
| Liu, DF; Meng, T; Wang, GM; Xu, YP; Zhu, F | 1 |
| Han, JK; Hur, BY; Joo, I; Kim, SH; Lee, DH | 1 |
| Cheng, X; Li, H; Wu, X | 1 |
| Cheon, GJ; Chung, JK; Im, HJ; Jang, JY; Jung, W; Kang, KW; Kim, EE; Kim, SW; Lee, DS; Oo, S | 1 |
| Anderson, TM; Lu, Y; Patel, D | 1 |
| An, YS; Jeong, SH; Lee, HW; Lee, SJ; Yoon, JK | 1 |
| Bennink, RJ; Geijsen, ED; Hulshof, MC; Machiels, M; van Laarhoven, HW; van Os, RM; Wouterse, SJ | 1 |
| Li, W; Liang, F; Zhang, S | 1 |
| Albano, D; Bertagna, F; Bosio, G; Dib, B; Giubbini, R; Piccardo, A | 1 |
| Deo, SV; Garg, PK; Gogia, A; Kumar, R; Mathur, SR; Sharma, DN; Shukla, NK; Thulkar, S | 1 |
| Jinguji, M; Kajiya, Y; Nakajo, M; Tani, A; Yoshiura, T | 1 |
| Bastos, D; Cerri, G; Etchebehere, E; Queiroz, MA; Santos, A; Viana, P | 1 |
| Ferraro, R; Marcus, C; Rahmim, A; Sheikhbahaei, S; Subramaniam, RM; Wray, R; Zan, E | 1 |
| Emi, M; Furukawa, T; Hamai, Y; Hihara, J; Ibuki, Y; Okada, M; Yamakita, I | 1 |
| Bernardini, MQ; Ferguson, SE; Halankar, J; McVey, R; Metser, U | 1 |
| Demirag, G; Kefeli, M; Kemal, Y; Kokcu, A; Kurtoglu, E; Tosun, FC; Yucel, I | 1 |
| Belohlavek, O; Fencl, P; Harustiak, T; Zemanova, M | 1 |
| Braun, M; Falch, C; Kirschniak, A; Klumpp, B; Koenigsrainer, A; Mueller, S | 1 |
| Achenbach, HJ; Amthauer, H; Apostolova, I; Furth, C; Genseke, P; Kalinski, T; Riedel, S; Rogasch, JM; Schreiber, J; Schultz, M; Steffen, IG; Steinkrüger, FL; Wertzel, H | 1 |
| Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
| Arya, S; Mahajan, A; Paul, PP | 1 |
| Kawasaki, H; Koyama, K; Nagai, H; Sasaki, K; Sato, M; Yoshimi, F | 1 |
| Asakura, K; Kaseda, K; Kazama, A; Ozawa, Y | 1 |
| Halaç, M; Ilvan, Ş; Işik, G; Kocael, P; Kuyumcu, S; Sağer, S; Sönmezoğlu, K; Türkmen, C; Vatankulu, B | 1 |
| Kang, DY; Lee, JW; Lee, SM; Lee, SY; Na, JO | 1 |
| Erkaya, S; Güngör, T; Öz, M; Özgü, BS; Özgü, E; Yıldız, Y | 1 |
| Cho, YS; Choe, YS; Im, YH; Kim, BT; Lee, KH; Lim, CH; Moon, SH | 1 |
| Bang, JH; Bang, YJ; Cha, Y; Ha, H; Han, SW; Im, SA; Jin, MH; Kim, JW; Kim, TY; Lee, KH; Nam, AR; Oh, DY; Park, JE | 1 |
| Chen, SS; Hsieh, CH; Kang, CJ; Liao, CT; Lin, CY; Su, YY; Yen, TC | 1 |
| Alauddin, Z; Fatima, N; Masood, M; Mirza, ZR; Qureshi, A; Shahid, A | 1 |
| Giordano, S; Kemppainen, J; Koskivuo, I; Minn, H; Seppänen, M; Veräjänkorva, E; Vihinen, P | 1 |
| Dasgupta, R; Gelfand, MJ; Kremer, N; Nagarajan, R; Pressey, JG; Sharp, SE; Tiao, GM; Turpin, BK; Wagner, LM; Yin, J | 1 |
| Choi, MG; Lee, HH; Lee, SH; Na, SJ; o, JH; Park, CH; Park, JM; Song, KY | 1 |
| Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
| Aide, N; Babin, E; Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Michels, JJ; Rame, JP | 1 |
| Yoon, SN | 1 |
| Ahn, MJ; Ahn, YC; Cho, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Son, YI | 1 |
| Bogsrud, TV; Dale, E; Moan, JM; Osnes, TA | 1 |
| Abdul-Rahman, H; Bauerfeind, P; Eshmuminov, D; Fischer, M; Gubler, C; Lehmann, K; Reiner, C; Schneider, PM; Veit-Haibach, P; Weber, A | 1 |
| Jadvar, H | 1 |
| İbiş, E; Kahraman, A; Konuralp Atakul, B; Koyuncu, K; Ortac, F; Soydal, Ç; Sükür, YE; Taşkın, S | 1 |
| Gauthé, M; Gilbeau, L; Hugentobler, A; Talbot, JN | 1 |
| Chiti, A; Costa, G; Lopci, E; Pedicini, V; Poretti, D; Rodari, M; Solbiati, L; Torzilli, G; Viganò, L | 1 |
| Bisdas, S; Boeßert, P; Fottner, C; Hempel, JM; Kloeckner, R; Krick, S; Miederer, M; Musholt, TJ; Pinto Dos Santos, D; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Bal, C; Karunanithi, S; Kumar, R; Naswa, N; Soundararajan, R; Walia, R | 1 |
| Gődény, M; Kásler, M; Lengyel, Z; Léránt, G; Nagy, ZT; Polony, G; Remenár, É; Tamás, L; Zámbó, O | 1 |
| Goto, T; Kurita, A; Matsuzaki, N; Nishimura, S; Nishimura, T; Okada, H; Terajima, H; Uchida, Y; Yazumi, S | 1 |
| Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT | 1 |
| Byeon, SJ; Jeon, SM; Lee, JY | 1 |
| Cambridge, L; Dunphy, M; Garcia, B; Goodman, KA; Wu, AJ | 1 |
| Kang, S | 1 |
| Fanfani, F; Ferrandina, G; Gentileschi, S; Mattoli, MV; Palluzzi, E; Pennacchia, I; Scambia, G; Valentini, AL; Zannoni, G | 1 |
| Jeon, JH; Kim, MS; Lee, GK; Lee, JM; Moon, DH; Yang, HC; Zo, JI | 1 |
| Barbosa, FG; Burger, IA; Delso, G; Huellner, MW; Mader, CE; Sah, BR; Sekine, T; Stolzmann, P; Ter Voert, EE; Veit-Haibach, P; von Schulthess, GK | 1 |
| Beaulieu, A; Beauregard, JM | 1 |
| Bray, V; Forstner, D; Fowler, A; Holloway, L; Lee, M; Lin, P; Min, M | 1 |
| Ali, S; Atri, M; Dehdashti, F; DiSilvestro, P; Gold, M; King, SA; Koh, WJ; Lee, SI; Mannel, RS; Marques, H; Moxley, KM; Pearl, M; Plante, M; Zhang, Z; Zhou, X | 1 |
| Bodner, WR; Cheng, H; Garg, M; Halmos, B; Kalnicki, S; Keller, SM; Ohri, N; Perez-Soler, R | 1 |
| Chang, HH; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Liu, CJ; Liu, YL; Lu, MY; Tzen, KY; Yang, YL; Yen, RF | 1 |
| Cai, Q; Liang, X; Wen, B; Xie, J; Yang, Q; Yu, J | 1 |
| Arigami, T; Kita, Y; Maemura, K; Natsugoe, S; Okumura, H; Omoto, I; Owaki, T; Sasaki, K; Uchikado, Y; Uenosono, Y | 1 |
| Fischer, G; Hakami, YA; Huellner, MW; Veit-Haibach, P; Wagner, F; Warnock, G | 1 |
| Jia, Z; Lan, Y; Ren, P; Shen, G; Zhang, K | 1 |
| Fujiwara, M; Fukamizu, H; Senoo, A; Suzuki, T; Tokura, Y | 1 |
| Bom, HS; Cho, IH; Choi, EK; Chong, A; Chun, KA; Ha, JM; Kim, J; Kim, SH; Kong, EJ; Kwon, SY; Min, JJ; O, JH; Song, HC | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Freudenberg, LS; Hauth, EA; Heusner, TA; Kuehl, H; Veit-Haibach, P | 1 |
| Lenglinger, J; Riegler, M; Ringhofer, C | 1 |
| Ishikawa, S; Kimura, N; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Yamamoto, Y | 1 |
| Cohn, DE; Farrar, WB; Hall, NC; Martin, EW; Povoski, SP; Seamon, LG | 1 |
| Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Kondo, T; Mochizuki, H; Omata, J; Tamura, K; Tsuda, H; Ueda, S | 1 |
| Hsiao, JK; Ko, JY; Lee, CY; Lou, PJ; Wang, CP; Yen, RF | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Iwaisako, K; Mori, A; Nakajima, A; Nakamoto, Y; Seo, S; Tada, M; Tamaki, N; Uemoto, S | 1 |
| Belinc, D; Chen, DT; Eikman, EA; Farma, JM; Malafa, M; Melis, M; Santillan, AA; Walters, J | 1 |
| Aleman, B; Bonniaud, G; Edeline, V; Ghalibafian, M; Girinsky, T; Lievens, Y; Meijnders, P; Noordijk, E; Paumier, A; Poortmans, P; Specht, L; Van Der Maazen, R | 1 |
| Cheng, HF; He, GQ; Liu, HB; Ye, XJ; Zhan, HW; Zhang, H; Zhao, CL | 1 |
| Nakagawa, T; Suzuki, Y; Yamada, M | 1 |
| Aimoni, C; Padovani, D; Paluzzi, A; Pastore, A; Zucchetta, P | 1 |
| Fu, Z; Guo, H; Hu, Q; Wang, W; Yu, J; Yuan, S; Zhong, X | 1 |
| Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T | 1 |
| Hoshikawa, H; Mitani, T; Mori, N; Nishiyama, Y; Ohkawa, M; Yamamoto, Y | 1 |
| Ayala, F; García, T; Gonzalez-Billalabeitia, E; Gonzalez-Cabezas, P; Macías, JA; Vicente, E; Vicente, V; Zafra, M | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Freudenberg, LS; Hauth, EA; Heusner, TA; Kimmig, KR; Koeninger, A; Kuemmel, S; Umutlu, L | 1 |
| Fu, Z; Hu, M; Li, M; Liu, N; Shi, F; Yang, G; Yu, J; Yuan, S; Zhang, P | 1 |
| Akiyoshi, T; Fujimoto, Y; Koyama, M; Kuroyanagi, H; Matsueda, K; Muto, T; Oya, M; Tanaka, H; Ueno, M; Yamaguchi, T | 1 |
| Nguyen, BD; Pockaj, BA; Roarke, MC | 1 |
| Cook, G; Harrington, KJ; Newbold, KL; Nutting, CM; Partridge, M; Rhys-Evans, P; Sharma, B | 1 |
| Alfonso, JM; Gonzalez, C; Gorospe, L; Jover, R; Lourido, D; Rojo, A | 1 |
| Fujii, H; Fukushi, M; Hirayama, A; Inoue, K; Ito, M; Kitamura, H; Kurosawa, H; Moriyama, N; Sato, T; Tanaka, T; Tsunoda, Y | 2 |
| Ignatov, V; Ivanov, K; Kolev, N; Madzhov, R; Temelkov, T | 1 |
| Duch, J; Fontanillas, M; Fuster, D; Muñoz, M; Paredes, P; Pons, F; Santamaría, G; Velasco, M | 1 |
| Ferhanoğlu, B; Iğdem, A; Iğdem, S; Okkan, S; Unalan, B | 1 |
| Dierckx, RA; Jager, PL; Links, TP; Phan, HT; Plukker, JT; Wolffenbuttel, BH | 1 |
| Chung, DK; Ho Shon, IA; Saw, RP; Thompson, JF | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Palmedo, H; Reinhardt, M; Singh, B; Strunk, H; Tüting, T | 1 |
| Guo, HB; Hu, M; Liu, LP; Liu, NB; Xu, XQ; Yang, GR; Yu, JM; Zhang, PL | 1 |
| Weder, W | 1 |
| Chen, MY; Fan, W; Liang, PY; Lin, XP; Zhang, X; Zhao, C; Zhi, SF | 1 |
| Berthelsen, AK; Brenøe, J; Loft, A; Ravn, J; Sørensen, JB | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Britton, P; Ell, PJ; Gaskarth, M; Groves, AM; Iddles, S; Miles, KA; Moyle, P; Shastry, M; Warren, RM; Wishart, GC | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; See, LC; Wang, HM; Yen, TC | 1 |
| Enomoto, K; Hatazawa, J; Higuchi, I; Inohara, H; Inoue, T; Osaki, Y; Tomiyama, Y; Yoshii, T | 1 |
| Ahn, HY; Chang, SK; Hwang, HS; Kim, JH; Lee, IJ; Rho, YS; Yoon, DY | 1 |
| Chang, JY; Chang, KY; Chao, J; Yen, Y | 1 |
| De Marinis, F; Miele, E; Pasciuti, G; Rossi, L; Spinelli, GP; Tomao, F; Tomao, S; Zoratto, F; Zullo, A | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Morita, S; Murakami, K; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Abe, T; Amemiya, R; Asato, Y; Iijima, T; Kiyoshima, M; Nagai, H; Okumura, T; Saito, H; Sato, M; Shioyama, Y | 1 |
| Lee, SI; Russell, AH | 1 |
| Aogi, K; Hara, F; Inoue, T; Nishimura, R; Ohsumi, S; Sugata, S; Taira, N; Takabatake, D; Takashima, S | 1 |
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| He, C; Hu, JB; Sun, XN; Xu, J | 1 |
| Assumpcao, L; Buijs, M; Choti, MA; Gleisner, AL; Pawlik, TM; Schulick, RD; Vossen, JA | 1 |
| Brenot-Rossi, I; Chuto, G; Gaudy-Marqueste, C; Grob, JJ; Nicol, I; Richard, MA | 1 |
| Goya, T; Honda, Y; Horio, H; Iyama, K; Kaji, M; Koizumi, K; Nakashima, R; Nomori, H; Sakaguchi, K; Shibata, H; Suzuki, T; Takanami, I; Uno, K | 1 |
| Nakazawa, K; Ohtsuka, M; Satoh, H; Sekizawa, K | 1 |
| Endo, K; Endou, H; Higuchi, T; Hisada, T; Imai, H; Ishikita, T; Ishizuka, T; Kaira, K; Kanai, Y; Mori, M; Nakajima, T; Oriuchi, N; Shimizu, K; Sunaga, N; Yanagitani, N | 1 |
| Aksu, G; Altun, E; Bilici, A; Karci, E; Ozkara, SK; Ustaalioglu, BB; Uygun, K | 1 |
| Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Kimura, H; Miyamori, I; Morikawa, M; Okazawa, H; Sasaki, M; Tsuchida, T | 1 |
| Henderson, R; Ho, L; Seto, J; Youngworth, H | 1 |
| De Neve, W; De Ruysscher, D; Dehing-Oberije, C; Lambin, P; Lievens, Y; Meersschout, S; Rao, B; Van Beek, K; van der Weide, H; Van Meerbeeck, J; Yu, S | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Ng, SH; Wang, HM; Yen, TC | 1 |
| Bortoluzzi, L; Hürlimann, S; Schwarz, E; Soyka, JD; Strobel, K | 1 |
| Arslan, N; Ataergin, S; Ozet, A; Ozguven, MA | 1 |
| Chang, HR; Chung, D; Debruhl, N; Gornbein, JA; Minami, CA; Prati, R | 1 |
| Kitagawa, M; Kobayashi, H; Ochiai, R; Omagari, J; Ono, K; Yamashita, Y; Yoshida, T | 1 |
| Carkaci, S; Cristofanilli, M; Dawood, S; Gonzalez Angulo, AM; Le-Petross, HT; Macapinlac, HA; Mawlawi, O; Resetkova, E; Rohren, E; Yang, WT | 1 |
| Duan, Y; Lu, PO; Wang, WZ; Yu, LJ | 1 |
| Cheng, Z; He, J; Lin, L; Liu, L; Mao, YS; Zheng, R | 1 |
| Chang, FC; Chang, SY; Chu, PY; Huang, JL; Liu, RS; Tai, SK; Tsai, TL; Wang, YF | 1 |
| Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Hosono, M; Kumano, S; Kuwabara, M; Murakami, T; Okada, M; Shimono, T; Shiozaki, H | 1 |
| Hata, K; Hata, T; Inubashiri, E; Kanenishi, K; Nishiyama, Y; Ohkawa, M; Ohno, M; Shiota, A; Yamamoto, Y | 1 |
| Reske, SN | 1 |
| Chiari, F; Eckel, HE; Gaggl, A; Hausegger, K; Kohlfürst, S; Kresnik, E; Lind, P; Markitz, M; Raunik, W; Salzwimmer, M | 1 |
| Bussink, J; Kaanders, JH; Oyen, WJ; Troost, EG | 1 |
| Denecke, T; Rothe, JH; Röttgen, R | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Motosugi, U; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A | 1 |
| Baillet, G; Barre, E; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME | 1 |
| Chang, E; Kim, J; Kim, S; Kim, Y; Lee, C; Lee, J; Song, I; Suh, K; Sul, J | 1 |
| Morita, N; Nishitani, H; Otomi, Y; Otsuka, H; Terazawa, K; Yamashita, K | 1 |
| Baba, H; Baba, Y; Hayashi, N; Hiyoshi, Y; Imamura, Y; Nagai, Y; Toyama, E; Watanabe, M; Yoshida, N | 1 |
| Graafland, NM; Hoefnagel, CA; Horenblas, S; Leijte, JA; Valdés Olmos, RA; van Boven, HH | 1 |
| Hoffmann, AL; Kaanders, JH; Oyen, WJ; Schinagl, DA; van Dalen, JA; Verstappen, SM; Vogel, WV | 1 |
| Chen, X; Song, JH; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Fujiwara, K; Kanazawa, S; Kawai, H; Matsuo, K; Okumura, Y; Rai, K; Sato, S; Sato, T; Shinya, T; Watanabe, K; Yonei, T | 1 |
| Borbély, K; Fekésházy, A; Lengyel, Z; Magyar, M; Markóczy, Z; Zsiray, M | 1 |
| Baum, RP; Hellwig, D; Kirsch, C | 1 |
| Araki, T; Ichikawa, T; Kato, S; Matsumoto, K; Nambu, A; Nishikawa, K; Okuwaki, H; Saito, A; Sato, Y | 1 |
| Fields, R; McWhorter, A; Mercante, DE; Nuss, D; Pou, AM; Rabalais, AG; Walvekar, R; Wood, C | 1 |
| Harada, T; Isowa, N; Kawasaki, Y; Maeda, R; Miura, H; Onuma, H; Tokuyasu, H; Touge, H | 2 |
| Mori, T; Nomori, H; Ohba, Y; Shibata, H; Shiraishi, K; Yoshimoto, K | 1 |
| Dinter, DJ; Haberkorn, U; Hermann, B; Mai, SK; Welzel, G; Wenz, F | 1 |
| Hsieh, CC; Hsu, PK; Hsu, WH; Huang, CS; Lin, KH; Wang, SJ; Wu, YC | 1 |
| Fox, JJ; Pandit-Taskar, N; Rohan, S | 1 |
| Cho, KS; Choi, HJ; Jung, DC; Kang, S; Kim, SK; Lee, HY; Park, SY; Seo, SS; Yoo, CW | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Kimmig, KR; Koeninger, A; Kuemmel, S; Otterbach, F; Stahl, A | 1 |
| Feins, R; Funkhouser, WK; Khandani, AH; Socinski, MA | 1 |
| Hiyama, A; Kawakami, Y; Matsumoto, T; Matsunaga, N; Okabe, K; Suga, K; Sugi, K; Tanaka, N; Ueda, K | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Lee, SP; Ng, KK; Tsai, CS; Yen, TC | 1 |
| Ardissone, F; Arena, V; Billé, A; Borasio, P; Errico, L; Mancini, M; Pelosi, E; Skanjeti, A | 1 |
| Ichiguchi, O; Yoshioka, M | 1 |
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
| Billiet, I; Lesage, K; Maes, A; Pottel, H; Swinnen, G; Vanneste, A; Werbrouck, P | 1 |
| Graafland, NM; Hoefnagel, CA; Horenblas, S; Leijte, JA; Teertstra, HJ; Valdés Olmos, RA | 1 |
| Sherif, A | 1 |
| Liu, Y | 1 |
| Hara, M; Mizuno, A; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Diederich, S; Engeser, P; Junker, K; Passlick, B; Pfluger, T; Pottgen, C; Reck, M | 1 |
| Damjanovich, L; Garai, I; Garami, Z; Hascsi, Z; Lukács, G; Tanyi, M | 1 |
| Che, WJ; Qiao, WL; Wang, TS; Xing, Y; Zhao, JH | 1 |
| Fujiuchi, N; Matsuda, H; Matsuura, K; Misumi, M; Nakamiya, N; Okubo, K; Osaki, A; Saeki, T; Sakurai, T; Sano, H; Shigekawa, T; Takahashi, T; Takeuchi, H | 1 |
| Quon, A; Zissen, MH | 1 |
| Fekésházy, A; Klinkó, T; Mayer, A; Nemeskéri, C; Sinkó, D; Tóth, V; Tóth, Z; Weisz, C | 1 |
| Baek, CH; Choi, JY; Chung, MK; Hyun, SH; Jeong, HS; Kim, HJ; Ko, YH; Park, GY; So, YK; Son, YI | 1 |
| Li, M; Liang, Y; Liu, Y; Wu, N; Zhang, WJ; Zhao, P; Zheng, R | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Zhang, WG; Zhang, X | 1 |
| Fan, CZ; Fan, QP; Li, FL; Li, L; Su, MG; Tian, R; Tian, Y; Yang, XC | 1 |
| Bellò, M; Beltramo, G; Cassoni, P; Castellano, I; Contu, V; Mistrangelo, M; Morino, M; Munoz, F; Mussa, A; Pelosi, E; Racca, P; Ricardi, U | 1 |
| Baron, O; Bridji, B; Despins, P; Duveau, D; Mugniot, A; Perigaud, C; Roussel, JC; Sagan, C | 1 |
| Aukema, TS; Straver, ME; Valdés Olmos, RA; Vogel, WV | 1 |
| Bastiaannet, E; Hoekstra, HJ; Kobold, AC; Kruijff, S; Suurmeijer, AJ; van Ginkel, RJ | 1 |
| Alberini, JL; Cherel, P; Fourme, E; Gontier, E; Le Stanc, E; Lerebours, F; Madar, O; Pecking, AP; Wartski, M | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR | 1 |
| Buda, A; Dell'Anna, T; Guerra, L; Mangili, G; Messa, C; Picchio, M; Signorelli, M; Sironi, S | 1 |
| DeCamp, MM; Gangadharan, SP; Kent, MS; Nicotera, SP; Okereke, IC; Shen, C | 1 |
| Bastiaannet, E; Brouwers, AH; de Klerk, JM; Hoekstra, HJ; Hoekstra, OS; Koelemij, R; Meijer, S; Oyen, WJ; van der Jagt, EJ; Wobbes, T | 1 |
| Bisdas, S; Chambron-Pinho, N; Mack, M; Middendorp, M; Sader, R; Seitz, O; Vogl, TJ | 1 |
| Abe, K; Baba, S; Hatakenaka, M; Honda, H; Kaneko, K; Sasaki, M; Tanabe, Y; Yabuuchi, H | 1 |
| Fan, W; Hu, YY; Liang, PY; Lin, XP; Sun, XR; Zhang, X | 1 |
| Lurain, JR; Nemcek, A; Rademaker, A; Schink, JC; Singh, DK; Small, W; Spies, S; Vern, TZ | 1 |
| Cha, SH; Kim, KW; Kim, MJ; Lee, JD; Lee, MJ; Park, MS; Yun, MJ | 1 |
| Hakenberg, OW; Protzel, C | 2 |
| Cao, YX; Dong, JC; Duan, XH; Guan, YH; Le, JJ; Liu, BJ; Wu, JF; Xu, CQ; Zhao, J; Zuo, CT | 1 |
| Gerbaudo, VH; Gill, RR; Hatabu, H; Sugarbaker, DJ | 1 |
| Bold, B; Ishida, R; Okada, N; Omura, K; Piao, Y; Shibuya, H; Tayier, A | 1 |
| Fujita, M; Hosokawa, M; Itoh, K; Shimizu, S; Shirato, H; Takahashi, H | 1 |
| Chu, HR; Hwang, HS; Kim, JH; Rho, YS; Yoon, DY | 1 |
| Adachi, S; Hanioka, K; Hirokaga, K; Monzawa, S; Sakuma, T; Suzuki, K; Takao, S | 1 |
| Feith, M; Siewert, JR; Stein, HJ | 1 |
| Mercier, G; Peller, P; Sakai, O; Subramaniam, RM; Truong, M | 1 |
| Chuang, KW; Coakley, FV; Hawkins, RA; Konety, BR; Patil, VV; Sollitto, RA; Wang, ZJ | 1 |
| English, JR; Kolodny, GM; Palmer, MR; Parker, JA; Werner, MK | 1 |
| Kaji, Y; Kitajima, K; Kubota, K; Murakami, K; Shimoda, M; Suganuma, N; Sugimura, K; Yamasaki, E | 1 |
| Feng, R; Kong, L; Li, MH; Shi, F; Yang, GR; Yu, JM | 1 |
| Chan, WK; Huang, B; Khong, PL; Kwong, DL; Mak, HK; Yeung, DW | 1 |
| Bruna-Muraille, C; Cuif-Job, A; Domange-Testard, A; Jovenin, N; Liehn, JC; Menéroux, B; Papathanassiou, D; Prévost, A | 1 |
| Agool, A; Brouwers, AH; Dijkstra, PU; Krabbe, CA; Phan, TT; Pruim, J; Roodenburg, JL; Scholtens, AM | 1 |
| Barranger, E; Bricou, A; Delpech, Y; Tulpin, L | 1 |
| Borschitz, T; Eichhorn, W; Fottner, C; Hansen, T; Lang, H; Musholt, TJ; Schad, A; Schadmand-Fischer, S; Schreckenberger, M; Weber, MM | 1 |
| Abe, K; Baba, S; Hatakenaka, M; Honda, H; Isoda, T; Kaneko, K; Sasaki, M; Yabuuchi, H | 1 |
| Takada, M; Yamamoto, S | 1 |
| Chang, HP; Chang, TC; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Wu, TI; Yen, TC | 1 |
| Blackman, G; Bomanji, J; Boulos, PB; Ell, PJ; Engledow, AH; Groves, A; Skipworth, JR; Warren, SJ | 1 |
| Chan, SC; Chang, JT; Liao, CT; Lin, CY; Lo, CW; Ng, SH; Wang, HM; Yen, TC | 1 |
| Guo, W; Li, SJ; Liao, JX; Ren, GX | 1 |
| Beyer, F; Buerke, B; Gerss, J; Heindel, W; Puesken, M; Scheffe, K; Schober, O; Weckesser, M; Wessling, J | 1 |
| Castiglione, F; Molino, C; Olivieri, S; Susini, T; Tavella, K; Viligiardi, R | 1 |
| Kawano, M; Seto, H; Shojaku, H; Tsuneyama, K; Wada, R; Watanabe, Y; Yasumura, S | 1 |
| Hara, M; Nakagawa, M; Nishio, M; Ozawa, Y; Sakurai, K; Shibamoto, Y; Tamaki, T | 1 |
| Ayala-Ramirez, M; Callender, GG; Chuang, HH; Goodarzi, M; Jimenez, C; Kupferman, ME; Perrier, ND; Rich, TA; Trent, J | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 2 |
| Arguis, P; Garcia, S; Gimferrer, JM; Gómez-Caro, A; Lomeña, F; Marrades, R; Reguart, N; Sanchez, M | 1 |
| Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Rutgers, EJ; Schot, ME; Straver, ME; Vogel, WV | 1 |
| Choi, BW; Kim, HW; Won, KS; Zeon, SK | 1 |
| Heys, SD; Peare, R; Staff, RT | 1 |
| Chung, DC; Kang, S; Kim, JY; Kim, SK; Nam, BH; Park, SY; Seo, SS | 1 |
| Fradet, Y; Friede, J; Lacombe, L; Lodde, M; Morin, F; Saourine, A | 1 |
| Aukema, TS; Hoefnagel, CA; Valdés Olmos, RA; Vogel, WV | 1 |
| De Marzi, P; Giovacchini, G; Mangili, G; Mapelli, P; Messa, C; Picchio, M; Samanes Gajate, AM; Sigismondi, C; Sironi, S; Spinapolice, EG; Viganò, R | 1 |
| Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T | 1 |
| Bournazos, A; Datseris, I; Exarhos, D; Housianakou, I; Panagiotidis, E | 1 |
| Boeing, C; Dissemond, J; Grabbe, S; Hillen, U; Klode, J; Poeppel, T | 1 |
| Fu, Z; Tan, GZ; Yang, WF; Yu, JM | 1 |
| Cook, GJ; Llamas Elvira, JM; Ramos-Font, C; Rebollo-Aguirre, AC; Romero Tabares, A; Villegas Portero, R | 1 |
| Adli, M; Celen, Z; Dirier, A; Yilmaz, M; Zincirkeser, S | 1 |
| Ariga, H; Jingu, K; Kaneta, T; Koto, M; Nemoto, K; Ogawa, Y; Sakayauchi, T; Takahashi, S; Takai, Y; Takeda, K; Yamada, S | 1 |
| Nwogu, C | 1 |
| Doi, R; Imai, H; Isoda, H; Iwanaga, Y; Kamo, N; Kanazawa, H; Kawaguchi, Y; Koizumi, M; Masui, T; Takada, Y; Uemoto, S | 1 |
| Cabrera, AR; Chen, L; Han, A; Han, D; Li, Y; Ma, L; Ma, Y; Mu, D; Sun, X; Teng, X; Yu, J; Yue, J; Zhao, S; Zhao, X; Zheng, F; Zheng, J | 1 |
| Bainbridge, A; Bandula, S; Bomanji, JB; Daw, S; De Vita, E; Hain, SF; Humphries, PD; Olsen, OE; Prakash, V; Punwani, S; Shankar, A; Stevens, N; Taylor, SA | 1 |
| Dehdashti, F; Grigsby, PW; Kidd, EA; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA | 1 |
| Baron, M; Chastan, M; Diologent, B; Hitzel, A; Manrique, A; Sanson, AE; Vera, P | 1 |
| Bentivegna, E; Duvillard, P; Gouy, S; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Schlumberger, M; Uzan, C | 1 |
| Aukema, TS; Klop, WM; Kroon, BB; Nieweg, OE; Valdés Olmos, RA; Vogel, WV; Wouters, MW | 1 |
| Campbell, J; Gates, VL; Ho, CL; Lewandowski, RJ; Qing, F; Salem, R; Savin, M; Tang, B; Thie, J; Wong, CY | 1 |
| Horn, J; Lock-Andersen, J; Loft, A; Sjøstrand, H | 1 |
| Cho, A; Choi, YJ; Hong, SW; Kim, CK; Lee, JD; Noh, TW; Park, CS; Yun, M | 1 |
| Argiris, A; Branstetter, BF; Ferris, RL; Gibson, MK; Grandis, JR; Heron, DE; Johnson, JT; Kim, SW; Lai, SY; Passero, VA; Shuai, Y | 1 |
| Fuwa, N; Inokuchi, H; Kodaira, T; Mizoguchi, N; Nakahara, R; Nakamura, T; Tachibana, H; Takada, A; Tamaki, T; Tomita, N | 1 |
| Izuishi, K; Masaki, T; Sano, T; Suzuki, Y; Takebayashi, R; Yamamoto, Y | 1 |
| Chung, DC; Kang, S; Kim, JY; Kim, SK; Lim, MC; Park, JY; Park, SH; Park, SY; Seo, SS; Song, YJ | 1 |
| Hanaoka, K; Hosono, M; Kanamori, S; Nakamatsu, K; Nishimura, Y; Okubo, M; Okumura, M; Shibata, T | 1 |
| Chang, JT; Chen, IH; Cheng, AJ; Hsueh, C; Huang, SF; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Ahn, MJ; Chung, MJ; Hyun, SH; Kim, BT; Kim, J; Kim, TS; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
| Doi, R; Hatano, E; Higashi, T; Ikai, I; Kitamura, K; Nakamoto, Y; Narita, M; Nitta, T; Seo, S; Taura, K; Uemoto, S; Yamanaka, K; Yasuchika, K | 1 |
| Lin, M; London, K | 1 |
| Cho, SY; Han, SS; Kim, SH; Kim, SK; Kim, YK; Lee, KW; Park, SJ | 1 |
| Laible, M; Lettau, M | 1 |
| Caamaño, AG; Figueiras, RG; Goh, V; Martin, CV; Naveira, AB; Padhani, AR | 1 |
| Chung, MP; Han, J; Jeon, K; Kim, H; Koh, WJ; Kwon, OJ; Lee, KS; Park, HK; Shim, YM; Suh, GY; Um, SW | 1 |
| Chen, Z; Li, F; Li, X; Ouyang, Q; Yu, T | 1 |
| Hiramatsu, Y; Hongo, A; Kanazawa, S; Kodama, J; Nakamura, K; Okumura, Y | 1 |
| Barnett, S; Baste, JM; Berlangieri, S; Knight, S; Murugappan, K; Scott, A; Seevanayagam, S; Tog, C | 1 |
| Higashi, K; Ishigaki, Y; Nishida, H; Oguchi, M; Ohta, Y; Sakuma, T; Takegami, T; Tonami, H; Ueda, Y; Xu, K; Zhang, L | 1 |
| Endo, K; Fukuchi, M; Inose, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Oriuchi, N; Sakai, M; Sano, A; Sohda, M; Suzuki, S; Tanaka, N | 1 |
| Fujiwara, A; Hasegawa, Y; Higashiyama, M; Hosoki, T; Kanzaki, R; Kodama, K; Kozuka, T; Maeda, J; Okami, J; Takami, M; Tokunaga, T; Tomita, Y | 1 |
| Champ, C; Dusing, RW; Fogh, S; Intenzo, C; Kubicek, GJ; Machtay, M; Reddy, E; Wang, F | 1 |
| Iizuka, K; Mizoguchi, K; Morita, S; Suzuki, M | 1 |
| Lai, CH; Yen, TC | 1 |
| Ahmad, N; Haerle, SK; Schmid, DT; Soltermann, A; Stoeckli, SJ; Strobel, K | 1 |
| Ahn, JH; Jeong, J; Kim, EK; Kim, JA; Kwak, JY; Ryu, YH; Son, EJ; Youk, JH | 1 |
| Bussink, J; Kaanders, JH; Oyen, WJ; Schinagl, DA; Troost, EG | 1 |
| Ferris, RL; Hagan, JL; Rabalais, A; Tauzin, M; Walvekar, RR; Wood, CG | 1 |
| Aukema, TS; Gilhuijs, KG; Olmos, RA; Peeters, MJ; Russell, NS; Rutgers, EJ; Straver, ME; Vogel, WV | 1 |
| Dubois, F; Dumollard, JM; Martin, C; Prades, JM; Prevot, N; Richard, C; Timoshenko, AP | 1 |
| Lang, BH; Law, TT | 1 |
| Horiuchi, C; Nishimura, G; Taguchi, T; Tsukuda, M; Yabuki, K | 1 |
| Gilardi, L; Paganelli, G | 1 |
| Duet, M; Faraggi, M; Hugonnet, F | 1 |
| de Bree, R | 1 |
| Adam, G; Bannas, P; Derlin, T; Frenzel, T; Klutmann, S; Mester, J; Weber, C | 1 |
| Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Dehdashti, F; Grigsby, PW; Olsen, JR; Schwarz, JK; Siegel, BA; Zighelboim, I | 1 |
| Haug, AR; Klingenstein, A; Nentwich, MM; Schaller, UC; Tiling, R | 1 |
| Bakhshi, S; Karunanithi, S; Radhakrishnan, V; Tanveer, N; Thulkar, S | 1 |
| Buriánková, E; Havlík, R; Klos, D; Koranda, P; Kysucan, J; Lovecek, M; Neoral, C; Tozzi, I | 1 |
| Brink, I; Denschlag, D; Gitsch, G; Hancke, K; Klar, M; Meyer, PT; Orlowska-Volk, M | 1 |
| Endo, K; Ishizuka, T; Kaira, K; Mori, M; Oriuchi, N; Sunaga, N; Yanagitani, N | 1 |
| Lai, G; Rockall, AG | 1 |
| Sahdev, A | 1 |
| Banziger-Tobler, NE; Detmar, M; Honer, M; Kaspar, M; Mumprecht, V; Neri, D; Proulx, ST; Schibli, R; Trachsel, E; Vigl, B | 1 |
| Jia, C; Lou, G; Lu, P; Tian, M; Wang, W; Wang, X; Yu, L | 1 |
| Miyashita, T | 1 |
| Abiko, M; Sato, T; Shiono, S | 1 |
| Choi, WH; Chung, SK; Kim, SH; O, JH; Yoo, IR | 1 |
| Bonardel, G; Carette, MF; de Labriolle-Vaylet, C; Grahek, D; Housset, B; Lebeau, B; Mangiapan, G; Margery, J; Meignan, M; Milleron, B; Talbot, JN; Vaylet, F | 1 |
| Chung, HH; Chung, JK; Eo, JS; Han, KH; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
| Hafner, J | 1 |
| Cathomas, R; Mueller, J; Putora, PM; Schmidt, F; Stallmach, T | 1 |
| Choi, JW; Kim, SM; Koo, BS; Yoon, YH | 1 |
| Doki, Y; Eguchi, H; Hatazawa, J; Hoshino, H; Kim, T; Kobayashi, S; Marubashi, S; Mori, M; Nagano, H; Shimosegawa, E; Takeda, Y; Tanemura, M; Wada, H | 1 |
| Minn, H; Vihinen, P | 1 |
| Furonaka, O; Miyata, Y; Noriyuki, T; Osaki, N; Shimoda, K; Shioya, S; Takahashi, G; Yonehara, S | 1 |
| Chung, DH; Goo, JM; Han, SK; Kang, CH; Kim, YT; Kim, YW; Lee, CH; Lee, SH; Min, JW; Park, CM; Shim, YS; Yim, JJ | 1 |
| Fu, Z; Li, M; Sun, X; Xie, P; Yu, J; Zhao, H | 1 |
| Bouchelouche, K; Gerke, O; Holt, P; Jensen, TK; Marcussen, N; Riehmann, M; Svolgaard, B | 1 |
| Fujii, H; Fukushi, M; Inoue, K; Kitamura, H; Moriya, E; Moriyama, N; Ohnuki, Y; Sasaki, T; Sato, T; Suzuki, T | 1 |
| Fury, MG; Jansen, JF; Koutcher, JA; Lee, NY; Patel, SG; Pfister, DG; Schöder, H; Shah, JP; Shukla-Dave, A; Stambuk, HE; Wang, Y | 1 |
| Agoglia, BG; Brambilla, D; Casiraghi, M; Guarize, J; Maisonneuve, P; Spaggiari, L; Tessitore, A; Travaini, LL | 1 |
| Kaushik, A; Nguyen, NC; Osman, MM; Wolverson, MK | 1 |
| Baek, HJ; Cheon, GJ; Choe, DH; Kim, KM; Koh, JS; Lee, JC; Na, II; Park, JY | 1 |
| Han, A; Xue, J; Yu, J; Yue, J; Zheng, J; Zhu, D | 1 |
| Chondrogiannis, S; Conti, G; D'Ambrosio, D; Farace, P; Marzola, P; Merigo, F; Nanni, C; Quarta, C; Rubello, D; Sbarbati, A; Tambalo, S | 1 |
| Hong, SH; Kang, EJ; Kim, DW; Kim, SH; Lee, KN | 1 |
| Buecher, B; Deleau, C; des Varannes, SB; Flamant, M; Frampas, E; Galmiche, JP; Kraeber-Bodéré, F; Matysiak-Budnik, T; Rousseau, C | 1 |
| Bridji, B; Campion, L; Campone, M; Devillers, A; Ferrer, L; Kraeber-Bodéré, F; Ricaud, M; Rousseau, C; Sagan, C | 1 |
| Koyama, M; Murakami, K; Okazumi, S; Shimada, H | 1 |
| Chevreau, C; Courbon, F; Julian, A; Meyer, N; Payoux, P; Wagner, T; Zerdoud, S | 1 |
| Dalus, K; Holzmannhofer, J; Kronberger, C; Pirich, C; Reitsamer, R; Rendl, G; Rettenbacher, L | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Choi, FP; Chu, WC; Mok, GS | 1 |
| Gokce, M; Kilicgun, A; Saydam, O; Tanriverdi, O | 1 |
| Belova, EA; Karelin, MI; Karlov, PA; Mus, VF; Shkol'nik, MI | 1 |
| Brown, JA; Coleman, T; Collins, M; Lightfoot, AJ; Rosevear, HM; Williams, H | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SB; Kim, SY; Lee, JH; Lee, SW; Nam, SY; Roh, JL; Yi, JS | 1 |
| Bennink, RJ; Busch, OR; Engelbrecht, MR; Gouma, DJ; Ruys, AT; van Gulik, TM; van Westreenen, HL | 1 |
| Bacharach, SL; Buvat, I; Carrasquillo, JA; Carson, JM; Hapdey, S; Whatley, M | 1 |
| Atasalihi, A; Iskender, I; Kadioglu, SZ; Kir, A; Kosar, A | 1 |
| Chen, JH; Hsieh, TC; Kao, CH; Liang, JA; Shum, WY; Su, CC; Yeh, JJ | 1 |
| Fleckenstein, J; Grgic, A; Gröschel, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C | 1 |
| Chang, JY; Fu, XL; Shen, L; Xiang, JQ; Yu, W; Zhang, YJ | 1 |
| Cho, KJ; Choi, SH; Doo, H; Kim, JS; Kim, SY; Lee, H; Lee, JH; Nam, SY; Roh, JL | 1 |
| Akhurst, TJ; Chessin, DB; Guillem, JG; Larson, SM; Leibold, T; Macapinlac, H; Mazumdar, M; Minsky, BD; Paty, PB; Riedel, E; Saltz, LB; Shia, J; Weiser, MR; Wong, WD; Yeung, HW | 1 |
| Fournet, S; Giacalone, PL; Rathat, G; Rouleau, C | 1 |
| Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Saint-Blancard, P; Salles, Y; Staub, E; Vaylet, F | 1 |
| Brenner, W; Buchert, R; Diekmann, F; Froeling, V; Nogami, M; Schreiter, N | 1 |
| Buerke, B; Gerss, J; Heindel, W; Puesken, M; Weckesser, M; Wessling, J | 1 |
| Beadsmoore, C; Geropantas, K; Loo, SW; Martin, WM; Montgomery, PQ; Roques, TW | 1 |
| Erasmus, JJ; Truong, MT; Viswanathan, C | 1 |
| Coleman, RL; Euscher, ED; Frumovitz, M; Jhingran, A; Macapinlac, HA; Munsell, MF; Ramirez, PT; Ramondetta, LM; Schmeler, KM; Soliman, PT | 1 |
| Brader, P; Fong, Y; Gönen, M; González, L; González, SJ; Strong, VE; Wong, J; Zakowski, M | 1 |
| Ahn, SJ; Chung, WK; Jeong, JU; Jeong, SY; Nah, BS; Nam, TK; Song, JY; Yoon, MS | 1 |
| Fockens, P; Groen, H; Janssens, AC; Plukker, JT; Pruim, J; Schreurs, LM; Sloof, GW; Steyerberg, EW; van Berge Henegouwen, MI; van Dullemen, HM; van Lanschot, JJ | 1 |
| Enomoto, A; Hamada, S; Nakahara, H; Tsuji, H; Uchihashi, T | 1 |
| Chen, YW; Hou, MF; Hou, PN; Lee, CS; Lin, CY; Tsai, EM | 1 |
| Aogi, K; Hara, F; Inoue, T; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S | 1 |
| Haerle, SK; Haile, SR; Hany, TF; Schuknecht, B; Stoeckli, SJ; Strobel, K | 1 |
| Chiang, IP; Hsieh, CY; Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF | 1 |
| Hihara, J; Ikeda, T; Mimura, T; Misumi, K; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Choi, IS; Choi, WJ; Kang, YH; Lee, SE; Min, HS; Moon, JI; Oh, HH; Ra, YM; Yoon, DS | 1 |
| Guan, DJ; He, ZY; Xu, GZ | 1 |
| Borri, A; Brambilla, D; Casiraghi, M; Ciprandi, B; De Pas, T; Donghi, SM; Galetta, D; Gasparri, R; Guarize, J; Maisonneuve, P; Petrella, F; Solli, P; Spaggiari, L; Tessitore, A; Veronesi, G | 1 |
| Ishibashi, T; Ishikawa, K; Kadoya, M; Kaji, M; Kato, T; Tamaki, N | 1 |
| Akbulut, Z; Asil, E; Atmaca, AF; Balbay, MD; Caglayan, A; Canda, AE | 1 |
| Bertolaccini, L; Bianchi, A; Rizzardi, G; Terzi, A | 1 |
| Cantos, B; Gasent, JM; Ibeas, P; Provencio, M; Rodríguez, B | 1 |
| Ak, I; Döner, E; Dündar, E; Simsek, FS; Sivrikoz, CM | 1 |
| Hoshikawa, H; Kishino, T; Mori, N; Nishiyama, Y; Yamamoto, Y; Yonezaki, M | 1 |
| Bonte, KM; Deron, PB; Van de Wiele, C; Vermeersch, HF | 1 |
| Doki, Y; Fujiwara, Y; Hatazawa, J; Higuchi, I; Miyata, H; Takiguchi, S; Yamasaki, M; Yano, M; Yasuda, T | 1 |
| Ho-Shon, I; Koh, ES; Lin, M; Lin, P; Som, S; Vinod, SK; Yap, J | 1 |
| Matsumoto, I; Oda, M; Tamura, M; Waseda, R; Watanabe, G | 1 |
| Chao, A; Ho, KC; Hong, JH; Huang, KG; Huang, YT; Lai, CH; Lin, G; Qiu, JT; Wang, CC; Yen, TC | 1 |
| Hand, F; Kell, MR; Robertson, IJ | 1 |
| Apfaltrer, P; Chu, TQ; Dinter, DJ; Fink, C; Henzler, T; Krissak, R; Manegold, C; Meyer, M; Nance, JW; Schmid-Bindert, G; Schoenberg, SO; Schoepf, UJ | 1 |
| Ahmed, K; Hanna, GB; Kayani, B; Zacharakis, E | 1 |
| Castellani, M; Ceriani, L; De Palma, D; Giovanella, L; Suriano, S; Verburg, FA | 1 |
| Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Hospers, GA; Kruijff, S; Nagengast, WB; Speijers, MJ; Suurmeijer, AJ | 1 |
| Chan, T; Gu, J; Khong, PL; Kwong, YL; Leung, AY; Zhang, J | 1 |
| Chan, SC; Chang, CJ; Chang, JT; Liao, CT; Lin, CY; Lin, SY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Mornex, F; Roelandts, M; Van Houtte, P | 1 |
| Choi, WH; Chung, YA; Han, EJ; Lee, SH; Sohn, HS | 1 |
| Dubray, B; Edet-Sanson, A; Mezzani-Saillard, S; Modzelewski, R; Thureau, S; Vera, P | 1 |
| Berenger, N; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Misset, JL; Toubert, ME; Vercellino, L | 1 |
| Beaulieu, S; Bélair, M; Boucher, L; Cohade, C; Coulombe, G; Delouya, G; Després, P; Filion, EJ; Hinse, M; Houle, A; Igidbashian, L; Martel, C; Nguyen-Tan, PF | 1 |
| Back, A; Bohn, P; Doyeux, K; Dubray, B; Edet-Sanson, A; Gardin, I; Hapdey, S; Modzelewski, R; Vera, P | 1 |
| Fujiwara, T; Fujiwara, Y; Hiraki, T; Kaji, M; Kanazawa, S; Mitani, M; Naomoto, Y; Noma, K; Okumura, Y; Sakurama, K; Shirakawa, Y; Takaoka, M; Tanabe, S; Yamatsuji, T | 1 |
| Kohno, H; Komatsu, S; Shibuya, K; Terui, K | 1 |
| Hatazawa, J; Inoue, T; Itoh, H; Kubota, K; Murakami, K; Saga, T; Shiomi, S | 1 |
| Antoch, G; Forsting, M; Geiger, B; Hartung, V; Herbrik, M; Heusner, TA; Riegger, C; Rosenbaum-Krumme, SJ; Treffert, J | 1 |
| Abulafi, M; Artho, G; Brown, G; Garant, A; Hunter, CJ; Lisbona, R; Tekkis, P; Vuong, T | 1 |
| Damjanovich, L; Dinya, T; Galuska, L; Garai, I; Garami, Z; Hascsi, Z; Tanyi, M; Varga, J | 1 |
| Feng, HJ; Hu, R; Liu, JH; Ouyang, W; Sun, YG | 1 |
| Fu, Z; Han, D; Mu, D; Xu, G; Yang, W; Yu, J; Zhang, B; Zhao, S; Zhong, X | 1 |
| Bal, M; De Jaeger, K; Meijer, G; Schuring, D; Steenhuijsen, J; Theuws, J | 1 |
| Hu, SL; Shi, W; Xu, JY; Yang, ZY; Zhang, YJ; Zhu, BL | 1 |
| Fronczewska-Wieniawska, K; Królicki, L; Kuźmińska, M; Niemczyk, K; Osuch-Wójcikiewicz, E | 1 |
| Kim, CG; Kim, DW | 1 |
| Chevreau, C; Courbon, F; Meyer, N; Mourey, L; Wagner, T; Zerdoud, S | 1 |
| Corry, J; Hicks, RJ; Lau, E; Mak, D; Rischin, D | 1 |
| Collyer, JC; Ghazali, N; Tighe, J | 1 |
| Aarntzen, EH; Blokx, WA; Boerman, OC; Bonenkamp, JJ; de Vries, IJ; De Wilt, JH; Figdor, CG; Jacobs, JF; Lesterhuis, WJ; Mus, RD; Oyen, WJ; Punt, CJ; Srinivas, M; Troost, EG; van Rossum, MM; Windhorst, AD | 1 |
| Akiyama, K; Ishihara, K; Iwano, M; Kobayashi, Y; Kumita, S; Satoh, H; Shiiba, M; Yoshihara, H | 1 |
| Kong, FM; Wang, J; Wang, L; Welch, K | 1 |
| Hsieh, TC; Hsu, CN; Kao, CH; Sun, SS; Wu, YC; Yang, CF; Yen, KY | 1 |
| Bartenstein, P; Cumming, P; Graute, V; Hacker, M; Hartenbach, M; Jansen, N; Klanke, K; Scherr, MK; Seitz, M; Thieme, S; Tiling, R; Ubleis, C | 1 |
| Chen, L; Chen, M; Hu, X; Li, X; Ma, H; Sun, X; Xie, P; Xing, L; Xu, W; Xu, X; Yu, J; Yue, J; Zhang, H; Zhang, L | 1 |
| Cheng, J; Pan, L; Yao, Z; Zhang, Y; Zhou, M | 1 |
| Evans, T; Fernandes, AT; Kucharczuk, JC; Langer, C; Lin, L; Mitra, N; Rengan, R; Stevenson, J; Xanthopoulos, E | 1 |
| Blanchot, J; Bouriel, C; de Crevoisier, R; Devillers, A; Fougerou, C; Garin, E; Le Prisé, E; Leseur, J; Levêque, J; Monpetit, E; Williaume, D | 1 |
| Aubard, Y; Fermeaux, V; Genet, D; Leobon, S; Marin, B; Maubon, A; Monteil, J; Renaudie, J; Roux, S; Tubiana-Mathieu, N | 1 |
| Bahnson, EE; Chow, AZ; Gaglani, JR; Hall, NC; Hitchcock, CL; Knopp, MV; Kuhrt, MP; Martin, EW; Mojzisik, CM; Murrey, DA; Povoski, SP | 1 |
| Kim, BS; Sung, SH | 1 |
| Belgers, HJ; Blom, RL; Oostenbrug, LE; Schreurs, WM; Sosef, MN; Stohr, I; Vliegen, RF | 1 |
| Ito, S; Iwano, S; Kato, K; Naganawa, S; Tsuchiya, K | 1 |
| Ansquer, C; Bouchot, O; Marconnet, L; Rigaud, J; Souillac, I | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H | 1 |
| Farrell, R; Gharpurhy, A; Gollub, F; Goodchild, K; Lemon, C; Saunders, M; Sonoda, LI; Wellsted, D; Wong, WL | 1 |
| Cho, A; Kang, WJ; Kim, J; Lee, JD; Lee, JH; Moon, HJ; Yun, M | 1 |
| Cui, ML; He, ZY; Zhao, L; Zhong, XN | 1 |
| Collaud, S; Lardinois, D; Stahel, R; Steinert, HC; Tischler, V; Weder, W | 1 |
| Chang, H; Cheng, YL; Hsieh, CM; Huang, TW; Huang, WS; Lee, SC; Tzao, C | 1 |
| Borgato, L; Cervino, AR; Dalla Palma, M; Evangelista, L; Fiduccia, P; Gregianin, M; Nicoletto, MO; Saladini, G; Zagonel, V | 1 |
| Agrawal, A; Meacham, R; Naiboğlu, B; Ozer, E; Ryoo, C; Schuller, DE | 1 |
| de Casso, C; Kane, T; Nigam, A; Soni-Jaiswall, A; Visvanathan, V | 1 |
| Huang, YT; Ravi Kumar, AS | 1 |
| Finger, PT; Patel, P | 1 |
| Gao, X; Geng, J; Qin, Y; Tian, M; Wang, D; Yu, L | 1 |
| Arai, Y; Komatsu, M; Matsuda, H; Nishimura, G; Sakuma, N; Sano, D; Taguchi, T; Takahashi, H; Takahashi, M | 1 |
| Inoue, M; Kadota, Y; Minami, M; Okumura, M; Ose, N; Sawabata, N; Shintani, Y | 1 |
| Arguis, P; Boada, M; Cabañas, M; Gómez-Caro, A; Lomeña, F; Molins, L; Ramirez, J; Sanchez, M | 1 |
| Bhuva, NJ; Glynne-Jones, R; Harrison, MK; Sonoda, L; Wong, WL | 1 |
| Adrada, BE; Buchholz, TA; Carkaci, S; Mawlawi, O; Quraishi, MA; Rohren, E; Wei, W; Yang, W | 1 |
| Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Yang, KT | 1 |
| Gao, S; Li, YJ; Xing, XL | 1 |
| Montini, KM; Tulchinsky, M | 1 |
| Bang, YJ; Cho, N; Chung, JK; Han, SW; Han, W; Im, SA; Kang, KW; Keam, B; Kim, JH; Kim, TY; Koh, Y; Moon, WK; Noh, DY; Oh, DY; Park, IA | 1 |
| Bradley, KM; Gillies, RS; Gleeson, FV; Han, C; Marshall, RE; Maynard, ND; Middleton, MR | 1 |
| Andersson, M; Bernsdorf, M; Berthelsen, AK; Binderup, T; Graff, J; Kjær, A; Kroman, N; Loft, A; Tange, UB; Teilum, D; Wielenga, VT | 1 |
| Goo, JM; Im, HJ; Kang, CH; Kim, JI; Kim, YW; Lee, HJ; Lee, SM; Paeng, JC; Park, CM | 1 |
| Debaere, T; Duclos, J; Gouy, S; Haie-Meder, C; Lumbroso, J; Morice, P; Souadka, A; Uzan, C | 1 |
| Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Hoekstra, OS; Oyen, W; Thompson, JF; Uyl-de Groot, CA; van der Jagt, EJ; van Ooijen, B; Verzijlbergen, F | 1 |
| Campbell, DB; Crist, HS; Kaul, S; Manni, A; Tulchinsky, M | 1 |
| Blanchard, P; Dumas, I; Haie-Meder, C; Leboulleux, S; Lhomme, C; Mazeron, R; Morice, P; Paumier, A | 1 |
| Eubank, WB; Kessler, L; Mankoff, DA; Specht, JM | 1 |
| Bodurtha, A; Down, N; Elavathil, L; George, R; Gulenchyn, KY; Hodgson, N; Holloway, CM; Julian, JA; Levine, MN; Lovrics, P; McCready, D; O'Malley, FP; Perera, F; Pritchard, KI; Shelley, W | 1 |
| Choi, YJ; Huh, CY; Ki, KD; Kim, GY; Lee, JM; Lee, SK; Lim, SJ; Seol, HJ; Tong, SY | 1 |
| Chen, IH; Fan, KH; Hsueh, C; Huang, SF; Kang, CJ; Lee, LY; Liao, CT; Lin, CH; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Chen, JH; Kao, CH; Liang, JA; Liao, CY; Yeh, JJ | 1 |
| Gao, X; Tian, M; Yu, L; Zhang, Y | 1 |
| Cheng, J; Hu, S; Pan, L; Xu, J; Yang, Z; Ye, D; Zhang, Y | 1 |
| Chang, CJ; Chiu, PH; Ho, KC; Kuo, WH; Lin, C; Wang, CW; Wu, CY; Wu, YC; Yen, TC; Yu, CT | 1 |
| Bom, HS; Byun, BH; Chong, A; Hong, SP; Jeong, UG; Min, JJ; Song, HC | 1 |
| Abe, K; Chikui, T; Goto, Y; Hirano, M; Jinno, T; Kawano, S; Kiyosue, T; Matsubara, R; Nagata, T; Nakamura, S; Oobu, K | 1 |
| Hui, CK | 1 |
| Han, A; Hu, M; Wang, X; Xue, J; Zheng, J | 1 |
| Chmielowska, E; Chłosta, P; Drewa, T; Jasiński, M; Jóźwicki, W; Kamecki, K; Kraśnicki, K; Małkowski, B; Mikołajczak, W; Petrus, A; Pietrzak, T; Siekiera, J; Wronczewski, A | 1 |
| Farlow, D; Gan, G; Hollands, M; Lam, VW; Laurence, JM; Pleass, HC; Richardson, A; Yao, J | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Nakamura, H | 1 |
| Kim, BS; Kim, IJ; Kim, K; Kim, SJ; Pak, K | 1 |
| Bolton, WD; Geraldson, CT; Greene, RA; Lagrew, JP; Schammel, CM; Schammel, DP; Stephenson, JE | 1 |
| Ha, HK; Kim, HJ; Kim, JC; Kim, JS; Kwak, JY; Yu, CS | 1 |
| Auranen, A; Carpén, O; Dean, K; Grénman, S; Hynninen, J; Kemppainen, J; Lavonius, M; Lisinen, I; Seppänen, M; Virtanen, J | 1 |
| Allan, C; Barbour, A; Bayley, G; Burmeister, B; Burmeister, E; Dwyer, P; Foote, M; Lambie, D; Meakin, J; Pullar, A; Smithers, M; Thomas, J | 1 |
| Antoch, G; Forsting, M; Grabellus, F; Hahn, S; Hartung, V; Hecktor, J; Heusner, TA; Kimmig, R; Pöppel, T | 1 |
| Hashiguchi, H; Morimoto, M; Nakajima, A; Nakamura, S; Nishiyama, K; Suzuki, O; Tanaka, K; Yoshino, K | 1 |
| Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
| Keelawat, S; Kunawudhi, A; Pak-art, R; Tepmongkol, S | 1 |
| Mason, DP | 1 |
| Cho, YK; Choi, MG; Chung, IS; Jung, HS; Lee, IS; Park, CH; Park, JM; Song, KY; Yoon, NR | 1 |
| Borbély, K; Fülöp, M; Kásler, M; Lengyel, Z; Remenár, E | 1 |
| Pu, Y; Wroblewski, K; Zhang, H | 1 |
| Harada, H; Kurabayashi, T; Mochizuki, Y; Nakamura, S; Omura, K; Shibuya, H | 1 |
| Abernethy, AP; Beasley, GM; Broadwater, G; Eikman, EA; Marzban, S; Parsons, C; Salama, AK; Selim, MA; Tyler, DS; Wong, T; Zager, JS | 1 |
| Asagi, A; Iguchi, H; Inoue, T; Nadano, S; Nasu, J; Nishimura, R; Ohta, K; Tanada, M; Teramoto, N; Yamamoto, K | 1 |
| Fuglø, HM; Hovgaard, D; Jørgensen, SM; Loft, A; Petersen, MM | 1 |
| Antoch, G; Bockisch, A; Buchbender, C; Forsting, M; Herbrik, M; Heusner, TA; Treffert, J | 1 |
| Botta, F; Botteri, E; De Cicco, C; Di Dia, GA; Fracassi, SL; Gilardi, L; Lombardo, D; Paganelli, G; Prisco, G; Rotmensz, N; Veronesi, U | 1 |
| Monteiro, E; Pereira, G; Silva, JC | 1 |
| Asada, T; Chijiiwa, K; Haruyama, Y; Hotokezaka, M; Nagamachi, S; Uchiyama, S | 1 |
| Berthelsen, AK; Christensen, CB; Costa, JC; Daugaard, G; Graff, J; Loft, A; Møller, AK; Pedersen, KD; Perell, K; Petersen, BL; Skovgaard, LT | 1 |
| Cha, SW; Cho, YD; Choi, DL; Jang, JY; Jeong, SW; Jin, SY; Kim, BS; Kim, HS; Kim, SG; Kim, YS; Lee, JE; Lee, SH | 1 |
| Choi, BB; Jeong, SH; Kang, BJ; Kim, SH; Lee, JH; Song, BJ; Yim, HW | 1 |
| Campbell, PD; Carlson, ER; Long, M; McCoy, JM; Schaefferkoetter, J; Townsend, D | 1 |
| Costouros, NG; Groome, T; Kashani-Sabet, M; Lee, GO; Leong, SP | 1 |
| Kamata, H; Machida, T; Ohizumi, Y; Okada, K; Sadahiro, S; Suzuki, T; Tanaka, A; Yasuda, S | 1 |
| Buda, A; Crivellaro, C; De Ponti, E; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M; Todde, S | 1 |
| Haerle, SK; Hany, TF; Huber, G; Schaefer, NG; Schmid, D; Seifert, B; Soyka, JD; Strobel, K; Studer, G; Veit-Haibach, P | 1 |
| De Ridder, M; Everaert, H; Fontaine, C; Lamote, J; Ratib, O; van Parijs, H; Vanhoeij, M; Vees, H; Verfaillie, G; Vinh-Hung, V; Vlastos, G; Voordeckers, M | 1 |
| Furukita, Y; Goto, M; Morimoto, M; Tangoku, A; Yamamoto, Y | 1 |
| Henne-Bruns, D; Hillenbrand, A; Luster, M; Ohlhauser, D; Reske, SN; Weber, T | 1 |
| Bastiaannet, E; Brouwers, AH; de Jong, JR; Hoekstra, HJ; Hoekstra, OS; Suurmeijer, AJ | 1 |
| Bae, DS; Choe, YS; Choi, JY; Kim, BT; Lee, KH; Moon, SH; Park, SB; Yoo, J | 1 |
| Kong, L; Li, M; Qu, W; Sun, X; Xing, L; Yu, J; Yue, J; Zhu, WQ | 1 |
| Ahn, SJ; Chung, WK; Jeong, JU; Nah, BS; Nam, TK; Song, HC; Song, JY; Yoo, SW; Yoon, MS | 1 |
| Danga, A; Hemmaway, CJ; Igbokwe, U; Radunovic, A | 1 |
| Abe, K; Baba, S; Honda, H; Ito, K; Kawano, D; Maehara, Y; Miura, N; Morodomi, Y; Shoji, F; Takenaka, T; Yano, T | 1 |
| Bellon-Guardia, M; Lozano-Martin, E; Perez-Romasanta, LA; Sanz-Martin, M; Torres-Donaire, J; Velasco-Jimenez, J | 1 |
| Routray, S; Shankar, AA | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Lee, WK; Song, BI | 1 |
| Buchegger, F; Chouiter, A; Dipasquale, G; Miralbell, R; Namy, S; Ratib, O; Steiner, C; Vees, H; Velazquez, M; Zilli, T | 1 |
| Dai, MM; Li, YM; Lin, Q; Luo, ZM; Sun, L; Wang, LC; Wu, H; Yang, RS; Zhao, L | 1 |
| Baek, CH; Choe, YS; Choi, JY; Jeong, HS; Kim, BT; Lee, KH; Moon, SH; Oh, YL; Son, YI | 1 |
| Li, C; Li, P; Qian, Y; Shi, Y; Wu, H; Wu, Y; Yang, J; Zhang, H; Zhang, J | 1 |
| Aide, N; Bardet, S; Beauregard, JM; Gervais, R; Guizard, AV; Hicks, RJ; Lasnon, C; Lemoel, G; Milner, A; Paciencia, M; Zalcman, G | 1 |
| Dong, W; Du, J; Li, X; Meng, L; Ni, Y; Shen, H; Wang, G | 1 |
| Wiggins, RH; Zollinger, LV | 1 |
| Funk, GF | 1 |
| Kawakami, Y; Kenzaki, K; Kondo, K; Otsuka, H; Sakiyama, S; Takizawa, H; Tangoku, A; Toba, H | 1 |
| Bodet-Milin, C; Carlier, T; Corradini, N; Dupas, B; Eugene, T; Leux, C | 1 |
| Bertagna, F; Cunico, SC; Fisogni, S; Giubbini, R; Simeone, C; Tardanico, R | 1 |
| Anai, S; Harada, T; Ijichi, K; Koga, T; Kubo, N; Nakanishi, Y; Otsubo, K; Takayama, K; Yoneshima, Y | 1 |
| Baba, J; Hirota, M; Iwai, T; Mitsudo, K; Omura, S; Shibasaki, M; Tohnai, I | 1 |
| Albiges, L; Bellmunt, J; Bonardel, G; Boutros, C; Fizazi, K; Loriot, Y; Massard, C; Wagner, M | 1 |
| Clark, OH; Duh, QY; Gosnell, J; Guerrero, MA; Munoz-Perez, N; Rinkes, IH; Schreinemakers, JM; Shen, WT; Suh, I; Vriens, MR | 1 |
| Honda, E; Ishimaru, N; Kubo, M; Miyamoto, Y; Otsuka, H; Sugawara, C; Takahashi, A | 1 |
| Burmeister, BH; Porceddu, SV; Pryor, DI; Scuffham, PA; Thomas, PA; Whitty, JA | 1 |
| Akiyama, K; Hoshikawa, H; Inamoto, R; Kishino, T; Mori, N; Mori, T; Nishiyama, Y; Yamamoto, Y | 1 |
| Aktolun, C; Celen, YZ; Elboga, U; Kalender, E; Yilmaz, M | 1 |
| Kampalath, R; Liao, S; Penney, BC; Pu, Y; Wroblewski, K; Zhang, H; Zhang, Y | 1 |
| Chen, JH; Chien, CR; Ding, HJ; Kao, CH; Lin, WY; Lu, YY | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hartung, V; Heusner, TA; Kimmig, R; Koeninger, A; Otterbach, F; Riegger, C | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Dogan, BE; Turnbull, LW | 1 |
| Banks, KP; Clemenshaw, MN; Craun, JB; Moren, RW | 1 |
| Abd El-Hafez, YG; Khalil, HF; Liao, CT; Moustafa, HM; Yen, TC | 1 |
| Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ | 1 |
| Kara Gedik, G; Kaya, B; Ozcan Kara, P; Sari, O; Varoglu, E | 1 |
| Brændengen, M; Glimelius, B; Hansson, K; Isacsson, U; Norrlid, O; Radu, C | 1 |
| Katayama, T; Kubota, K; Machida, Y; Shibuya, H; Toriihara, A | 1 |
| Li, M; Liu, Q; Peng, Z; Sun, J; Yao, S | 1 |
| Ito, T; Kawabata, K; Noguchi, A; Okano, S; Shimizu, T; Tani, N; Yamaguchi, M; Yamane, T | 1 |
| Bergman, AM; Fioole-Bruining, A; Horenblas, S; Kerst, JM; Mertens, LS; van Rhijn, BW; Vegt, E; Vogel, WV | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MJ; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, HJ; Lee, JH; Nam, SY; Park, GC; Roh, JL | 1 |
| Calles, L; García-Espantaleón, M; Iglesias, E; Jiménez, JS; Mucientes, J; Pereira, A; Perez-Medina, T; Rodríguez, B | 1 |
| Berveling, MJ; Beukema, JC; Langendijk, JA; Muijs, CT; Plukker, JT; Pruim, J | 1 |
| Dank, M; Galgóczy, H; Györke, T; Kulka, J; Lengyel, Z; Somlai, K; Székely, B; Szentmártoni, G; Tőkés, T; Torgyík, L | 1 |
| Cho, KJ; Joo, YH; Kim, MS; Nam, IC; Park, JO; Yoo, IR | 1 |
| Baik, SH; Hur, H; Kang, J; Kim, H; Kim, NK; Lee, KY; Min, BS; Sohn, SK | 1 |
| Matsunaga, T; Miyasaka, Y; Oh, S; Suzuki, K; Takamochi, K | 1 |
| Ishigami, S; Kajiya, Y; Kita, Y; Matsumoto, M; Mori, S; Natsugoe, S; Okumura, H; Omoto, I; Owaki, T; Sasaki, K; Setoyama, T; Tanoue, K; Uchikado, Y; Ueno, S | 1 |
| Li, L; Su, M | 1 |
| Capitain, O; Cellier, P; Denis, F; Girault, S; Hamy, A; Mahé, MA; Mesgouez-Nebout, N; Paumier, A; Poirier, AL; Rousseau, D | 1 |
| Ansquer, C; Bodere, F; Bouchot, O; Branchereau, J; Hitier-Berthault, M; Renaudin, K; Rigaud, J | 1 |
| Akdemir, UO; Atasever, T; Benekli, M; Buyukberber, S; Cetin, B; Coskun, U; Senturk, S; Tufan, G; Turan, N | 1 |
| Ben-Nun, A; Simansky, D; Soudack, M; Yelin, A | 1 |
| Claussen, CD; Hetzel, J; Horger, MS; Klotz, E; Pfannenberg, C; Reimold, M; Sauter, AW; Schulze, M; Spira, D | 1 |
| Eid, H; El-Gammal, M; Murakami, K; Zytoon, AA | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, JW; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Abolmaali, N; Abramyuk, A; Appold, S; Baumann, M; Zöphel, K | 1 |
| Berthezene, Y; Bracoud, L; Durupt, F; Giammarile, F; Journe, C; Jouvet, JC; Morelec, I; Thomas, L; Thomson, V; Yanes, M | 1 |
| Dong, L; Eifel, PJ; Fontanilla, HP; Iyer, RB; Jhingran, A; Kelly, P; Klopp, A; Levenback, CF; Takiar, V; Zhang, Y | 1 |
| Baldwin, J; Blaydorn, L; Downhour, M; Hoff, DD; Korn, RL; Thacker, CA; Tibes, R; Weiss, GJ; White, E | 1 |
| Findikcioglu, A; Onal, C; Oymak, E; Reyhan, M | 1 |
| Hu, XC; Jia, Z; Li, G; Ragaz, J; Wang, BY; Wang, ZH; Zhang, J; Zhang, YJ; Zhang, YP; Zhou, M | 1 |
| Andikyan, V; Burger, IA; Chi, DS; Donati, OF; Goldman, DA; Gonen, M; Hricak, H; Sala, E; Schöder, H; Vargas, HA | 1 |
| Brizel, DM; Choudhury, KR; Das, SK; Hoang, JK; Yoo, DS | 1 |
| de Bree, R; Hoekstra, OS | 1 |
| Li, M; Li, N; Liang, Y; Liu, Y; Wu, N; Zhang, W; Zhao, P; Zheng, R | 1 |
| Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Smit, EF; Stroobants, SG; Vansteenkiste, JF | 1 |
| Dehdashti, F; Siegel, BA | 1 |
| Aufschnaiter, M; Heinisch, M; Jörg, L; Langsteger, W; Panholzer, PJ; Rechberger, E; Sega, W; Tausch, C; Wieser, B | 1 |
| Kresnik, E | 1 |
| Peschina, W | 1 |
| Akhurst, T; Berlangieri, S; Chan, JG; Hannah, A; McKay, WJ; Price, D; Schelleman, T; Scott, AM; Sizeland, A; Smith, GJ; Tochon-Danguy, H | 1 |
| Brouwer, J; Comans, EF; de Bree, R; Hoekstra, OS; Leemans, CR; Pruim, J; Regelink, G; Roodenburg, JL; Vaalburg, W; van der Laan, BF; Vissink, A | 1 |
| Becker, I; Herz, M; Krüger, A; Rau, FC; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ | 1 |
| Asaka, M; Kato, T; Katoh, C; Kondo, S; Kuge, Y; Nambu, T; Nobuta, A; Tamaki, N; Tsukamoto, E | 1 |
| Ali, A; Dave, NN; Shor, M; Walia, R | 1 |
| Bachmann, S; Berger, J; Bleckmann, C; Bohuslavizki, KH; Dose, J; Habermann, CR; Jãnicke, F; Jenicke, L | 1 |
| Cheng, KY; Kao, CH; Lin, WY; Tsai, SC; Yen, RF | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; García Velloso, MJ | 1 |
| Bartenstein, P; Junginger, T; Kneist, W; Menzel, C; Oberholzer, K; Schreckenberger, M | 1 |
| Aloj, L; Bacharach, SL; Carrasquillo, JA; Chow, C; Danforth, DN; Galen, B; Merino, M; Neumann, RD; Whatley, M; Zujewski, J | 1 |
| Angelard, B; Kerrou, K; Lacau St Guily, J; Montravers, F; Périé, S; Talbot, JN; Tassart, M | 1 |
| Becherer, A; Hoffmann, M; Kletter, K; Oberhuber, G; Raderer, M | 1 |
| Joyce, JM; Myers, DT; Petursson, SR; Pohland, ML | 1 |
| Boom, RP; Comans, EF; Hoekstra, OS; Lammertsma, AA; Meijer, S; Pijpers, R; Teule, GJ; van der Hoeven, JJ; van Geldere, D | 1 |
| Himeno, S; Makuuchi, H; Shimada, H; Tajima, T; Yasuda, S | 1 |
| Buchwald, C; Eigtved, A; Hansen, HS; Johansen, J; Theilgaard, SA | 1 |
| Binns, D; Frydenberg, M; Hicks, R; Hogg, A; Salminen, E | 1 |
| Di Martino, E; Gagel, B; Hausmann, R; Krombach, GA; Nowak, B; Tietze, L; Westhofen, M; Zimny, M | 1 |
| Comans, EF; De Winter, GV; Hoekstra, OS; M Herder, GJ; Welling, A | 1 |
| Stroobants, S; Vansteenkiste, J; Verschakelen, J | 1 |
| Brinkbaeumer, K; Dresel, S; Hahn, K; Hautmann, H; Kellner, W; Moisseev, A; Poellinger, B; Schmid, RA; Weiss, M | 1 |
| Beyer, T; Townsend, DW | 1 |
| Hoekstra, O | 1 |
| Hyde, NC; Keshtgar, MR; Prvulovich, E | 1 |
| Cohade, C; Osman, M; Pannu, HK; Wahl, RL | 1 |
| Dehdashti, F; Grigsby, PW; Miller, TR; Pinkus, E | 1 |
| Kitagawa, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y; Yoshida, M | 1 |
| Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
| Bachmann, LM; Goerres, GW; Mosna-Firlejczyk, K; Steurer, J; von Schulthess, GK | 1 |
| Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
| Dehdashti, F; Grigsby, PW; Mutch, DG; Siegel, BA | 1 |
| Nguyen, BD | 2 |
| Adachi, S; Hamanaka, A; Kadoh, T; Kono, M; Kotani, Y; Monzawa, S; Ohbayashi, K; Sakamoto, S; Senda, M; Sugimura, K; Takada, Y; Uotani, K | 1 |
| Carlson, KA; Davidson, D; Hutchins, GD; Jung, SH; Schauwecker, DS; Siddiqui, AR; Wagner, JD | 1 |
| Bueno, C; Carreras, JL; Lázaro, P; Longo, MI; Montz, R | 1 |
| Bakker, PF; de Klerk, JM; Schlösser, NJ; Stevens, H; van Rijk, PP | 1 |
| Choi, CW; Choi, SC; Kim, MH; Lee, KH; Ryu, SY | 1 |
| Wagner, JD | 1 |
| Goerres, GW; Mosna-Firlejczyk, K; Stoeckli, SJ | 1 |
| Kaim, AH; von Schulthess, GK | 1 |
| Dehdashti, F; Grigsby, PW; Lewis, JS; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
| Endo, K; Higuchi, T; Inoue, T; Khan, N; Oriuchi, N; Sato, N; Tian, M; Zhang, H | 1 |
| Hung, YC; Kao, CH; Lin, WC; Shen, YY; Yeh, LS; Yen, RF | 1 |
| Fehr, MK; Goerres, GW; Kamel, EM; von Schulthess, GK; Wyss, MT | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Singh, AK | 1 |
| Brinkbäumer, K; Dresel, S; Grammerstorff, J; Hahn, K; Pfluger, T; Schmid, R; Schwenzer, K | 1 |
| Bourguet, P | 3 |
| Chang, CH; Changlai, SP; Kao, A; Shen, YY; Tsai, JJ; Wu, HC | 1 |
| Gambhir, SS; Wu, D | 1 |
| Fulham, MJ; Heard, RN; McCarthy, SW; McCaughan, BC; Wilkinson, MD | 1 |
| Kim, BT; Kim, K; Kim, TS; Lee, KS; Shim, YM; Yoon, YC | 1 |
| Belhocine, T; De Barsy, C; Foidart-Willems, J; Hustinx, R; Kridelka, F; Rigo, P; Thille, A | 1 |
| Huddart, RA | 1 |
| Cook, GJ; Husband, JE; Koh, DM | 1 |
| Hany, TF; Kamel, EM; Korom, S; Lardinois, D; Seifert, B; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Antoine, M; Barranger, E; Grahek, D; Montravers, F; Talbot, JN; Uzan, S | 1 |
| Agostini, D; Aide, N; Bensadoun, H; Bottet, P; Bouvard, G; Cappele, O; Comoz, F; Regeasse, A; Sobrio, F | 1 |
| Hatazawa, J; Higuchi, I; Nakamura, H | 1 |
| Cho, SB; Chung, KY; Jung, J; Lee, KH; Yun, M | 1 |
| Guller, U; Moch, H; Nitzsche, E; Zuber, M | 1 |
| Aizer-Dannon, A; Bar-Am, A; Even-Sapir, E; Flusser, G; Ron, IG | 1 |
| Bakheet, R; Bakheet, SM; Baslaim, MM; El-Foudeh, M; Ezzat, A; Tulbah, A | 1 |
| Nakamoto, Y | 1 |
| Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
| Bartalucci, AA; Bass, CS; Bryant, AS; Cerfolio, RJ; Mountz, JM; Ojha, B | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Siegel, BA; Tran, BN | 1 |
| Cobben, DC; Havenga, K; Hoekstra, HJ; Nienhuijs, S; Oyen, WJ; Ruers, TJ; Wobbes, T | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Kuehl, H; Marnitz, S; Nemat, AT; Stattaus, J | 1 |
| Ham, H; Loose, D; Otte, A; Van de Wiele, C; Vermeersch, H | 1 |
| Groen, H; Heeren, PA; Jager, PL; Plukker, JT; van Dullemen, HM; van Westreenen, HL | 1 |
| Chen, JT; Chou, HH; Hsueh, S; Lai, CH; Lin, WJ; Ma, SY; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Bartenstein, P; Grünwald, F; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M | 1 |
| Chan, JK; Demas, AN; Gould, MK; Kuschner, WG; Maclean, CC; Owens, DK; Rydzak, CE; Shigemitsu, H | 1 |
| Buscombe, JR; Hilson, AJ; McCool, D | 1 |
| Coleman, RE; D'Amico, TA; Gonzalez-Stawinski, GV; Harpole, DH; Lemaire, A; Merchant, F; O'Halloran, E | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, M; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Spaggiari, L; Veronesi, G | 1 |
| Downey, RJ; Harpole, DH; Heelan, RT; Jung, SH; MacApinlac, HA; Meyers, BF; Posther, KE; Reed, CE; Rusch, VW; Siegel, BA; Silvestri, GA; Woolson, SL | 1 |
| Kawahara, K; Naito, A; Nishio, M; Tamaki, T | 1 |
| Coleman, RE; Gatsonis, CG; Siegel, BA; Wahl, RL | 1 |
| Ghesani, M; Hanif, MZ; Kasai, T; Shah, AA | 1 |
| Beorlegui, C; Garcia-Velloso, MJ; Pina, L; Regueira, FM; Sola, J; Zornoza, G | 1 |
| Dietz, A; Dollner, R; Harms, W; Henze, M; Jungehülsing, M; Rudat, V | 1 |
| Cappellari, JO; Geisinger, K; Greven, KM; Keyes, JW; McGuirt, WF; Rogers, JW; Watson, NE; Williams, DW | 1 |
| Bares, R; Dittmann, H; Dohmen, BM; Fersis, N; Machulla, HJ; Reischl, G; Smyczek-Gargya, B; Vogel, U; Wallwiener, D | 1 |
| Chan, SC; Chang, JT; Chang, YC; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Yen, TC | 1 |
| Baillet, G; Moretti, JL; Tamgac, F; Tofighi, M; Weinmann, P | 1 |
| Barry, B; Baujat, B; Gehanno, P; Lazard, DS; Le Guludec, D | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; Tsai, CC; Tsai, CS; Yen, TC | 1 |
| Koumanis, DJ; Meterissian, S; Tzimas, GN | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Eimoto, T; Hara, M; Iida, A; Murase, T; Ogino, H; Shibamoto, Y; Shiraki, N; Tamaki, T | 1 |
| Gillessen, S; Joerger, M; Klaeser, B; Kluckert, JT; Schmid, HP; Warzinek, T | 1 |
| Holmstrom, A; Kelly, RF; Murar, J; Segurola, RJ; Tran, T | 1 |
| Bootsma, GP; Brouwer, MH; Corstens, FH; Cox, AL; Oyen, WJ; Tjan-Heijnen, VC; van der Wilt, GJ; Verhagen, AF | 1 |
| Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Menzel, C; Zaplatnikov, K | 1 |
| Hoekstra, OS; Krak, NC; Lammertsma, AA | 1 |
| Aksoy, E; Buck, AK; Glatting, G; Halter, G; Hetzel, M; Liewald, F; Mühling, B; Neumaier, B; Nüssle-Kügele, K; Reske, SN; Schirrmeister, H; Sunder-Plassmann, L | 1 |
| Chao, D; Gregson, NA; Leff, A; Mak, I; McCabe, DJ; Perkin, GD; Schapira, AH; Turner, NC; Womersley, HJ | 1 |
| Bender, H; Biersack, HJ; Palmedo, H | 1 |
| Buck, AK; Mattfeldt, T; Reske, SN; Schirrmeister, H | 1 |
| Chung, JK; Jeong, JM; Kang, WJ; Lee, DS; Lee, MC; So, Y | 1 |
| Agresti, R; Alessi, A; Bombardieri, E; Crippa, F; Gerali, A | 1 |
| Buell, U; Rath, W; Siggelkow, W; Zimny, M | 1 |
| Alavi, A; Talati, E; Xiu, Y; Yu, JQ; Zhuang, H | 1 |
| Avril, N | 1 |
| Bongaerts, F; Heeren, PA; Jager, PL; Plukker, JT; Sluiter, W; van Dullemen, H | 1 |
| Baek, HJ; Cheon, GJ; Cho, KJ; Choi, CW; Chung, JH; Lee, SS; Lim, SM; Park, JH | 1 |
| Eifel, PJ | 1 |
| Dehdashti, F; Grigsby, PW; Rader, J; Siegel, BA; Singh, AK; Zoberi, I | 1 |
| Fuse, H; Hisada, K; Kamisaki, Y; Kato, H; Matsunari, I; Noguchi, K; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Dietlein, M; Eschner, W; Jungehülsing, M; Schicha, H; Schmalenbach, M; Schmidt, M; Schröder, U; Stennert, E; Theissen, P | 1 |
| Bar-Shalom, R; Israel, O; Keidar, Z | 1 |
| Eubank, WB; Mankoff, DA | 3 |
| Chang, TC; Chang, YC; Chao, A; Chen, MY; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Law, KS; Lin, CT; Liou, JD; Ma, SY; Ng, KK; See, LC; Tsai, CS; Wu, TI; Yen, TC | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Skwarchuk, M; Smith, RB; Yao, M | 1 |
| Baum, RP; Hellwig, D; Mezzetti, M | 1 |
| Aktolun, C; Berk, F; Bohuslavizki, KH; Clausen, M; Daugaard, G; Demir, H; Harmer, C; Lassen, U; Malamitsi, J; Peters, M; Plowman, PN; Raderer, M | 1 |
| Chander, S; Ergün, EL; Nandkumar, U; Powell, W; Westphal, S; Zerin, JM | 1 |
| Brink, I; Digel, W; Ghanem, N; Henke, M; Mix, M; Moser, E; Nitzsche, EU; Ruhland, S; Schumacher, T; Stoelben, E | 1 |
| Bootsma, GP; Bussink, J; Corstens, FH; Oyen, WJ; Verhagen, AF | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Bellon, JR; Dunnwald, LK; Ellis, GK; Eubank, WB; Gralow, JR; Livingston, RB; Mankoff, DA | 1 |
| Alavi, A; Chiang, S; Fuster, D; Johnson, G; Schuchter, LM; Zhuang, H | 1 |
| Bloom, DA; Chander, S; Getzen, TM; Joyrich, RN; Zak, IT; Zingas, AP | 1 |
| Dehdashti, F; Drebin, JA; Fernandez, FG; Linehan, DC; Siegel, BA; Strasberg, SM | 1 |
| Halkar, RK; Schuster, DM | 1 |
| Li, XP; Liang, Y; Liu, X; Wang, QS; Wu, HB | 1 |
| Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Suemasu, K; Uno, K; Watanabe, K | 1 |
| Antoine, JC; Cinotti, L; Cottin, V; Honnorat, J; Janier, MF; Ternamian, PJ; Tronc, F; Trouillas, P; Younes-Mhenni, S | 1 |
| Aquino, SL; Fischman, AJ | 1 |
| Büll, U; Coenen, HH; Dimartino, E; Eble, MJ; Gagel, B; Hamacher, K; Maneschi, P; Pinkawa, M; Reinartz, P; Stanzel, S; Westhofen, M; Zimny, M | 1 |
| Cham, D; Conti, PS; Henderson, R | 1 |
| Alavi, A; Kumar, R | 1 |
| Friedman, KP; Wahl, RL | 1 |
| Larson, SM; Schöder, H | 1 |
| Coppens, E; El Nakadi, I; Gay, F; Gelin, M; Goldman, S; Liberale, G; Nagy, N; Van Laethem, JL | 1 |
| Naruke, T; Nomori, H; Ohtsuka, T; Uno, K; Watanabe, K | 1 |
| Liu, FY; Shang, JB; Wang, QS; Zhang, XL | 1 |
| Baldetorp, B; Brun, E; Fallenius, G; Kjellén, E; Tennvall, J; Wennerberg, J | 1 |
| Brinkmann, M; Könemann, S; Schober, O; Weckesser, M; Willich, N | 1 |
| Koshy, M; Paulino, AC; Rusthoven, KE | 1 |
| Choe, YS; Choi, JY; Choi, Y; Jang, HJ; Kim, BT; Kim, K; Lee, KH; Lee, KS; Shim, YM | 1 |
| Abe, T; Fukuda, H; Ishioka, C; Iwata, R; Kanamaru, R; Kitagawa, Y; Kubota, K; Yamaguchi, K; Yamaura, G; Yoshioka, T | 1 |
| Futatsubashi, M; Kanno, T; Nakamura, F; Nakamura, S; Sakahara, H; Sugiyama, M; Torizuka, T | 1 |
| Passlick, B | 1 |
| Chapet, O; Lagerwaard, FJ; Senan, S; Ten Haken, RK | 1 |
| Berkhof, J; Franssen, EJ; Hoekstra, OS; Sturkenboom, MG | 1 |
| Dehdashti, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Horowitz, NS; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA | 1 |
| De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, T; Van Cutsem, E; Vrieze, O | 1 |
| Barranger, E; Cortez, A; Daraï, E; David-Montefiore, E; Kerrou, K; Petegnief, Y | 1 |
| Agarwala, SS; Andrade, RS; Avril, N; Flickinger, J; Heron, DE; Johnson, J; Kalnicki, S; Wu, A | 1 |
| Greenspan, B; Singh, A; Thomas, A | 1 |
| Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
| Birim, O; Bogers, AJ; Kappetein, AP; Stijnen, T | 1 |
| Chan, SC; Chang, JT; Chang, YC; Fu, YK; Hsu, CH; Lin, KJ; Lin, WJ; Ng, SH; Yen, TC | 1 |
| Corry, J; Hicks, RJ; Jarmolowski, E; Peters, LJ; Porceddu, SV; Rischin, D; Ware, R; Weih, L | 1 |
| Anzai, Y; Coltrera, MD; Eary, J; Ford, E; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellyn, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B | 1 |
| Buatti, JM; Dornfeld, KJ; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Vansteenkiste, JF | 2 |
| Ishii, G; Murakami, K; Nagai, K; Niho, S; Nishimura, M; Nishiwaki, Y; Suzuki, K; Takamochi, K; Yoshida, J | 1 |
| Ding, YG; Kim, CK; Kim, S; Krynyckyi, BR; MacHac, J | 1 |
| Kato, H; Kuwano, H; Sohda, M | 1 |
| Dehdashti, F; Grigsby, PW; Herzog, TJ; Mutch, DG; Rader, J; Siegel, BA; Zoberi, I | 1 |
| Fukui, MB; Kapoor, V; McCook, BM | 2 |
| Cho, SB; Chung, KY; Lee, MG; Yun, M | 1 |
| Higashi, K; Higuchi, T; Hiramatsu, Y; Ishikawa, T; Ito, K; Kuga, G; Matsunari, I; Miura, K; Sakuma, T; Tonami, H; Yamamoto, I | 1 |
| Allen, P; Cox, JD; Erasmus, J; Forster, K; Herbst, RS; Komaki, R; Macapinlac, H; Moran, CA; Podoloff, DA; Putnam, JB; Roth, JA; Sasaki, R | 1 |
| Chou, HH; Ho, KC; Ng, KK; Yen, TC | 1 |
| Alavi, A; Alinari, L; Battista, G; Canini, R; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Monetti, N; Nanni, C; Pourdehnad, M; Rubello, D; Stefoni, V; Tani, M; Zinzani, P | 1 |
| Bares, R; Claussen, C; Claussen, CD; Dammann, F; Eschmann, S; Hoffman, J; Horger, M; Mueller-Berg, M; Schlemmer, H | 1 |
| Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
| Mistry, RC; Pramesh, CS | 1 |
| Liu, Y; Xu, HF; Yuan, MH; Zhang, JH; Zhou, FH; Zhou, RS | 1 |
| Chen, J; Cheong, JH; Hyung, WJ; Kim, J; Lim, JS; Noh, SH; Yun, MJ | 1 |
| Ahn, YC; Bae, DS; Choi, JY; Huh, SJ; Kim, BG; Kim, BH; Lee, J; Lim, DH; Park, W; Park, YJ | 1 |
| Castelain, B; Delannes, M; Leblanc, E; Querleu, D; Sonoda, Y | 1 |
| Low, SC; Sinha, AK; Sundram, FX | 1 |
| Dehdashti, F; Gibb, RK; Grigsby, PW; Lamoreaux, WT; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Zoberi, I | 1 |
| Aoyagi, S; Sato-Matsumura, KC; Shimizu, H | 1 |
| Coleman, JJ; Daggy, J; Davidson, D; Hutchins, G; Logan, T; Love, C; Schauwecker, D; Wagner, JD; Wenck, S | 1 |
| Bénard, F; Turcotte, E | 1 |
| Finger, PT; Kurli, M; Pavlick, AC; Reddy, S; Tena, LB | 2 |
| Chan, SC; Chang, JT; Ko, SF; Liao, CT; Ng, SH; Wang, HM; Wong, HF; Yen, TC | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Eberhard, S; Gönen, M; Herrmann, K; Hricak, H; Larson, SM; Scardino, P; Scher, HI; Schöder, H | 1 |
| Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
| Choi, JY; Chung, MJ; Han, J; Kim, BT; Kim, S; Kwon, OJ; Lee, EJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Krabbe, PF; Oyen, WJ; van Dalen, JA; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Grosu, AL; Jeremic, B; Molls, M; Picchio, M; Piert, M; Schratzenstaller, U; Schwaiger, M; Weber, WA; Zimmermann, FB | 1 |
| Macapinlac, HA | 1 |
| Buatti, JM; Chang, K; Dornfeld, KJ; Funk, GF; Graham, MM; Graham, SM; Hoffman, HT; Menda, Y; Smith, RB; Tan, H; Yao, M | 1 |
| Bucerius, J; Flacke, S; Hortling, N; Jaeger, U; Joe, A; Palmedo, H; Reinhardt, M; Strunk, H | 1 |
| Cho, DS; Hong, EK; Kang, KW; Kim, JY; Kim, SK; Lee, JS; Lee, S; Park, SY; Roh, JW; Seo, SS; Sim, JS | 1 |
| Drieskens, O; Flamen, P; Mortelmans, L; Oyen, R; Van Poppel, H; Vankan, Y | 1 |
| Hinohara, S; Ide, M; Kameyama, G; Kawada, S; Koide, S; Suzuki, Y; Takahashi, W | 1 |
| Asakura, H; Haba, R; Mitani, M; Ohkawa, M; Seo, R; Takashima, H; Toyama, Y; Yokoe, K | 1 |
| Brokx, HA; Comans, EF; Herder, GJ; Hoekstra, OS; Pasic, A; Postmus, PE; Risse, EK; Sutedja, TG | 1 |
| Dresel, S; Hahn, K; Herzog, P; Hungerhuber, E; Reiser, M; Scher, B; Schneede, P; Seitz, M; Tiling, R | 1 |
| Abe, K; Hayashi, K; Iwasaki, Y; Kosuda, S; Watanabe, S; Yano, F | 1 |
| Sun, Y; Tian, J; Wang, K | 1 |
| Bong, JK; Cheong, JH; Cho, A; Hyung, WJ; Lee, JD; Lim, JS; Noh, SH; Yun, M | 1 |
| Arenas de Pablo, A; Calero-García, R; García de Barajas, S; García-Lujan, R; Lopez-Encuentra, A; Maldonado, A; Martín de Nicolás, JL; Martín-Escribano, P; Martín-García, I; Pozo, MA; Pozo-Rodríguez, F; Sánchez-Nistal, MA | 1 |
| Gotoh, M; Haba, R; Kameyama, K; Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Yamamoto, Y | 1 |
| Bae, JM; Chang, HJ; Choi, JY; Kang, KW; Kim, HK; Kim, SK; Kim, YW; Lee, JH; Lee, JS; Ryu, KW | 1 |
| Hanada, M; Kajiwara, M; Mizoguchi, H; Mutaguchi, K; Ohguchi, T | 1 |
| Hsu, CH; Lee, CM; Lee, TJ; Lou, HY | 1 |
| Alavi, A; Hustinx, R; Zhuang, H | 1 |
| Monden, T; Nishiyama, Y; Ohkawa, M; Sasakawa, Y; Satoh, K; Tsutsui, K; Yamamoto, Y; Yokoe, K | 1 |
| Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS | 1 |
| Biesma, B; Golding, RP; Hoekstra, CJ; Hoekstra, OS; Lammertsma, AA; Postmus, PE; Schramel, FJ; Smit, EF; Stroobants, SG; van Tinteren, H; van Zandwijk, N; Vansteenkiste, J | 1 |
| Gor, DM; Langer, JE; Loevner, LA | 1 |
| Grigsby, PW; Hope, AJ; Saha, P | 1 |
| Buda, A; Colombo, M; Fazio, F; Mangioni, C; Messa, C; Moreni, R; Pellegrino, A; Perego, P; Picchio, M; Sironi, S | 1 |
| Hu, M; Liu, BD; Su, L; Wang, HR; Xu, QS; Zhang, Y; Zhi, XY | 1 |
| Bonenkamp, JJ; Bulten, J; Hendrickx, BW; Oyen, WJ; van Herpen, CM | 1 |
| de Langen, AJ; Hoekstra, OS; Paul, MA; Raijmakers, P; Riphagen, I | 1 |
| Fogelman, I; Heinisch, M; Langsteger, W | 1 |
| Chang, CJ; Chang, TC; Chao, A; Chou, HH; Hsueh, S; Huang, HJ; Huang, KG; Jung, SM; Lai, CH; Lin, CT; Ma, SY; Ng, KK; Wu, TI; Wu, YC; Yen, TC | 1 |
| Grigsby, PW | 2 |
| Cornide, M; de las Heras, PM; Domínguez, ML; García-Bernardo, L; García-Rico, E; Maldonado, A; Ortega, F; Serna, JA; Suárez, JP | 1 |
| Feng, YL; Liu, DJ; Pan, YJ; Wei, GY; Yu, FW; Zhang, N | 1 |
| Maeda, S; Sagawa, M; Sakuma, T; Sugita, M | 1 |
| Dusart, M; Eisendrath, P; Faber, J; Haller, A; Hutsebaut, J; Ninane, V; Pierard, P; Plat, G; Sculier, JP | 1 |
| Clement, O; Itti, E; Luciani, A; Meignan, M; Rahmouni, A | 1 |
| Antoch, G; Bockisch, A; Kuehl, H; Mueller, S; Ruehm, S; Stergar, H; Veit, P | 1 |
| Cameron, RB; Czernin, J; Fishbein, MC; Phelps, ME; Schiepers, C; Weber, WA; Yap, CS | 1 |
| Bradford, CR; Mukherji, SK | 1 |
| Choti, M; Frassica, D; Gearhart, SL; Rosen, R; Schulick, R; Wahl, R | 1 |
| Fukuda, H; Hakamatsuka, T; Higano, S; Kaneta, T; Kinomura, S; Sato, A; Takahashi, S; Takase, K; Yamada, S; Yamada, T | 1 |
| Chong, BW; Nelson, KD; Nguyen, BD; Roarke, MC | 1 |
| Asadpour, B; Buell, U; Coenen, HH; Demirel, C; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Pinkawa, M; Piroth, M; Reinartz, P; Stanzel, S; Zimny, M | 1 |
| Fukuda, K; Kaneda, T; Kubota, K | 1 |
| Haug, AR; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Schneider, K | 1 |
| Clark, PB; Kraas, J; Levine, EA; Shen, P; Soo, V | 1 |
| Bisi, G; Deandreis, D; Douroukas, A; Mancini, M; Pelosi, E; Pennone, M | 1 |
| Guest, P; Isaac, J; John, A; Khan, S; Mirza, DF; Singhvi, S; Tan, YM | 1 |
| Castellucci, P; Fanti, S; Farsad, M; Gross, MD; Mariani, G; Nanni, C; Rampin, L; Rubello, D | 1 |
| Biersack, HJ; Bucerius, J; Hortling, N; Jaeger, U; Joe, A; Meyka, S; Palmedo, H; Roedel, R; Strunk, H; Wardelmann, E; Wolff, M | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
| Aschoff, P; Bihl, H; Hagen, R; Hrasky, A; Schneider, K | 1 |
| De Oliveira, C; Mota, F | 1 |
| Beorlegui, C; Cervera, M; García-Velloso, MJ; Gil-Rendo, A; Regueira, FM; Zornoza, G | 1 |
| Pickles, J; Price, T | 1 |
| Carlson, DL; Erdi, YE; Gönen, M; Huvos, AG; Kraus, DH; Larson, SM; Schöder, H; Shah, JP; Stambuk, HE; Wong, RJ; Yeung, HW | 1 |
| Marres, HA; Merkx, MA; Oyen, WJ; Postema, EJ; van den Hoogen, FJ; Vogel, WV; Wensing, BM | 1 |
| Bourgain, C; Everaert, H; Lamote, J; Makkat, S; Sacré, R; Stadnik, TW | 1 |
| Cui, NJ; Han, F; Lu, LX; Lu, TX; Su, Y; Sun, Y; Wu, HB; Xie, CM; Zeng, ZY; Zhao, C | 1 |
| Dinh, M; Dinh, S; Guntinas-Lichius, O; Mueller, RP; Peter Klussmann, J; Schmidt, M; Semrau, R | 1 |
| Arpaci, F; Arslan, N; Bulakbaşi, N; Kocaoğlu, M; Ozgüven, M; Oztürk, E | 1 |
| Hisada, K; Kageyama, M; Kamisaki, Y; Kato, H; Kawabe, H; Matsunari, I; Murakami, J; Seto, H; Shimizu, M; Watanabe, N | 1 |
| Freeman, HJ | 1 |
| Brkovich, VS; Hussey, DH; Karnad, AB; McGuff, HS; Miller, FR; Otto, RA | 1 |
| He, Z; Ke, Z; Liu, M; Liu, Y; Zhang, W; Zhang, Y | 1 |
| Kohlfürst, S; Lind, P | 1 |
| Ell, PJ; Groves, AM; Pakzad, F | 1 |
| Doki, Y; Ichiki, K; Misaki, T; Oya, T; Shimizu, M; Tsuda, M; Usuda, K | 1 |
| Plukker, JT; Sloof, GW; Van Lanschot, JJ; Van Westreenen, HL; Westerterp, M | 1 |
| Jacene, HA; Stearns, V; Wahl, RL | 1 |
| Bastiaannet, E; Hoekstra, HJ; Hoekstra, OS; Jager, PL; Oyen, WJ; Wobbes, T | 1 |
| Bar Shalom, R; Ben Arush, MW; Haimi, M; Israel, O; Militianu, D; Postovsky, S; Zaidman, I | 1 |
| Alinari, L; Ambrosini, V; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Nanni, C; Rubello, D; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Choe, G; Chung, JH; Chung, JK; Kim, SE; Lee, MC; Lee, WW; Park, SY; Sung, SW | 1 |
| Bryant, AS; Cerfolio, RJ; Klemm, KM; Ojha, B | 1 |
| Chao, KS; Chen, S; Fu, Z; Guo, H; Liu, T; Yang, G; Yang, X; Yin, Y; Yu, J; Yu, Y; Yuan, S | 1 |
| Englmeier, KH; Schaefer, JF; Seemann, MD | 1 |
| Alexander, M; Brasić, JR | 1 |
| Chung, A; Fujimoto, K; Hagiike, M; Karlan, S; Liou, D; Phillips, EH; Waxman, A | 1 |
| Bryant, AS; Cerfolio, RJ | 2 |
| Alberini, JL; Gontier, E; Guinebretiere, JM; Wartski, M | 1 |
| Ishida, Y; Isozaki, H; Morimoto, T; Mukai, K; Nishiyama, S; Okajima, K | 1 |
| Baehre, M; Gerl, J; Meller, B; Richter, E; Sommer, K; Surowiec, A; von Hof, K; Wollenberg, B | 1 |
| Choi, JY; Kim, BT; Kim, H; Kim, J; Kim, S; Kwon, OJ; Lee, KS; Shim, SS; Shim, YM | 1 |
| Waldron, JN | 1 |
| Chan, SC; Chang, JT; Kang, CJ; Ko, SF; Lee, LY; Liao, CT; Ng, SH; Wang, HM; Wong, AM; Yen, TC | 1 |
| Plukker, JT; van Westreenen, HL | 1 |
| Benes, P; Koranda, P; Stárek, I | 1 |
| Dam, HQ; Manzone, TM; Sagar, VV | 1 |
| Chung, JH; Chung, JK; Eo, JS; Jang, SJ; Kim, SE; Lee, MC; Lee, WW; Park, SY; So, Y; Sung, SW | 1 |
| Miranda, EP | 1 |
| Acikgoz, G; Alavi, A; Cermik, TF; Houseni, M; Intenzo, CM; Kim, SM | 1 |
| Hill, AD; Ryan, ER; Skehan, SJ | 1 |
| Joyce, RM; Parker, JA; Williams, G | 1 |
| Groeschel, A; Hellwig, D; Kirsch, CM; Kremp, S; Nestle, U; Rübe, C; Schaefer-Schuler, A | 1 |
| Franc, BL; Jablons, DM; Odisho, AY; Raz, DJ | 1 |
| Demmy, T; Fischer, G; Glinianski, M; Lamonica, D; Nwogu, C; Tan, D | 1 |
| Bhat, S; Bhatt, B; Camazine, B; Erickson, RA; Gupta, R; Jadhav, Y; Khan, A; Khode, R; Mukhopadhyay, P; Reddy, R; Shah, RS; Sharma, A; Sikka, P; Singh, P; Smith, DD; Yaqub, Y; Zheng, Q | 1 |
| Abbey, CK; Borowsky, AD; Cardiff, RD; Cherry, SR; Gregg, JP | 1 |
| Bares, R; Budach, W; Eschmann, SM; Friedel, G; Hehr, T; Langen, HJ; Paulsen, F; Reimold, M | 1 |
| Döbert, N; Kovács, AF; Landes, CA; Walendzik, H; Zaplatnikov, K | 1 |
| Akhurst, T | 1 |
| Hicks, RJ; Lau, EW; Ware, RE | 1 |
| Rankin, SC | 1 |
| Quint, LE | 1 |
| Baek, CH; Choi, JY; Chung, M; Jeong, HS; Ko, YH; Son, YI | 1 |
| Bertling, J; Cederblad, L; Johansson, S; Karlsson, M; Langström, B; Nilsson, P; Riklund, K; Sörensen, J; Sun, A; Turesson, I | 1 |
| Ginsberg, MS; Grewal, RK; Heelan, RT | 1 |
| Berrettini, A; De Cicco, C; Fernandez, JR; Galimberti, VE; Intra, M; Luini, A; Paganelli, G; Rotmensz, N; Spano, G; Veronesi, P; Veronesi, U; Viale, G | 1 |
| Bryant, AS; Cerfolio, RJ; Garver, RI; Robert, F; Scott, E; Sharma, M; Spencer, SA | 1 |
| Cabrera Martín, MN; Calvo Manuel, F; Carreras Delgado, JL; Pasamontes Pingarrón, JA; Pérez Castejón, MJ; Scola Yurrita, B | 1 |
| Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
| Alavi, A; Basu, S | 1 |
| Nieweg, O; Valdés Olmos, R | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Katsumata, N; Sawada, M | 1 |
| Blackstone, EH; Lauer, MS; Murthy, SC; Okereke, IC; Rice, TW | 1 |
| Krüger, S; Mottaghy, FM; Pauls, S | 1 |
| Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE | 1 |
| Choi, JY; Chung, MJ; Kim, BT; Kim, H; Kim, HY; Kim, YK; Kwon, OJ; Lee, KS; Shim, YM; Yi, CA | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 2 |
| Aramendía, JM; Ceamanos, C; García-Velloso, MJ; Garrastachu, MP; Jurado, M; López-García, G; Richter, JA | 1 |
| Hirai, T; Katsuragawa, S; Murakami, D; Murakami, R; Nishimura, R; Ota, K; Oya, N; Shiraishi, S; Tomiguchi, S; Uozumi, H; Yamashita, Y | 1 |
| Choi, SH; Kim, JS; Kim, MR; Kim, SY; Nam, SY; Roh, JL | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, MR; Kim, SY; Lee, JH; Nam, SY; Roh, JL | 1 |
| Alberini, JL; Banal, A; Gontier, E; Le Stanc, E; Pecking, AP; Tainturier, C; Vilain, D; Wartski, M | 1 |
| Akaki, S; Iguchi, T; Kanazawa, S; Matsuoka, J; Mifune, H; Okumura, Y; Omori, M; Sato, S | 1 |
| Berthelsen, AK; Hillingsoe, J; Kirkegaard, P; Larsen, PN; Loft, A; Mogensen, AM; Rappeport, ED; Rasmussen, A; Thomsen, C; von der Recke, P; Wettergren, A | 1 |
| Berthelsen, AK; Engelholm, SA; Højgaard, L; Knudsen, J; Loft, A; Lundvall, L; Nedergaard, L; Ottosen, C; Roed, H | 1 |
| Chen, S; Cheng, TK; Ho, CL; Yeung, DW | 1 |
| Abe, S; Ikeda, M; Ishigaki, T; Ito, S; Iwano, S; Kato, K; Makino, N; Naganawa, S; Nakano, S; Nishino, M; Tadokoro, M | 1 |
| Aupérin, A; Avril, MF; Boitier, F; Cavalcanti, A; Kolb, F; Leboulleux, S; Lumbroso, J; Mamelle, G; Masson, F; Maubec, E; Spatz, A; Suciu, V | 1 |
| Adelstein, DJ; Carroll, MA; Esclamado, RM; Lorenz, RR; Rybicki, LA; Saxton, JP; Strome, M; Tan, A; Wood, BG | 1 |
| Huang, LL; Liang, TJ; Nie, YX; Qin, SL; Wang, Q; Wang, Y; Yue, MG; Zhang, CQ; Zhao, YM | 1 |
| Fujii, H; Goto, K; Kubota, K; Murakami, K; Nagase, S; Nawano, S; Niho, S; Nishiwaki, Y; Ohmatsu, H; Saijo, N; Sekiguchi, R; Yoh, K | 1 |
| Buatti, JM; Chang, K; Graham, MM; Hoffman, HT; Luo, P; Menda, Y; Tan, H; Yao, M | 1 |
| Binns, DS; Drummond, E; Hicks, RJ; Hogg, A; Lau, EW; Shakher, R; Wang, GH | 1 |
| Fleshman, JW; Strasberg, SM; Yang, YY | 1 |
| Abenhardt, W | 1 |
| Chen, DW; Cheng, YL; Huang, TW; Lee, SC; Tsai, WC; Tzao, C | 1 |
| Asadpour, B; Coenen, HH; Demirel, C; DiMartino, E; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Maneschi, P; Pinkawa, M; Piroth, M; Reinartz, P; Scholbach, T; Stanzel, S; Zimny, M | 1 |
| Chen, Y; Cui, NJ; Ma, J; Sun, Y; Tang, LL; Wang, Y; Wu, HB; Zong, JF | 1 |
| Abgral, R; Bizais, Y; Couturier, O; Kraeber-Bodéré, F; Querellou, S; Salaun, PY; Valette, G | 1 |
| Dietl, B; Kölbl, O; Marienhagen, J; Murthum, T | 1 |
| Li, JG; Li, YM; Zhao, TT | 1 |
| Fu, Z; Guo, HB; Li, WW; Liu, TH; Yang, GR; Yang, XH; Yu, JM; Yu, YH; Yuan, SH | 1 |
| Dilege, S; Ece, T; Erelel, M; Halac, M; Mudun, A; Sonmezoglu, K; Toker, A; Turkmen, C; Yilmazbayhan, D | 1 |
| Al-Sarraf, N; Aziz, R; Doddakula, K; Gately, K; McGovern, E; Wilson, L; Young, V | 1 |
| Honma, Y; Koga, S; Nakano, S; Ogasawara, N | 1 |
| Gosselin, R; Kelles, A; Maddens, S; Tournoy, KG; Van Maele, G; van Meerbeeck, JP | 1 |
| Hayashi, M; Murakami, K; Oyama, T; Shimoda, W; Sunagawa, M | 1 |
| Fujii, M; Ogawa, K; Ozawa, H; Sakamoto, K; Tagawa, T; Tomita, T; Yamaguchi, H | 1 |
| Chen, JH; Li, D; Ling, R; Wang, J; Wang, L; Yao, Q | 1 |
| Huang, DQ; Li, WR; Ou, XY | 1 |
| Dooms, C; Stroobants, S; Vansteenkiste, J; Wynants, J | 1 |
| Hicks, RJ; Mac Manus, MP | 1 |
| Adler, LP; Avril, N | 1 |
| Bybel, B | 1 |
| Chang-Yu, W; Chen, MT; Chen, YJ; Li, SH; Wang, SL | 1 |
| Espié, M; Giacchetti, S; Groheux, D; Hindie, E; Misset, JL; Moretti, JL; Toubert, ME; Vercellino, L | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Chami, L; Dromain, C; Giraudet, AL; Hartl, D; Lassau, N; Leboulleux, S; Lumbroso, J; Ny Tovo, N; Schlumberger, M; Travagli, JP; Vanel, D | 1 |
| Dietl, B; Kölbl, O; Kühnel, T; Marienhagen, J; Schreyer, A | 1 |
| Chen, GB; Guan, YS; Luo, ZM; Pan, WM; Sun, L; Wu, H | 1 |
| Bootsma, G; De Ruysscher, D; Dehing-Oberije, C; Geraedts, W; Hochstenbag, M; Lambin, P; Pitz, C; Rahmy, A; Simons, J; Steck, H; Teule, J; Thimister, P; van der Weide, H | 1 |
| Becker, K; Fink, U; Lordick, F; Ott, K; Peschel, C; Schwaiger, M; Siewert, JR; Stein, HJ; Weber, WA | 1 |
| Koyama, H; Nogami, M; Ohbayashi, C; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yoshimura, M | 1 |
| Erasmus, JJ; Macapinlac, HA; Swisher, SG | 1 |
| Balogova, S; Chater, PE; Grahek, D; Hugentobler, A; Kerrou, K; Montravers, F; Périé, S; St Guily, JL; Susini, B; Talbot, JN | 1 |
| Kunst, PW; Lee, P; Paul, MA; Senan, S; Smit, EF | 1 |
| Bassi, MC; Brambilla, M; Cannillo, B; Inglese, E; Krengli, M; La Mattina, P; Loi, G; Sacchetti, G; Turri, L | 1 |
| Inoue, M; Ito, M; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Numao, N | 1 |
| Galysh, RL; Hernandez, A; Jones, DR; Kahaleh, M; McDonough, PB; Northup, PG; Shami, VM; Shen, KR; White, GE | 1 |
| Graeter, TP; Groeschel, A; Hellwig, D; Kirsch, CM; Schaefers, HJ; Sybrecht, GW; Ukena, D | 1 |
| Avci, ME; Duman, Y; Ertopcu, K; Sayhan, S; Sehirali, S; Tinar, S; Yildirim, Y; Yilmaz, C | 1 |
| Chang, TC; Chao, A; Hong, JH; Hsueh, S; Lai, CH; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Alavi, A; Basu, S; Cermik, TF; Mavi, A | 1 |
| Antoch, G; Barkhausen, J; Bockisch, A; Fischer, M; Freudenberg, L; Gutzeit, A; Kuehl, H; Nassenstein, K; Stergar, H; Veit-Haibach, P | 1 |
| Arima, S; Hasegawa, Y; Nakashima, T; Nishio, M; Ogawa, T; Ozawa, T; Suzuki, H; Suzuki, M; Tamaki, T; Terada, A | 1 |
| Fu, Z; Guo, HB; Han, AQ; Liu, LP; Yang, GR; Yu, JM | 1 |
| Dalesio, O; de Jong, WK; Groen, HJ; Oyen, WJ; Pruim, J; van der Heijden, HF | 1 |
| Chuthapisith, S; El-Sheemy, M; Eremin, JM; Eremin, O; Griffiths, PA; Jibril, JA; Marshall, C; Mustafa, S; Wheatley, DC | 1 |
| Fujishita, M; Fujishita, T; Kishida, M; Kobayashi, M; Maruyama, M; Miyabayashi, K; Mizushima, Y; Shinoda, C; Taki, H | 1 |
| Boersma, L; Bosmans, G; De Ruysscher, D; Dekker, A; Lambin, P; Ollers, M; van Baardwijk, A; Wanders, S | 1 |
| Haug, A; Sommer, HL; Tiling, R | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Ochi, M; Oshitani, N; Sasaki, E; Shiba, M; Tanaka, F; Tominaga, K; Uchida, T; Watanabe, T; Yamada, T | 1 |
| Bundgaard, T; Buus, S; Grau, C; Hansen, HS; Johansen, J; Keiding, S; Kirkegaard, J; Loft, A; Overgaard, J; Overgaard, M | 1 |
| Giaccone, G | 1 |
| Evans, WK; Gulenchyn, K; Lacchetti, C; Maziak, DE; Smith, CA; Ung, YC; Vanderveen, JA | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T | 1 |
| Laing, R; Nam, H; Smith, S | 1 |
| Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, JK; Lee, JD; Rha, SY; Yoon, KT; Yun, M | 1 |
| Acland, K; Constantinidou, A; Harries, M; Healy, C; Hofman, MS; O'Doherty, M | 1 |
| Choi, JY; Kim, BT; Kim, S; Kwon, OJ; Lee, KS; Sung, YM; Yang, SO | 1 |
| Bender, H; Biersack, HJ; Pleiss, C; Risse, JH | 1 |
| Aulmann, S; Buchmann, I; Haberkorn, U; Hoffner, S; Mack, U; Riedmüller, K | 1 |
| Avisar, E; Molina, M | 1 |
| Bedrosian, I; Buchholz, TA; Cavalcanti, JL; Macapinlac, HA; Oh, JL; Perkins, GH; Reed, VK; Strom, EA; Tereffe, W; Whitman, GJ; Woodward, WA; Yeung, H; Yu, TK | 1 |
| Hwang, CY; Kim, JS; Kim, JY; Kim, MH; Lee, SK; Lee, SS; Lee, TY; Seo, DW; Yun, SC | 1 |
| Hinterthaner, M; Stamatis, G | 1 |
| Heijenbrok-Kal, MH; Hunink, MG; Kuipers, EJ; Siersema, PD; van Vliet, EP | 1 |
| Gulenchyn, KY; Hodgson, NC | 1 |
| Bral, S; De Coninck, P; Everaert, H; Storme, G; Vinh-Hung, V | 1 |
| Aogi, K; Inoue, T; Nishimura, R; Ohsumi, S; Taira, N; Takabatake, D; Takashima, S | 1 |
| Al-Sarraf, N; Gately, K; Lucey, J; McGovern, E; Wilson, L; Young, V | 1 |
| Chang, YC; Chen, KC; Cheng, MF; Lee, JM; Lee, YC; Wang, J; Wu, YW; Yen, RF | 1 |
| De Leyn, P; Dooms, C; Nackaerts, K; Stroobants, S; Vansteenkiste, J; Verbeken, E | 1 |
| Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Chung, JH; Kim, SE; Lee, WW; Nguyen, XC; Park, SY; So, Y | 1 |
| Maele, GV; Praet, M; Ryck, FD; Tournoy, KG; van Meerbeeck, JP; Vanwalleghem, L; Vermassen, F | 1 |
| Englmeier, KH; Seemann, MD | 1 |
| Gold, MA; Lanciano, R; Rose, PG; Tian, C; Whitney, CW | 1 |
| Borger, J; Bosmans, G; De Ruysscher, D; Dekker, A; Dingemans, AM; Hochstenbag, M; Houben, R; Lambin, P; Oellers, M; Offermann, C; Snoep, G; Teule, J; van Baardwijk, A; van Loon, J; Wanders, R | 1 |
| Carlson, D; Fury, M; Kraus, DH; Larson, SM; Lee, NY; Ong, SC; Patel, SG; Pfister, DG; Schöder, H; Shah, JP | 1 |
| Boterberg, T; Goethals, I; Ost, P; Rottey, S; Smeets, P; Stragier, B | 1 |
| Fukuda, H; Kaneta, T; Kinomura, S; Takahashi, S; Takanami, K; Yamada, S; Yamada, T | 1 |
| Chin, K; Finger, PT; Kurli, M | 1 |
| Gelblum, D; Greco, C; Jackson, A; Rosenzweig, KE; Sura, S; Yorke, ED | 1 |
| Harisinghani, MG; John, SS; Shipley, WU; Zietman, AL | 1 |
| Abe, Y; Asakawa, H; Fukatsu, K; Hama, Y; Ishida, J; Kondo, N; Mochizuki, H; Shigekawa, T; Tamura, K; Tsuda, H; Ueda, S; Yamamoto, M | 1 |
| Fujii, H; Ito, M; Kuwano, H; Saito, N; Tsunoda, Y | 1 |
| Baillet, G; Cuvier, C; Espie, M; Filmont, JE; Giacchetti, S; Groheux, D; Hennequin, C; Hindie, E; Misset, JL; Moretti, JL; Sarandi, F; Toubert, ME; Vilcoq, JR | 1 |
| Chao, M; Feigen, M; Joon, DL; Joon, ML; Kai, C; Khoo, V; Nguyen, BT; Quong, G; Rykers, K; Scott, A; See, A; Wada, M; Zupan, E | 1 |
| Lucignani, G | 1 |
| Macapinlac, HA; Schwartz, DL; Weber, RS | 1 |
| Denaxa-Kyza, D; Evangelou, E; Ioannidis, JP; Kyzas, PA | 1 |
| Chan, SC; Chang, JT; Chin, SC; Fan, KH; Liao, CT; Lin, CY; Ng, SH; Wang, HM; Yen, TC | 1 |
| Boughanim, M; Duvillard, P; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Pham, CT; Rey, A; Schlumberger, M; Zafrani, Y | 1 |
| Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
| Funada, H; Kameda, K; Kamisaki, Y; Kato, H; Murakami, J; Noguchi, K; Seto, H; Watanabe, N | 1 |
| Inubushi, M; Kanegae, K; Kitagawa, Y; Notani, K; Saitoh, M; Takinami, S; Tamaki, N; Tei, K; Totsuka, Y; Yamazaki, Y | 1 |
| Celik, M; Erbagci, A; Erturhan, S; Karakok, M; Seçkiner, I; Yagci, F; Zincirkeser, S | 1 |
| Imabayashi, E; Kuji, I; Matsuda, H; Minagawa, A; Miyauchi, T | 1 |
| Chao, A; Cheng, HH; Ho, KC; Lai, CH; Lin, G; Wang, CC; Yen, TC | 1 |
| Blessing, C; Carl, M; Feine, U; Fierlbeck, G; Geiger, L; Rassner, G | 1 |
| Darcourt, J; Lagrange, JL; Maublant, J | 1 |
| Goodman, PC; Herndon, J; Lowe, VJ; Patz, EF | 1 |
| Arnold, W; Avril, N; Herz, M; Kau, RJ; Kruschke, C; Laubenbacher, C; Saumweber, D; Schwaiger, M; Wagner-Manslau, C; Ziegler, S | 1 |
| Dickinson, CZ; Meier, DA; Scott, GC | 1 |
| Chevretton, E; Croft, D; McGurk, M; Wong, WL | 1 |
| Hubner, KF; Raja, S; Yasuda, S | 1 |
| Dewan, NA; Gobar, LS; Hauser, LG; Scott, WJ; Sugimoto, JT; Sunderland, JJ | 1 |
| Cappellari, JO; Geisinger, KR; Greven, KM; Keyes, JW; McGuirt, WF; Watson, NE; Williams, DW | 1 |
| Bohdiewicz, PJ; Dworkin, HJ; Fink-Bennett, D; Juni, JE; Nagle, C; Scott, GC; Wilner, F | 1 |
| Ahlström, H; Bergh, J; Jansson, T; Långström, B; Lilja, A; Westlin, JE | 1 |
| Bachor, R; Gropengiesser, F; Hautmann, RE; Kocher, F; Reske, SN | 1 |
| Boering, G; Braams, JW; Freling, NJ; Nikkels, PG; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Adler, LP; Crowe, JP; Shenk, RR; Sunshine, J | 1 |
| Drane, WE; Landau, S; Mancuso, AA; Mukherji, SK; Tart, RP | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Reisser, C; Seifert, E; Strauss, LG | 1 |
| Dewan, NA; Gupta, NC; Reeb, SD; Schwabe, JL; Scott, WJ; Sugimoto, JT | 1 |
| Drane, WE; Mancuso, AA; Mukherji, SK | 1 |
| Greenough, RL; Meyer, CR; Orringer, MB; Quint, LE; Wahl, RL; White, RI | 1 |
| Bares, R; Büll, U; Cremerius, U; Fass, J; Hauptmann, S; Hellwig, D; Klever, P; Mittermayer, C; Schumpelick, V | 1 |
| Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Wong, WH | 1 |
| Benchaou, M; Donath, A; Lacroix, JS; Lehmann, W; Rüfenacht, D; Ryser, JE; Slosman, DO; Townsend, D; Widmann, JJ | 1 |
| Francis, IR; Gritters, LS; Wahl, RL; Zasadny, KR | 1 |
| Broussard, WF; Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Tilbury, RS; Wong, WH | 1 |
| Bailet, J; Chaiken, L; Choi, Y; Hanafee, WN; Hoh, CK; Jabour, BA; Lufkin, RB; Maddahi, J; Rege, SD; Soong, JC | 1 |
| Dimitrakopoulou, A; Doll, J; Haberkorn, U; Helus, F; Oberdorfer, F; Reisser, C; Seiffert, E; Strauss, LG; van Kaick, G; Ziegler, S | 1 |
| Adler, LP; al-Kaisi, NK; Crowe, JP; Sunshine, JL | 1 |
| Chin, R; Choplin, RH; Haponik, EF; Hudspeth, AS; Keyes, JW; Reed, JC; Wallenhaupt, S; Ward, R | 1 |
| Blahd, W; Brown, C; Khonsary, A; Mandelkern, M; Santiago, SM; Sazon, DA; Soo Hoo, GW; Williams, AJ | 1 |
| de Wit, M; Durig, J; Fiedler, W; Hossfeld, DK; Steffen, M | 1 |
| Gross, MD; Grossman, HB; Shreve, PD; Wahl, RL | 1 |
| Drane, WE; Mancuso, AA; Mendenhall, WM; Mukherji, SK; Parsons, JT; Stringer, S | 1 |
| Bachor, R; Brändle, E; Gottfried, HW; Hautmann, R; Kotzerke, J; Reske, SN | 1 |
| Göhring, UJ; Pietrzyk, U; Scharl, A; Scheidhauer, K; Schicha, H; Schomäcker, K; Wagner, R | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Ishida, T; Kuwabara, Y; Masuda, K; Murayama, S; Sasaki, M; Sugio, K; Yoshida, T | 1 |
| Bassa, P; Buzdar, AU; Hicks, KW; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Gunel, E; Gupta, NC; Maloof, J | 1 |
| Holle, LH; Lung-Kurt, S; Oberhausen, E; Püschel, W; Schmidt, S; Trampert, L; Villena-Heinsen, CE | 1 |
| Arweiler, D; Müller, S; Schipper, JH; Schrader, M; Sciuk, J | 1 |
| Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
| Hawkins, RA; Hoh, CK; Huang, SC; Phelps, ME; Wu, HM; Yao, WJ | 1 |
| Bares, R; Büll, U; Cremerius, U; Dohmen, BM; Fass, J; Teusch, M | 1 |
| Avril, N; Dose, J; Graeff, H; Herz, M; Jänicke, F; Nathrath, W; Römer, W; Schwaiger, M; Weber, W; Ziegler, S | 1 |
| Bishop, AF; Smith, SM; Young, CS | 1 |
| Utech, CI; Winter, PF; Young, CS | 1 |
| Albert, A; Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Limet, R; Paulus, P; Radermecker, M; Rigo, P; Schoffers, J; Weber, T | 1 |
| Allemann, F; Berthold, T; Engel, H; Hauser, M; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Adler, LP; Al-Kasi, NL; Faulhaber, PF; Schnur, KC; Shenk, RR | 1 |
| Coleman, JJ; Hutchins, G; Schauwecker, D; Wagner, JD | 1 |
| Greenough, R; Grossman, HB; Kison, PV; Kosuda, S; Wahl, RL | 1 |
| Bangerter, M; Diederichs, CG; Guhlmann, A; Herrmann, F; Kolokythas, O; Kotzerke, J; Merkle, E; Moog, F; Reske, SN | 1 |
| Ahmed, M; Bakheet, SM; Hammami, MM; Powe, JE | 1 |
| Deloar, HM; Fujiwara, T; Hayashi, Y; Itoh, M; Kanamaru, R; Miyake, M; Nakamura, T; Takahashi, H; Watabe, H; Yoshioka, T | 1 |
| Baddeley, H; Beaney, R; Chevretton, EB; Davis, J; Hussain, K; Maisey, M; McGurk, M; Tierney, P; Wong, WL | 1 |
| Burdon, TA; Hagberg, RC; Pompili, MF; Segall, GM; Stark, P | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Ruhlmann, J; Schräder, M; Willkomm, P | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Zamora, P | 1 |
| Hautzel, H; Müller-Gärtner, HW | 1 |
| Belani, CP; Ferson, PF; Keenan, RJ; Landreneau, RJ; Luketich, JD; Meltzer, CC; Schauer, PR; Townsend, DW; Urso, GK | 1 |
| Bailey, MS; Block, MI; Cooper, JD; Dehdashti, F; Flanagan, FL; Patterson, GA; Siegel, BA; Sundaresan, RS | 1 |
| Belani, CP; Cidis Meltzer, C; Ferson, PF; Keenan, RJ; Luketich, JD; Schauer, P; Townsend, DW; Urso, K | 1 |
| De Leyn, PR; Dupont, PJ; Mortelmans, LA; Nackaerts, KL; Stroobants, SG; Vansteenkiste, JF; Verschakelen, JA | 1 |
| Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Hustinx, R; Paulus, P; Radermecker, M; Rigo, P | 1 |
| Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; Vesselle, H | 1 |
| Agresti, R; Bogni, A; Bombardieri, E; Chiesa, C; Crippa, F; De Sanctis, V; Delledonne, V; Greco, M; Leutner, M; Pascali, C; Salvadori, B; Seregni, E | 1 |
| Higashi, K; Nambu, Y; Nishikawa, T; Oguchi, M; Okimura, T; Seki, H; Tonami, H; Ueda, Y; Yamamoto, I; Yuasa, K | 1 |
| Dietlein, M; Scheidhauer, K; Schicha, H; Theissen, P; Voth, E | 1 |
| Lamonica, D; Myers, LL; Nabi, H; Simpson, GT; Wax, MK | 1 |
| Abdel-Nabi, H; Carbone, GM; Cronin, VR; Doerr, RJ; Galantowicz, PJ; Lamonica, DM; Spaulding, MB | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
| Abdel-Dayem, HM; Abujudeh, H; Atay, S; El-Zeftawy, HM; Luo, JQ; Marans, HY; Mithilesh, K; Naddaf, SY; Omar, WS; Radin, AI; Wong, S | 1 |
| Ali, A; Alibazoglu, H; LaMonica, G; Megremis, D | 1 |
| Deters, EC; Gross, MD; Kison, PV; Shreve, PD; Steventon, RS; Wahl, RL | 1 |
| Johnson, T; Macfarlane, DJ; Sondak, V; Wahl, RL | 1 |
| Altenvoerde, G; Kuwert, T; Lerch, H; Matheja, P; Schäfers, M; Schober, O | 1 |
| Beyer, W; Clausen, M; Grimm-Riepe, C; Lübeck, M; Schirren-Bumann, K; Schlüter, B | 1 |
| Wahl, RL | 1 |
| Agresti, R; Bombardieri, E; Chiti, A; Crippa, F; Draisma, A; Greco, M; Maffioli, L | 1 |
| Lowe, VJ; Naunheim, KS | 1 |
| Adamietz, IA; Adams, S; Baum, RP; Bormeth, SB; Böttcher, HD; Hör, G; Mose, S; Rahn, AN; Sengupta, S | 1 |
| Ah-See, AK; Eremin, O; Heys, SD; Jibril, JA; Miller, ID; Norton, M; Ogston, KN; Sharp, P; Smith, FW; Smith, IC; Whitford, P | 1 |
| Adams, S; Baum, RP; Bitter, K; Hör, G; Stuckensen, T | 1 |
| AAssar, OS; Caputo, GR; Dillon, WP; Fischbein, NJ; Hawkins, RA; Kaplan, MJ; Price, DC; Singer, MI | 2 |
| Donald, PJ; Manolidis, S; Pounds, TR; Volk, P | 1 |
| Al Suhaibani, H; Bakheet, SM; Ezzat, A; Powe, J; Rostom, A; Tulbah, A | 1 |
| Benz, P; Grötz, KA; Kuffner, HD; Kunkel, M; Spitz, J; Wagner, W; Wahlmann, U | 1 |
| Alavi, A; Albelda, SM; Bénard, F; Kaiser, LR; Smith, RJ; Sterman, D | 1 |
| Bockisch, A; Brandt-Mainz, K; Müller, SP; Sonnenschein, W | 1 |
| Cook, GJ; Mason, R; Rankin, SC; Taylor, H | 1 |
| Collignon, J; Deneufbourg, JM; Hustinx, R; Moreau, P; Paulus, P; Rigo, P; Sambon, A; Vivegnis, D | 1 |
| Bogaert, JG; De Leyn, PR; De Wever, WF; Dupont, PJ; Maes, FP; Nuyts, JL; Stroobants, SG; Vansteenkiste, JF; Verbeken, EK | 1 |
| Präuer, HW; Römer, W; Schwaiger, M; Treumann, T; Weber, WA; Ziegler, SI | 1 |
| Myers, LL; Wax, MK | 1 |
| De Leyn, PR; Dupont, PJ; Stroobants, SG; Vansteenkiste, JF; Verbeken, EK | 1 |
| Fukuchi, K; Hamada, S; Hayashida, K; Ishida, Y; Nakanishi, N; Nishimura, T; Satoh, T; Shimotsu, Y; Takamiya, M; Toba, M | 1 |
| Ackermann, R; Fürst, G; Gerharz, CD; Müller-Gärtner, HW; Müller-Mattheis, V; Reinhardt, M; Vosberg, H | 1 |
| Saunders, M; Wong, WL | 1 |
| Bruchhaus, H; Hillinger, S; Largiadèr, F; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Kison, PV; Raylman, RR; Wahl, RL | 1 |
| Hoh, CK; Schiepers, C | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC; Rogers, JS | 1 |
| Ivancevic, V | 1 |
| Bachor, R; Hautmann, R; Kotzerke, J; Reske, SN | 1 |
| Borgstein, PJ; Hoekstra, OS; Meijer, S; Mijnhout, GS; Pijpers, R; Teule, GJ | 1 |
| Dietlein, M; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Smolarz, K; Stützer, H | 1 |
| Graeber, GM; Gupta, NC; Murray, GF | 1 |
| Austin-Seymour, MM; Cortese, AA; Ellis, GK; Gralow, JR; Hathaway, PB; Hayes, CE; Mankoff, DA; Maravilla, KR; Moe, RE | 1 |
| Johkoh, T; Kusuoka, H; Miyoshi, S; Nakamura, H; Nishimura, T; Tatsumi, M; Tomiyama, N; Watanabe, Y; Yutani, K | 1 |
| Dussek, JE; Maisey, MN; O'Doherty, MJ; Saunders, CA | 1 |
| Jadvar, H; McDougall, IR; Segall, GM | 1 |
| Coleman, JJ; Davidson, D; Hayes, JT; Hutchins, G; Love, C; Saxman, S; Schauwecker, D; Wagner, JD | 1 |
| Hanasono, MM; Ku, GH; Kunda, LD; Segall, GM; Terris, DJ | 1 |
| Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H | 1 |
| Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Greven, KM; Joyce, WT; Keyes, JW; McGuirt, WF; Williams, DW | 1 |
| Koh, JH; Pai, M; Park, CH; Suh, JH | 1 |
| Eisbruch, A; Kison, PV; Kosuda, S; Recker, BE; Sugawara, Y; Wahl, RL | 1 |
| Dworkin, HJ; Wong, CO | 2 |
| Cho, BY; Choi, CW; Chung, JK; Hong, SW; Lee, DS; Lee, JS; Lee, MC; Lim, SM; So, Y; Youn, YK | 1 |
| Kusuoka, H; Nishimura, T; Shiba, E; Tatsumi, M; Yutani, K | 1 |
| Wagner, HN | 1 |
| Abdul-Karim, FW; Adler, LP; Faulhaber, PF; Miraldi, F; Rodriguez, M; Rose, PG | 1 |
| Fujiwara, T; Fukuda, H; Gamo, M; Ido, T; Ishioka, C; Iwata, R; Kanamaru, R; Murakawa, Y; Yoshioka, T | 1 |
| Coleman, RE; Culhane, DK; Erasmus, JJ; Goodman, PC; Herndon, JE; Marom, EM; McAdams, HP; Patz, EF | 1 |
| Avril, N; Schwaiger, M; Weber, WA | 1 |
| Bohuslavizki, KH; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Thoms, J; Werner, JA | 1 |
| Delbeke, D | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Friberg, L; Lassen, U | 1 |
| Choe, KJ; Chung, JK; Kang, HS; Kim, JS; Kim, YC; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK; Yun, IJ | 1 |
| Arocena, J; Berián, JM; Giménez, M; Richter, JA; Robles, JE; Rodriguez-Rubio, F; Rosell, D; Sánchez, D; Sanz, G | 1 |
| Biersack, HJ; Oehr, P; Ruhlmann, J | 1 |
| Alia, AG; Amin, T; Bakheet, SM; Kuzo, R; Powe, J | 1 |
| Carretta, A; Del Maschio, A; Fazio, F; Gilardi, MC; Landoni, C; Lucignani, G; Magnani, P; Messa, C; Rizzo, G; Vanzulli, A; Zannini, P | 1 |
| Adam, G; Büll, U; Cremerius, U; Di Martino, E; Jänicke, S; Nowak, B; Reinartz, P; Zimny, M | 1 |
| Bleckmann, C; Bohuslavizki, KH; Buchert, R; Clausen, M; Dose, J; Jänicke, F; Klutmann, S; Mester, J | 1 |
| Kase, S; Sasaki, M; Sugimachi, K; Sugio, K; Yamazaki, K | 1 |
| Andersson, AP; Dahlstrøm, K; Drzewiecki, KT; Eigtved, A; Friberg, L; Holm, S; Højgaard, L; Jensen, M; Rabøl, A; Sørensen, SS | 1 |
| Hordijk, GJ; Koole, R; Stokkel, MP; ten Broek, FW; van Rijk, PP | 1 |
| Brown, C; Juillard, G; Mandelkern, M; Mark, R; Rege, S; Sadeghi, A; Safa, A; Santiago, S; Tran, L; Weng, E | 1 |
| Beger, HG; Brambs, HJ; Diederichs, CG; Glasbrenner, B; Glatting, G; Reske, SN; Staib, L; Vogel, J | 1 |
| Bishop, HA; Graeber, GM; Gupta, NC | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| Baier, P; Dingeldey, A; Einert, A; Farthmann, EH; Imdahl, A; Mix, M; Nitzsche, EU; Reinhardt, MJ | 1 |
| Choi, JY; Kim, BT; Kim, JJ; Kim, SE; Lee, KH; Lee, KS; Shim, YM | 1 |
| Bohuslavizki, KH; Buchert, R; Clausen, M; Klutmann, S; Kröger, S; Mester, J; Sonnemann, U; Werner, JA | 1 |
| Farrell, MA; Herndon, JE; McAdams, HP; Patz, EF | 1 |
| Chisin, R; Freedman, N; Gimon, Z; Klein, M; Lotem, M; Marciano, R; Moshe, S | 1 |
| Börner, AR; Flügel, M; Knapp, WH; Kühnel, G; Redeker, J; Weckesser, E | 1 |
| Büll, U; Cremerius, U; Di Martino, E; Hausmann, R; Krombach, GA; Nowak, B; Sellhaus, B; Westhofen, M | 1 |
| Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, SP; Saller, B | 1 |
| Hain, SF; Huddart, RA; Leslie, MD; O'Doherty, MJ; Partridge, SE; Timothy, AR | 1 |
| De Leyn, PR; De Wever, W; Gatti, GG; Huyskens, DP; Kutcher, GJ; Stroobants, SG; Vansteenkiste, JF; Vanuytsel, LJ; Verbeken, EK | 1 |
| Fidler, V; Groen, HJ; Koëter, GH; Meuzelaar, JJ; Mooyaart, EL; Pieterman, RM; Pruim, J; Vaalburg, W; van Putten, JW | 1 |
| Berlangieri, SU; Scott, AM | 1 |
| Grahek, D; Kerrou, K; Monceaux, G; Montravers, F; Périé, S; St Guily, JL; Talbot, JN | 1 |
| Damm, M; Eckel, H; Jungehülsing, M; Pietrzyk, U; Scheidhauer, K; Schicha, H; Stennert, E | 1 |
| Bormans, G; Coosemans, W; De Leyn, P; De Wever, W; Dupont, P; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, A; Mortelmans, L; Peeters, M; Stroobants, S; Van Cutsem, E; Van Raemdonck, D | 1 |
| Belli, F; Bombardieri, E; Cascinelli, N; Crippa, F; Gallino, F; Greco, M; Leutner, M; Pilotti, S | 1 |
| Hara, T; Inagaki, K; Kosaka, N; Morita, T | 1 |
| Dietlein, M; Gossmann, A; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Stützer, H | 1 |
| Grosse, S; Guhlmann, A; Halter, G; Liewald, F; Reske, S; Storck, M; Sunder-Plassmann, L | 1 |
| Kubota, M; Makuuchi, H; Ohta, M; Okumura, A; Saitoh, Y; Shohtsu, A; Suzuki, Y; Tajima, T; Tokuda, Y; Yasuda, S | 1 |
| Enomoto, K; Fujii, H; Hojo, T; Ide, M; Ikeda, T; Kameyama, K; Kubo, A; Shohtsu, A; Yasuda, S | 1 |
| Bangard, M; Bender, H; Biersack, HJ; Decker, P; Grünwald, F; Willkomm, P | 1 |
| Bender, H; Biersack, HJ; Grünwald, F; Guhlke, S; Oehr, P; Ruhlmann, J | 1 |
| Charron, M; Dachille, MA; Friedman, D; Luketich, JD; Meehan, M; Meltzer, CC; Strollo, D; Townsend, DW; Urso, GK | 1 |
| Dietlein, M; Gandjour, A; Lauterbach, KW; Moka, D; Schicha, H; Theissen, P; Weber, K | 2 |
| Coosemans, W; De Leyn, P; De Wever, W; Decker, G; Deneffe, G; Ectors, N; Flamen, P; Hiele, M; Lerut, T; Mortelmans, L; Peeters, M; Van Cutsem, E; Van Raemdonck, D | 1 |
| Beuthien-Baumann, B; Bredow, J; Burchert, W; Franke, WG; Hliscs, R; Kropp, J; Kühne, A; Tiepolt, C | 1 |
| ChangLai, SP; Chieng, PU; Ho, YJ; Hsieh, JF; Kao, CH; Tsai, SC; Yen, RF | 1 |
| Cachin, F; Lumbroso, J; Maublant, J; Raoul, JL; Syrota, A; Vuillez, JP | 1 |
| Akino, H; Kanamaru, H; Okada, K; Oyama, N | 1 |
| de Dreuille, O; Dot, JM; Foehrenbach, H; Gaillard, JF; Grassin, F; Guigay, J; L'Her, P; Margery, J; Maszelin, P; Vaylet, F | 1 |
| de Klerk, JM; Hordijk, GJ; Stokkel, MP | 1 |
| Kim, BT; Kim, K; Lee, KS; Park, SJ; Shim, YM | 1 |
| Ehritt-Braun, C; Högerle, S; Ihling, C; Krause, TM; Mix, M; Moser, E; Reinhardt, MJ; Vogelgesang, D | 1 |
| Ahn, IM; Cho, BY; Chung, JK; Hong, SJ; Kim, S; Lee, DS; Lee, E; Lee, MC; So, Y; Yeo, JS; Youn, YK | 1 |
| Agresti, R; Asero, S; Bombardieri, E; Cascinelli, N; Crippa, F; Ferraris, C; Gennaro, M; Gerali, A; Giovanazzi, R; Greco, M; Micheli, A; Seregni, E | 1 |
| Angelides, S; Dixon, J; Roman, MR; Rossleigh, MA; Walker, BM | 1 |
| Kato, T; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Nakada, K; Shiga, T; Tamaki, N; Tsukamoto, E; Yoshinaga, K | 1 |
| de Vries, EG; Groen, HJ; Jager, PL; Piers, DA; Pieterman, RM; van der Leest, A; van Putten, JW | 1 |
| Kanakura, Y; Kitayama, H; Nakamura, H; Nishimura, T; Sugahara, H; Tatsumi, M; Tokita, N | 1 |
| Ackermann, R; Börner, AR; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Müller-Mattheis, V | 1 |
| Borges-Neto, S; Ravizzini, GC; Wagner, M | 1 |
| Barthel, H; Berr, F; Caca, K; Georgi, P; Hesse, S; Huster, D; Kluge, R; Schmidt, F; Seese, A | 1 |
| Acland, KM; Calonje, E; Healy, C; Higgins, E; Nunan, T; O'Doherty, M; Page, C; Russell-Jones, R | 1 |
| Hoegerle, S; Joe, A; Moser, E | 1 |
| Brink, I; Digel, W; Henke, M; Herget, G; Mix, M; Moser, E; Nitzsche, E; Reinhardt, M; Schumacher, T | 1 |
| Fischer, U; Georgi, P; Hesse, S; Horn, LC; Kluge, R; Kühnel, G; Seese, A | 1 |
| Al Suhaibani, H; Bakheet, S; Kerr, IG; Manji, MF; Powe, J; Subhi, J | 1 |
| Ball, DL; Hicks, RJ; Hogg, A; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE; Wirth, A | 1 |
| Cho, BY; Chung, JK; Jang, JJ; Jeong, JM; Lee, DS; Lee, MC; Lee, YJ; Min, JJ | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Füzy, M; Kásler, M; Lengyel, Z; Perner, F; Repa, I; Szakáll, S; Szavcsur, P; Szentirmay, Z; Trón, L | 1 |
| Cousins, C; deSouza, NM; Dina, R; Fuchsel, F; McIndoe, GA; Mubashar, M; Peters, AM; Soutter, WP; Williams, AD | 1 |
| Adams, S; Baum, RP; Kovács, AF; Stuckensen, T | 1 |
| Davidson, D; Hutchins, G; Jung, SH; Schauwecker, DS; Wagner, JD; Wenck, S | 1 |
| Altehoefer, C; Ghanem, N; Hoegerle, S; Koehler, G; Moser, E; Nitzsche, E; Scheruebl, H; Waller, CF | 1 |
| Austin-Seymour, MM; Charlop, A; Eary, JF; Ellis, GK; Eubank, WB; Funkhouser, CP; Gralow, JR; Lindsley, KL; Livingston, RB; Mankoff, DA; Shanley, TJ; Takasugi, J; Vesselle, H | 1 |
| Bishop, HA; Graeber, GG; Gupta, NC; Hobbs, GR; Tamim, WJ | 1 |
| Gallowitsch, HJ; Gomez, I; Grünbacher, G; Heinisch, M; Kogler, D; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P; Raunik, W; Unterweger, O; Wiesser, S | 1 |
| Coche, E; Lonneux, M; Noirhomme, P; Poncelet, AJ; Weynand, B | 1 |
| Ang, KK; Byers, RM; Garden, AS; Gillenwater, AM; Morrison, WH; Nguyen, LN; Podoloff, DA; Schechter, NR | 1 |
| Dehdashti, F; Grigsby, PW; Siegel, BA | 1 |
| Mac Manus, M; Salminen, E | 1 |
| Haberkorn, U | 2 |
| Schumpelick, V; Zimny, M | 1 |
| Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
| Courtois, A; De Dreuille, O; Foehrenbach, H; Gaillard, JF; Garcia, D; Kossowski, M; Maszelin, P; Merlet, P; Poncet, JL | 1 |
| Hoekstra, OS; Licht, J; Meijer, S; Torrenga, H; van der Hoeven, JJ; van Diest, PJ | 1 |
| Balogh, JM; Caldwell, CB; Danjoux, CE; Ehrlich, LE; Ganguli, SN; Mah, K; Ung, YC | 1 |
| Blocklet, D; Donckier, V; Goldman, S; Laporte, M; Van Geertruyden, J; Vereecken, P | 1 |
| de Dreuille, O; Foehrenbach, H; Gaillard, JF; Grassin, F; Guigay, J; L'her, P; Margery, J; Maszelin, P; Vaylet, F | 1 |
| Brinkbäumer, K; Dresel, S; Hahn, K; Pöpperl, G; Schmid, R; Schwenzer, K; Szeimies, U | 1 |
| Broelsch, EC; Clausen, M; Frilling, A; Görges, R; Tecklenborg, K; Weber, F | 1 |
| Hollenbeak, CS; Lowe, VJ; Stack, BC | 1 |
| Fujino, K; Hashikawa, K; Nishimura, T; Paul, AK; Tatsumi, M; Yutani, K | 1 |
| Canuel, C; De Gramont, A; Godeberge, P; Grahek, D; Kerrou, K; Montravers, F; Perniceni, T; Talbot, JN; Younsi, N | 1 |
| Bombardieri, E; Crippa, F | 1 |
| Agoston, P; Bajzik, G; Dabasi, G; Esik, O; Repa, I; Sinkovics, I; Szakáll, S; Trón, L | 1 |
| Börner, AR; Knapp, W; Kühnel, G; Rades, D; Schmoll, HJ; Wildfang, I | 1 |
| Braban, LE; Chui, CS; Erdi, AK; Erdi, YE; Hu, YC; Humm, JL; Larson, SM; Macapinlac, HA; Rosenzweig, K; Squire, OD; Yorke, ED | 1 |
| Endo, K; Inoue, T; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Takeuchi, K | 1 |
| Brown, CK; Bushnell, DL; Graham, MM; Kahn, DJ; Kernstine, KH; Madsen, MT; Mclaughlin, KA; Menda, Y; Rossi, NP | 1 |
| Elsinga, PH; Groen, HJ; Pieterman, RM; Pruim, J; Que, TH; Vaalburg, W; van Putten, JW; Willemsen, AT | 1 |
| Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
| Adler, LP; Siegel, BA; Wahl, RL | 1 |
| Balogh, JM; Caldwell, CB; Danjoux, CE; Ehrlich, LE; Ganguli, SN; Mah, K; Tirona, R; Ung, YC | 1 |
| Hellman, P; Juhlin, C; Ladjevardi, S; Sörensen, J; Wärnberg, F | 1 |
| Guller, U; Harder, F; Langer, I; Marti, WR; Moch, H; Nitzsche, EU; Oertli, D; Schirp, U; Torhorst, J; Viehl, CT; Zuber, M | 1 |
| Czernin, J; Filmont, JE; Meta, J; Phelps, ME; Rao, J; Silverman, DH; Valk, PE; Vranjesevic, D | 1 |
| Bohuslavizki, KH; Dose, J; Hemminger, GE | 1 |
| Aquino, SL; Asmuth, JC; Fischman, AJ; Moore, RH; Weise, SB | 1 |
| Binns, DS; Greer, B; Hicks, RJ; Hogg, A; Kalff, V; Ware, RE | 1 |
| Endo, K; Inoue, T; Kato, H; Kuwano, H; Miyazaki, T; Nakajima, M; Ojima, H; Oriuchi, N; Tsukada, K; Yoshikawa, M | 1 |
| Cohn, DE; Dehdashti, F; Gibb, RK; Herzog, TJ; Mutch, DG; Rader, JS; Siegel, BA | 1 |
| Pfaltz, M; Schmid, S; Steinert, H; Stoeckli, SJ | 1 |
| De Geus-Oei, LF; Kiemeney, LA; Oyen, WJ; Spermon, JR; Witjes, JA | 1 |
| Murata, H; Tamura, K; Tsujii, H; Yoshikawa, K | 1 |
| Bormans, G; Cambier, JP; De Leyn, P; De Wever, W; Ectors, N; Flamen, P; Haustermans, K; Lerut, A; Maes, A; Mortelmans, L; Van Cutsem, E; Van Raemdonck, D | 1 |
| Grigsby, PW; Miller, TR | 1 |
| Bares, R; Budach, W; Dohmen, BM; Eschmann, SM; Friedel, G; Harer-Mouline, C; Paulsen, F | 1 |
| Dworkin, HJ; Gates, VL; Raman, S; Salem, R; Wong, CY | 1 |
| Dagdelen, O; Hahn, K; Jäger, L; Lang, S; Pöpperl, G; Tatsch, K; Tiling, R | 1 |
| Ikeda, H; Murakami, K; Nawano, S | 1 |
| Endo, K; Mogi, K; Nakasone, Y | 1 |
| Noboru, O | 1 |
| Deák, B; Esik, O; Lengyel, Z; Molnár, Z; Rosta, A; Schneider, T; Székely, J; Trón, L; Várady, E | 1 |
| Emri, M; Erdélyi, L; Erfán, J; Esik, O; Füle, E; Lengyel, E; Lengyel, Z; Olajos, J; Trón, L | 1 |
| Bajzik, G; Dabasi, G; Esik, O; Miklovicz, T; Repa, I; Sinkovics, I; Szakáll, S | 1 |
| Avril, N; Dose, J; Rosé, C | 1 |
| Brunicardi, FC; Choi, Y; Dahlbom, M; Glaspy, JA; Hawkins, RA; Hoh, CK; Maddahi, J; Phelps, ME; Tse, NY; Zinner, MJ | 1 |
| Haberkorn, U; Reisser, C; Strauss, LG | 1 |
| Ethier, SP; Hutchins, GD; Kaminski, MS; Wahl, RL | 1 |
| Paul, R | 1 |
220 review(s) available for fluorodeoxyglucose f18 and Lymph Node Metastasis
| Article | Year |
|---|---|
Diagnostic efficacy of combined CT and MRI in detecting nodal metastasis in patients with oral cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2022 |
The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2022 |
The Role of Preoperative Imaging in the Detection of Lateral Lymph Node Metastases in Rectal Cancer: A Systematic Review and Diagnostic Test Meta-analysis.
Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity | 2022 |
PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Stomach Neoplasms | 2022 |
[A Resected Case of Mesenteric Nodal Metastases from Small Cell Lung Carcinoma].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2022 |
Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thoracic Surgery, Video-Assisted | 2023 |
18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Patient Care Planning; Patient Selection; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2020 |
Diagnostic role of F-18 FDG PET/CT for preoperative lymph node staging in thyroid cancer patients; A systematic review and metaanalysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroid Neoplasms | 2020 |
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography; Uterine Cervical Neoplasms | 2020 |
PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.
Topics: Axilla; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2020 |
18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer.
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
[
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms; Young Adult | 2020 |
Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period | 2021 |
Systemic treatment of a metastatic carotid body tumor: A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Carotid Body Tumor; Cyclophosphamide; Dacarbazine; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vincristine | 2020 |
PET/CT in Surgical Planning for Head and Neck Cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2021 |
Diagnostic values of F-18 FDG PET or PET/CT, CT, and US for Preoperative Lymph Node Staging in Thyroid Cancer: A Network Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Neoplasm Staging; Network Meta-Analysis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Preoperative Care; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2021 |
Diagnostic Accuracy of Combined PET/CT with MRI, 18F-FDG PET/MRI, and 18F-FDG PET/CT in Patients with Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2021 |
Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Preoperative Care; Publication Bias; ROC Curve | 2018 |
Advancements in staging and imaging for penile cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Sentinel Lymph Node Biopsy | 2017 |
Cervical metastasis of gingival carcinoma misdiagnosed as branchiogenic carcinoma, a rare entity - report of a case and review of literature.
Topics: Branchioma; Carcinoma, Squamous Cell; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gingival Neoplasms; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Proteomics; Radiopharmaceuticals; Risk Factors; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Whole Body Imaging | 2018 |
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity | 2019 |
Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Ultrasonography; Uterine Cervical Neoplasms | 2018 |
Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Tumor Burden | 2018 |
Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; ROC Curve; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2018 |
Pancreatic metastasis of papillary thyroid carcinoma preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy: a case report with review of literatures.
Topics: Aged, 80 and over; Carcinoma, Papillary; Chemotherapy, Adjuvant; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pancreatectomy; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |
PET/MRI in Breast Cancer.
Topics: Adult; Algorithms; Axilla; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2 | 2019 |
Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Space; Seminoma; Testicular Neoplasms | 2018 |
[18F-FDG PET/CT features on paraganglioma of testis with multiple lymph node and lung metastasis: A case report and literature review].
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2018 |
Diagnostic value of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for preoperative lymph node metastasis of esophageal cancer: A meta-analysis.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Diagnostic accuracy of preoperative
Topics: Abdomen; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
The use of PET/MRI for imaging rectal cancer.
Topics: Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2019 |
Meta-analysis of 18FDG PET-CT for nodal staging in patients with esophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Meta-Analysis as Topic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dideoxynucleosides; Early Detection of Cancer; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2013 |
18FDG-PET/CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Meta-Analysis as Topic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Evaluation of (18)F-FDG PET/CT in preoperative staging of gastric cancer: a meta-analysis].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Stomach Neoplasms | 2013 |
FDG PET/CT in the management of primary pleural tumors and pleural metastases.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mesothelioma; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
[Highly conformal radiotherapy of primary and secondary lung malignancies].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Radiotherapy, Conformal | 2013 |
Role of positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Precision Medicine; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Role of positron emission tomography/computed tomography in bone malignancies.
Topics: Biopsy; Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Multiple Myeloma; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Positron emission tomography/computed tomography in melanoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2013 |
Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
[Clinical application of 18F-FDG PET/CT in the treatment of sarcomas].
Topics: Biopsy; Cell Transformation, Neoplastic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Diagnosis and evaluation of gastric cancer by positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Role of imaging in diagnosis, staging and follow-up of lung cancer.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2015 |
Metabolic imaging in non-small-cell lung cancer radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Organs at Risk; Patient Selection; Positron-Emission Tomography; Precision Medicine; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2014 |
[Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment].
Topics: Adenocarcinoma; Brachytherapy; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy | 2014 |
Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2015 |
FDG PET-CT in follicular lymphoma: a case-based evidence review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis | 2015 |
(18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Inflammatory Pseudotumor-like Follicular Dendritic Cell Tumor of the Spleen: Case Report and Review of the Literature.
Topics: Aged; Breast Neoplasms; Contrast Media; Dendritic Cells, Follicular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Granuloma, Plasma Cell; Histiocytic Disorders, Malignant; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Spleen; Splenic Diseases; Splenic Neoplasms; Tomography, X-Ray Computed | 2015 |
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Squamous Cell; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Prognostic Implications of the SUVmax of Primary Tumors and Metastatic Lymph Node Measured by 18F-FDG PET in Patients With Uterine Cervical Cancer: A Meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Uterine Cervical Neoplasms | 2016 |
Cervical lymph node metastases from remote primary tumor sites.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Urinary Bladder Neoplasms | 2016 |
Advances in diagnosis and treatment of metastatic cervical cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2016 |
PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.
Topics: Biomarkers, Tumor; Cell Proliferation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Traumatic Neuroma at the Inferior Mesenteric Artery Stump after Rectal Cancer Surgery: A Case Report and Literature Review.
Topics: Common Bile Duct Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mesenteric Artery, Inferior; Middle Aged; Neuroma; Positron Emission Tomography Computed Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2016 |
Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.
Topics: Abdominal Wall; Adenocarcinoma, Clear Cell; Adult; Antibiotics, Antineoplastic; Biopsy, Fine-Needle; Cell Transformation, Neoplastic; Cesarean Section; Cicatrix; Doxorubicin; Endometrial Neoplasms; Endometriosis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Laparoscopy; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Ovariectomy; Pelvis; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Pregnancy; Rectus Abdominis; Salpingectomy | 2016 |
MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2017 |
[Role of sentinel lymph nodes and lymphatic mapping of colorectal cancer].
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2005 |
Imaging in cutaneous melanoma.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Modern staging and utility of PET imaging in esophageal cancer management.
Topics: Combined Modality Therapy; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[PET and PET-CT of malignant tumors of the exocrine pancreas].
Topics: Adenocarcinoma; Carcinoma, Acinar Cell; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Advantages of PET-CT in the work-up of cervical cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review.
Topics: Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Tomography, X-Ray Computed | 2009 |
Positron emission tomography in lung cancer.
Topics: Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2009 |
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[Response judgement - conventional versus new methods].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cone-Beam Computed Tomography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Patient Care Team; Positron-Emission Tomography; Quality of Life; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Survival Rate; Tomography, Spiral Computed; Treatment Outcome | 2009 |
Advances in imaging in the work-up of head and neck cancer patients.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Emerging apoptosis agonists for bladder cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; ErbB Receptors; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Urinary Bladder Neoplasms | 2009 |
Current trends in radiologic management of malignant pleural mesothelioma.
Topics: Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mesothelioma; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Pleural Effusion, Malignant; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgical Procedures; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett's cancer].
Topics: Adenocarcinoma; Barrett Esophagus; Blood Glucose; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Precancerous Conditions; Prognosis | 2009 |
18F-FDG PET/CT of transitional cell carcinoma.
Topics: Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2009 |
[Lymph node surgical staging for locally advanced cervical cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
Topics: Adult; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.
Topics: Area Under Curve; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2010 |
Diagnostic value of (18)F-FDG PET for evaluation of paraaortic nodal metastasis in patients with cervical carcinoma: a metaanalysis.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2010 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; Fatal Outcome; Fluorodeoxyglucose F18; Gastrectomy; Gastroscopy; Granulocyte Colony-Stimulating Factor; Humans; Leukocytosis; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenectomy; Stomach Neoplasms; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Is FDG-PET suitable for evaluating neoadjuvant therapy in non-small cell lung cancer? Evidence with systematic review of the literature.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Lung Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies | 2010 |
Sentinel node and positron emission tomography mapping in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Coloring Agents; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Rosaniline Dyes; Technetium | 2009 |
The role of functional imaging in colorectal cancer.
Topics: Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
Topics: Fluorodeoxyglucose F18; Forecasting; Humans; Lymphatic Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.
Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2010 |
Role of positron emission tomography (PET) in head and neck cancer.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Treatment Outcome | 2010 |
Lymph node imaging in gynecologic malignancy.
Topics: Contrast Media; Dextrans; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Nanoparticles; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Cervical tumors.
Topics: Cervix Uteri; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Uterine Cervical Diseases; Uterine Cervical Neoplasms | 2010 |
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastric Mucosa; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome | 2011 |
Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
(18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT in the staging of local/regional metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Lymph node metastases and prognosis in oesophageal carcinoma--a systematic review.
Topics: Adenocarcinoma; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
[Radiotherapy of lung cancer: Any room left for elective mediastinal irradiation in 2011?].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Organs at Risk; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Unnecessary Procedures | 2011 |
[Interest of FDG-PET for lung cancer radiotherapy].
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Time Factors; Treatment Outcome; Tumor Burden | 2011 |
Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
[FDG-PET and endometrial cancer].
Topics: Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Sensitivity and Specificity | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
(18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2012 |
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Topics: Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Membrane Proteins; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2012 |
18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in non-small cell lung cancer: comparison of TB and non-TB endemic regions.
Topics: Carcinoma, Non-Small-Cell Lung; Comorbidity; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2012 |
The role of surgery for locally advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Tomography, X-Ray Computed | 2012 |
Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Endoscopy; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The new era of staging as a key for an appropriate treatment for esophageal cancer.
Topics: Decision Support Techniques; Diagnostic Imaging; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Topics: Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2013 |
A head and neck radiologist's perspective on best practices for the usage of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Patient Care Planning; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Imaging of triple-negative breast cancer.
Topics: Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Neoadjuvant Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Ultrasonography, Mammary | 2012 |
Evaluation of breast and gynecologic cancers by positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Positron emission tomography (PET) in clinical oncology [Part III]].
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Value of FDG-PET in the management of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Radiopharmaceuticals; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 2003 |
[Combined functional and morphological imaging with PET/CT systems].
Topics: Carcinoma, Bronchogenic; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
Topics: Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the thyroid].
Topics: Carcinoma, Medullary; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroid Nodule; Tomography, Emission-Computed | 2003 |
Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
Topics: Breast Neoplasms; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; United States | 2003 |
Staging of primary cervical cancers: the role of nuclear medicine.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Positron emission tomography in oncology].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Is positron emission tomography an accurate non-invasive alternative to sentinel lymph node biopsy in breast cancer patients?
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Fused functional-anatomic images of metastatic cancer of cervix obtained by a combined gamma camera and an X-ray tube hybrid system with an illustrative case and review of the 18F-fluorodeoxyglucose literature.
Topics: Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Clinical application of FDG-PET for cancer diagnosis].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Topics: Carcinoma, Squamous Cell; Clinical Trials as Topic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nuclear Medicine; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[The interest of 18FDG-PET in the management of testicular cancer].
Topics: Adolescent; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Positron emission tomography and colorectal carcinoma: an update.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mass Screening; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
FDG-PET in monitoring therapy of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Decision Support Systems, Clinical; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Radiotherapy; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2004 |
Biological characterisation of breast cancer by means of PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Proto-Oncogene Mas; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
FDG-PET for axillary lymph node staging in primary breast cancer.
Topics: Axilla; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2004 |
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
Topics: Biomarkers, Tumor; Breast Neoplasms; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2004 |
Positron emission tomography in the evaluation of lymphoma.
Topics: Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Current and future uses of positron emission tomography in breast cancer imaging.
Topics: Axilla; Biomarkers, Tumor; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed; Treatment Outcome | 2004 |
Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
The role of nuclear medicine in the diagnosis of cancer of unknown origin.
Topics: Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasms, Unknown Primary; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Role of FDG-PET in the diagnosis and management of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Molecular imaging in breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunodetection; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Fluorodeoxyglucose-PET in the management of breast cancer.
Topics: Breast Neoplasms; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |
Clinical use of positron emission tomography in the management of cutaneous melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2004 |
Positron emission tomography for prostate, bladder, and renal cancer.
Topics: Carcinoma, Renal Cell; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2004 |
Defining target volumes for non-small cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, Emission-Computed | 2004 |
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Research Design; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Diagnosis of gastrointestinal tract malignancies using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG)].
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastroscopy; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2004 |
Role of 18FFDG PET/CT in the treatment of head and neck cancers: principles, technique, normal distribution, and initial staging.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Staging; Radiography, Interventional; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Evolving role of positron emission tomography in breast cancer imaging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Treatment Outcome | 2005 |
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Topics: Amino Acids; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ligands; Lymphatic Metastasis; Neoplasm Recurrence, Local; Nucleosides; Positron-Emission Tomography; Protein Biosynthesis; Radiopharmaceuticals; Receptors, Estrogen; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Positron emission tomography for radiation treatment planning.
Topics: Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms; Neoplasms, Unknown Primary; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2005 |
[Ureteral cancer producing granulocyte colony-stimulating factor: a case report].
Topics: Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Ureteral Neoplasms | 2005 |
Imaging of cervical lymph nodes in head and neck cancer: the basics.
Topics: Adult; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palpation; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
[Contribution of positron emission tomography to the detection and staging of breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Lymph node imaging: basic principles.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2006 |
Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Medical Oncology; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2006 |
FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature.
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiography; Radiopharmaceuticals | 2006 |
[Recent progress in diagnosis of otorhinolaryngologic diseases: positron emission tomography of head and neck neoplasms].
Topics: Animals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Otorhinolaryngologic Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2006 |
Synchronous bilateral tonsillar carcinoma: role of fluoro-deoxyglucose positron emission tomography scanning in detecting occult primary tumours in metastatic nodal disease of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tonsillar Neoplasms; Tonsillectomy | 2006 |
Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiometry; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroid Nodule; Thyrotropin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 2006 |
The role of positron emission tomography in the management of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Case Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Role of positron emission tomography in the (re-)staging of oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Staging in oesophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Endosonography; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.
Topics: Adenocarcinoma; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
Current and future use of positron emission tomography (PET) in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography.
Topics: Animals; Carcinoma in Situ; Carcinoma, Ductal, Breast; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Longitudinal Studies; Lymphatic Metastasis; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Positron-Emission Tomography; Whole-Body Counting | 2006 |
Lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lung; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; Sex Factors; Time Factors; Tomography, X-Ray Computed | 2007 |
[Impact of FDG-PET in therapeutic management of patients with suspected recurrence of head and neck cancer].
Topics: Aged; Carcinoma; Case Management; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Surveys and Questionnaires | 2006 |
Detection and management of extrahepatic colorectal cancer in patients with resectable liver metastases.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Staging of lung cancer.
Topics: False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Impact of PET on radiation therapy planning in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2007 |
F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Mammography; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
[Interests and perspectives of PET-CT for breast cancer: review of the literature].
Topics: Bone Neoplasms; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
FDG-PET and FDG-PET/CT in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
[Role of mediastinoscopy and repeat mediastinoscopy today].
Topics: Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Staging investigations for oesophageal cancer: a meta-analysis.
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Is there a role for positron emission tomography in breast cancer staging?
Topics: Antineoplastic Agents; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy | 2008 |
Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
Topics: Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Nanoparticles; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The power of synergy in the mediastinal staging of lung cancer.
Topics: Biopsy, Fine-Needle; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Topics: Confidence Intervals; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2008 |
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group.
Topics: Deoxyglucose; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Overview of the current status of PET in breast cancer imaging.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carbon Radioisotopes; Copper; Copper Radioisotopes; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Methionine; Neoplasm Metastasis; Neoplasm Staging; Organometallic Compounds; Oxygen Radioisotopes; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, Emission-Computed | 1998 |
Nuclear medicine approaches for detection of axillary lymph node metastases.
Topics: Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Colloids; Cost-Benefit Analysis; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplastic Cells, Circulating; Prognosis; Radioimmunodetection; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Survival Rate; Tomography, Emission-Computed | 1998 |
Positron emission tomography in lung cancer.
Topics: Carcinoma, Bronchogenic; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 1998 |
Role of PET FDG in the management of head and neck squamous cell cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
18-FDG imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[Positron emission tomography (PET) in diagnosis of breast carcinoma].
Topics: Blood Glucose; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Tomography, Emission-Computed | 1998 |
Relevance of positron emission tomography (PET) in oncology.
Topics: Carbon Radioisotopes; Fluorides; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Methionine; Misonidazole; Neoplasm Staging; Neoplasms; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Thymidine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Oncological applications of FDG PET imaging.
Topics: Breast Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Pancreatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
FDG-PET in clinical oncology: review of the literature and report of one institution's experience.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Medical Oncology; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Positron emission tomography for detection of lymph node metastases in lung cancer].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
[Nuclear medicine in oncology: new diagnostic and therapeutic methods].
Topics: Carcinoma, Hepatocellular; Contraindications; Contrast Media; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodized Oil; Liver Neoplasms; Lymphatic Metastasis; Medical Oncology; Neoplasms; Nuclear Medicine; Radioimmunotherapy; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[Positron emission tomography in thoracic radiography].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiography, Thoracic; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm, Residual; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
Topics: Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Pancreatic Neoplasms; Pancreatitis; Patient Selection; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Interest in 18-FDG positron emission tomography in radiotherapy planning: example of lung cancer radiotherapy].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Patient Care Planning; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography (PET) of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
PET imaging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2001 |
Imaging in lung cancer: positron emission tomography scan.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Head and neck cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for the diagnosis of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
140 trial(s) available for fluorodeoxyglucose f18 and Lymph Node Metastasis
| Article | Year |
|---|---|
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Prospective Studies; Quality of Life; Radiopharmaceuticals; Risk Assessment; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2021 |
Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Machine Learning; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Tumor Burden | 2020 |
18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies | 2018 |
The impact of endoscopic ultrasound-guided fine-needle aspiration of lymph nodes on subsequent positron emission tomography/computed tomography imaging: a prospective study.
Topics: Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2019 |
Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mastectomy; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2018 |
Preliminary clinical assessment of dynamic
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; ROC Curve | 2019 |
Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Care Team; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reading; Retrospective Studies; Whole Body Imaging | 2019 |
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; False Negative Reactions; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Salpingo-oophorectomy; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2019 |
Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Denmark; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Distant metastatic lesions in patients with differentiated thyroid carcinoma. Clinical implications of radioiodine and FDG uptake.
Topics: Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Treatment Outcome | 2013 |
Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Topics: Adolescent; Adult; Aged; Algorithms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2014 |
Systemic control and evaluation of the response to neoadjuvant chemotherapy in resectable thoracic esophageal squamous cell carcinoma with ¹⁸F-fluorodeoxyglucose positron emission tomography-positive lymph nodes.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Young Adult | 2015 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER):
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Survival Rate; Taxoids; Trastuzumab | 2014 |
The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiation-Protective Agents; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2015 |
Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
Topics: Adolescent; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging; Young Adult | 2016 |
Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cetuximab; Chemoradiotherapy; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2016 |
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high-risk cutaneous squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Skin Neoplasms | 2016 |
Therapeutic implication of HER2 in advanced biliary tract cancer.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Gene Amplification; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Positron-Emission Tomography; Receptor, ErbB-2; Signal Transduction; Treatment Outcome; Xenograft Model Antitumor Assays | 2016 |
Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Young Adult | 2016 |
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retroperitoneal Neoplasms; Risk Assessment; Sensitivity and Specificity | 2017 |
Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Rate; Treatment Outcome | 2008 |
The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Phantoms, Imaging; Positron-Emission Tomography; Radiography, Thoracic; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2009 |
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Body Burden; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Topics: Adult; Aged; Aorta; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2010 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2011 |
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
Topics: Adipose Tissue, Brown; Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Transport; Breast Neoplasms; Cohort Studies; Diazepam; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Seasons; Temperature; Tomography, X-Ray Computed | 2010 |
Measuring tumor cell proliferation with 18F-FLT PET during radiotherapy of esophageal squamous cell carcinoma: a pilot clinical study.
Topics: Aged; Aged, 80 and over; Bone Marrow Cells; Carcinoma, Squamous Cell; Cell Proliferation; Diagnosis, Differential; Dideoxynucleosides; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid c
Topics: Adenocarcinoma, Papillary; Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2010 |
Evaluation of ¹⁸F-FDG PET/CT in early-stage cervical carcinoma.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
[Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Decision Making; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Palliative Care; Patient Care Planning; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome | 2011 |
Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; International Agencies; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Registries; Retrospective Studies; Sarcoma; Survival Rate; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Topics: Aged; Carcinoma, Squamous Cell; Dideoxynucleosides; Esophageal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Penile Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms | 2012 |
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Confidence Intervals; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ontario; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2012 |
Impact of a second FDG PET scan before adjuvant therapy for the early detection of residual/relapsing tumours in high-risk patients with oral cavity cancer and pathological extracapsular spread.
Topics: Adult; Aged; Chemoradiotherapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm, Residual; Positron-Emission Tomography; Radiotherapy, Adjuvant; Recurrence; Risk; Survival Analysis | 2012 |
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Topics: Aged; Carcinoma, Ovarian Epithelial; Diaphragm; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2012 |
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes.
Topics: Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Confirmation of histology of PET positive lymph nodes recovered by hand-video-assisted thoracoscopy surgery.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2012 |
Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aorta, Abdominal; Carcinoma, Squamous Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Uterine Cervical Neoplasms | 2013 |
18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cystectomy; Fluorodeoxyglucose F18; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
[F-18 fluorodeoxyglucose positron emission tomography in evaluation of tumors of the ENT area: personal results and review of the literature].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Doxorubicin; False Negative Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Sensitivity and Specificity; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carbon Radioisotopes; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings.
Topics: Adult; Aorta, Abdominal; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2003 |
[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2003 |
Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2003 |
Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[Diagnosis with (18)F-FDG PET scan after larynx preservation by primary radiochemotherapy].
Topics: Aged; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiation Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Salvage Therapy; Tomography, Emission-Computed; Treatment Outcome | 2004 |
PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
Topics: Adult; Aged; Breast Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taiwan | 2004 |
[Is coincidence detection emission tomography (CDET) as reliable as positron emission tomography (PET) in head and neck cancer?].
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET--radiological-pathological correlation.
Topics: Aged; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed | 2004 |
FDG-PET in staging lung cancer: how does it change the algorithm?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2004 |
Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Middle Aged; Neoplasms, Unknown Primary; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2004 |
Detection of distant metastases in esophageal cancer with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.
Topics: Antigens, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Predictive Value of Tests; Serpins; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Topics: Abdominal Neoplasms; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Misonidazole; Oximetry; Oxygen; Oxygen Consumption; Polarography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Korea; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2004 |
Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Topics: Aorta; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Uterine Neoplasms | 2004 |
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
Topics: Adult; Aged; Carcinoma; Endosonography; Esophageal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole-Body Counting | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
FDG-PET for preoperative staging of bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Belgium; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Survival Rate; Urinary Bladder Neoplasms; Whole Body Imaging | 2005 |
18F-FDG PET/CT for staging of penile cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Pancreatic Ductal; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting | 2005 |
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Monitoring; Europe; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Survival Analysis | 2005 |
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Deoxycytidine; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Positron-Emission Tomography; Prospective Studies; Pulmonary Embolism; Radiopharmaceuticals; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
Topics: Adult; Aged; Axilla; Bayes Theorem; Breast Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Iron; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Middle Aged; Neoplasm Staging; Oxides; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Thoracic Neoplasms; Tomography, X-Ray Computed | 2006 |
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome | 2007 |
The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prevalence; Prognosis; Radiography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2007 |
Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Movement; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Respiration; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2007 |
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pilot Projects; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2007 |
The use of molecular imaging to evaluate radiation fields in the adjuvant setting of breast cancer: a feasibility study.
Topics: Adult; Aged; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiometry; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Computer-Assisted | 2008 |
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Pet-FDG imaging in the clinical evaluation of head and neck cancer.
Topics: Aged; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed | 1995 |
Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Methionine; Tomography, Emission-Computed | 1995 |
Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma.
Topics: Adult; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Pilot Projects; Prospective Studies; Tomography, Emission-Computed | 1997 |
Performance study of a miniature gamma ray scintillation vivo probe for tumor localization.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Citrates; Deoxyglucose; Endoscopes; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasms; Phantoms, Imaging; Tomography, Emission-Computed | 1997 |
FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Bronchogenic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1998 |
Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group.
Topics: Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1999 |
Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1999 |
Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer.
Topics: Adult; Calcitonin; Carcinoma, Medullary; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Radiography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Fluorodeoxyglucose PET in the initial staging of germ cell tumours.
Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
Preoperative staging of non-small-cell lung cancer with positron-emission tomography.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Prospective Studies; Radionuclide Imaging | 2000 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma.
Topics: Adult; Aged; Angiography; Calcitonin; Carcinoma, Medullary; Diagnosis, Differential; Diarrhea; Female; Fluorodeoxyglucose F18; Flushing; Humans; Liver; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prevalence; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Models, Anatomic; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pilot Projects; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Vulvar Neoplasms | 2002 |
FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2002 |
1589 other study(ies) available for fluorodeoxyglucose f18 and Lymph Node Metastasis
| Article | Year |
|---|---|
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma.
Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity | 2022 |
Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2021 |
Neurosarcoidosis pathologically diagnosed via biopsy of a normal-sized inguinal lymph node with fluorodeoxyglucose accumulation on positron emission tomography/computed tomography in a patient with a history of brain Ewing's sarcoma.
Topics: Biopsy; Brain; Central Nervous System Diseases; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Sarcoidosis; Sarcoma, Ewing | 2022 |
An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients.
Topics: Artificial Intelligence; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2022 |
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided; Ultrasonography | 2021 |
The importance of anatomical localization of non-small cell lung carcinoma in predicting mediastinal lymph node metastasis.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Topics: Adult; Aged; China; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Rectal Neoplasms; Sensitivity and Specificity | 2021 |
The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis.
Topics: Computational Biology; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Iron Oxide Nanoparticles; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2021 |
Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Retrospective Studies | 2021 |
Clinical Significance of [
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Pulmonary Sarcomatoid Carcinoma With Epiglottis and Ileum Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Epiglottis; Fluorodeoxyglucose F18; Humans; Ileum; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Predictive value of metabolic activity detected by pre-operative 18F FDG PET/CT in ampullary adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphocytes; Male; Middle Aged; Neoplasm Staging; Neutrophils; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2021 |
Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
Topics: COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymphadenopathy; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; SARS-CoV-2; Vaccination | 2021 |
SUV
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2022 |
18F-FDG PET/CT in Patients with Vulvar and Vaginal Cancer: A Preliminary Study of 20 Cases.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vaginal Neoplasms | 2022 |
A design of forceps-type coincidence radiation detector for intraoperative LN diagnosis: clinical impact estimated from LNs data of 20 esophageal cancer patients.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Surgical Instruments | 2022 |
New mimic of relapse or regional lymph node metastasis in a cancer survivor: a case of mRNA COVID-19 vaccine-induced lymphadenitis with high FDG uptake.
Topics: Adult; Cancer Survivors; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymphadenitis; Lymphatic Metastasis; Neoplasm Recurrence, Local; RNA, Messenger; SARS-CoV-2 | 2022 |
18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tumor Microenvironment | 2022 |
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2022 |
Impact of
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Muscles; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2022 |
Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Solitary Lymph Node Metastasis From a Malignant Peripheral Nerve Sheath Tumor of the Thoracic Vertebra Revealed on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Neurofibrosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Thoracic Vertebrae | 2022 |
Radiomics analysis of [
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tongue; Tongue Neoplasms | 2023 |
First experiences with PET-MRI/CT in radiotherapy planning for cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2022 |
FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Topics: Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; mRNA Vaccines; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies; Vaccination; Vaccines, Synthetic | 2022 |
FDG PET/CT in Prostate Metastasis From Gastric Cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence.
Topics: Axilla; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2022 |
Preoperative prediction of the pathological stage of advanced gastric cancer by
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2022 |
Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Micrometastasis; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
FDG PET/CT in Unilateral Renal Metastasis From Colon Cancer.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
FDG PET/CT in a Patient With Syphilis Suspected of Having Penile Cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syphilis | 2022 |
The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Efficacy of PET/CT in diagnosis of regional lymph node metastases in patients with colorectal cancer: retrospective cohort study.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
Topics: Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2022 |
Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Machine Learning; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Systematic endoscopic staging of mediastinum to determine impact on radiotherapy for locally advanced lung cancer (SEISMIC): protocol for a prospective single arm multicentre interventional study.
Topics: Carcinoma, Non-Small-Cell Lung; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Multicenter Studies as Topic; Neoplasm Staging; Prospective Studies | 2022 |
Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms | 2022 |
Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Nomograms; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Respiratory-gated
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
What is the effect of tumor diameter, lymph node metastases, and SUVmax value on prognosis in limited-stage small cell lung cancer?
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection.
Topics: Adenocarcinoma; CA-19-9 Antigen; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms | 2022 |
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Tumor Burden | 2022 |
Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Rectal Neoplasms; Retrospective Studies | 2022 |
Multispectral optoacoustic tomography to differentiate between lymph node metastases and coronavirus-19 vaccine-associated lymphadenopathy.
Topics: Coronavirus; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Oxyhemoglobins; Positron Emission Tomography Computed Tomography; Vaccination | 2023 |
Progressive Transformation of Germinal Centers Simulating Malignant Axillary Lymphadenopathy in a Breast Cancer Patient on FDG PET/CT.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2022 |
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Muscles; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urinary Bladder Neoplasms | 2023 |
Cervical Lymph Node Metastasis From Recurrent Glioblastoma Detected by MRI and 2-[18F]FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2023 |
The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
[Traumatic Neuroma Mimicking Lymph Node Metastasis of Pancreatic Neuroendocrine Neoplasms Developed after Pancreatoduodenectomy-A Case Report].
Topics: Aged; Bile Ducts; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neuroendocrine Tumors; Neuroma; Pancreatic Neoplasms; Pancreaticoduodenectomy | 2022 |
The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
Topics: Claudin-1; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms | 2023 |
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2023 |
The influence of metastatic patterns and tumor load on therapeutic efficacy of immunotherapy in patients with metastatic melanoma as determined by quantitative PET-parameters using [ 18 F]-fluorodeoxyglucose PET/computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2023 |
Added Clinical Value of
Topics: Aged; Cystectomy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Non-Muscle Invasive Bladder Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Urinary Bladder Neoplasms | 2023 |
A prediction model of nodal metastasis in cN0 oral squamous cell carcinoma using metabolic and pathological variables.
Topics: Carcinoma, Squamous Cell; China; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
The value on SUV-derived parameters assessed on
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron Emission Tomography Computed Tomography | 2023 |
Incidence and predictive factors of retropharyngeal lymph node metastases in patients with oropharyngeal cancer undergoing multimodality treatment planning imaging.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies | 2023 |
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Tumor Burden | 2023 |
The Role of Axillary SUV
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2023 |
Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2023 |
Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
PET-CT underestimates the true pathological extent of disease at lymphadenectomy for melanoma patients after systemic therapy.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Accuracy of pre-operative 18-fluoride fluorodeoxyglucose positron emission tomography (FDG-PET) in predicting lymph node involvement in colon cancer.
Topics: Australia; Colonic Neoplasms; Fluorides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
[A Case of Secondary Syphilis Mimicking a Penile Cancer with Lymph Node Metastases].
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Penile Neoplasms | 2023 |
Prevalence and risk factors for retropharyngeal and retro-styloid lymph node metastasis in hypopharyngeal carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prevalence; Retrospective Studies; Risk Factors | 2023 |
Solitary Axillary Lymph Node Metastasis From Bladder Cancer Detected by FDG PET/CT.
Topics: Aged; Axilla; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2023 |
Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Topics: Castleman Disease; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms | 2023 |
Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
A comparison of 18 F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
Topics: Adenocarcinoma of Lung; Deep Learning; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Retrospective Studies | 2023 |
Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2023 |
Impact of
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2024 |
Head-to-Head Comparison of 18 F-FDG and 68 Ga-FAPI-04 PET/CT for Radiological Evaluation of Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2023 |
Axillary Lymph Node Metastasis as the First Symptom of Colon Cancer.
Topics: Axilla; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2023 |
Prognostic value of
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
The predictive value, sensitivity, specificity, and accuracy of PET CT in the evaluation of axillary metastases in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2023 |
MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2023 |
Retrospective analysis of the
Topics: China; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2023 |
The ability of pre-treatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Analysis | 2019 |
Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2019 |
Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate | 2020 |
Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multiparametric Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Lymph Node Metastases Diagnosed by
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome | 2019 |
Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Topics: Adult; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Randomized Controlled Trials as Topic | 2020 |
The value of
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Micrometastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tumor Burden | 2019 |
Diagnostic Value of
Topics: Aged; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Obesity, Morbid; Positron Emission Tomography Computed Tomography; Prospective Studies; Sentinel Lymph Node Biopsy | 2021 |
PET-CT for Evaluating Breast Cancer Yields Incidental Finding in the Lung.
Topics: Aged; Biopsy; Breast Neoplasms; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymphatic Metastasis; Mammography; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
The value of PET/CT in determining lymph node metastasis of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Topics: Adult; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neoplasm Staging; Nephrectomy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2019 |
Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.
Topics: Aged; Aged, 80 and over; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2020 |
Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Topics: Aged; China; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals | 2020 |
[FDG-PET/CT for exclusion of cervical lymph node metastases in clinically N0 head and neck tumors].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
Topics: Aged; Algorithms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intraoperative Period; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Risk Factors; Sentinel Lymph Node | 2020 |
Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
Topics: Aged; Biological Transport; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2020 |
Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2020 |
Accuracy of
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2020 |
Uterine adenomatoid tumor associated with lymph node lesions: a case report.
Topics: Adenomatoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterus | 2020 |
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2020 |
Intra-parotid lymph node metastasis in patients with non-cutaneous head and neck cancers: clinical and imaging features for differentiation from simultaneous parotid primary tumor.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI.
Topics: Anatomic Landmarks; Axilla; Breast Neoplasms; Datasets as Topic; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sentinel Lymph Node | 2020 |
Pilot Study of [
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Muscles; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Urinary Bladder Neoplasms | 2020 |
[A Case of Subphrenic Lymph Node Metastasis from Gastric Cancer in Which FDG-PET/CT Was Useful for Diagnosis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Stomach Neoplasms | 2019 |
Efficacy of positron emission tomography and computed tomography in clinical staging of cutaneous malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy | 2020 |
Successful treatment of combined thymic epithelial tumor with hepatic metastasis: a long disease-free survival case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymectomy; Thymoma; Thymus Neoplasms | 2020 |
Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
Topics: Adult; Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Retrospective Studies; Risk Factors | 2020 |
Hounsfield units and fractal dimension (test HUFRA) for determining PET positive/negative lymph nodes in pediatric Hodgkin's lymphoma patients.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Fractals; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Extranodal Extension; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
The Diagnostic Capacity of Pre-treatment 18F-FDG PET/CT for Predicting the Extranodular Spread of Lymph Node Metastases in Patients with Oral Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Squamous Cell Carcinoma of Head and Neck | 2020 |
The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2021 |
18F-FDG PET/CT in Follicular Dendritic Cell Sarcoma With Paraneoplastic Pemphigus as the First Manifestation.
Topics: Dendritic Cell Sarcoma, Follicular; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Positron Emission Tomography Computed Tomography | 2020 |
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Testing; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2020 |
Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2020 |
Investigating the Reliability of Fluorodeoxyglucose 18 Positive Emission Tomography-Computed Tomography Detection of Regional Lymph Node Metastasis in Head and Neck Malignancy.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2020 |
Sentinel node theory helps tracking of primary lesions of cancers of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Young Adult | 2020 |
Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2021 |
Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
Topics: Adenocarcinoma of Lung; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2021 |
Metastasectomy for Isolated Right-Sided Thoracic Lymph Node Metastasis From Tubal Carcinoma.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Contrast Media; Fallopian Tube Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Robotic Surgical Procedures; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2020 |
Unusual presentation of extramammary Paget's disease with multiple lymph node metastases showing scant uptake of
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography | 2020 |
Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Survival Rate; Tomography, X-Ray Computed | 2020 |
One-by-One Comparison of Lymph Nodes Between 18F-FDG Uptake and Pathological Diagnosis in Esophageal Cancer.
Topics: Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity | 2020 |
Prognostic Value of Preoperative Imaging: Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Computed Tomography Alone for Preoperative Planning in High-risk Histology Endometrial Carcinoma.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2020 |
The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2021 |
FDG PET/CT of Hepatoid Adenocarcinoma of the Gallbladder.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Ultrasonography | 2020 |
The feasibility of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2020 |
Hybrid positron emission tomography imaging for initial staging of sinonasal tumors: Total lesion glycolysis as prognosticator of treatment response.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2021 |
Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Time Factors | 2020 |
Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Topics: Adult; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |
Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET/computed tomography images of largest metastatic lymph node.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2021 |
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Urinary Bladder Neoplasms | 2021 |
Reply by Authors.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2021 |
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2020 |
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia
Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms | 2020 |
Ileal Ulcer Associated With a Large Bezoar Mimicking Malignancy on FDG PET/CT.
Topics: Adult; Bezoars; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ileal Neoplasms; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography | 2021 |
A Comparison of the Diagnostic Value of Positron Emission Tomography/Computed Tomography and Ultrasound for the Detection of Metastatic Axillary Nodal Disease in Treatment-Naive Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
Machine learning-based diagnostic method of pre-therapeutic
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis | 2021 |
Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Preoperative Care; Radiotherapy, Adjuvant; Risk Assessment | 2021 |
18F-FDG PET/CT Assessment of Malignant Granular Cell Tumor of the Soft Tissue.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2021 |
DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Follow-Up Studies; Groin; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2021 |
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Machine Learning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
[Para-aortic lymph node staging in grade IB2 and above cervical cancers: Comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Registries; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
Real-Time Ultrasound Image Fusion with FDG-PET/CT to Perform Fused Image-Guided Fine-Needle Aspiration in Neck Nodes: Feasibility and Diagnostic Value.
Topics: Adult; Aged; Biopsy, Fine-Needle; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Ultrasonography; Young Adult | 2021 |
An Unusual Case of Esophageal Carcinosarcoma on 18F-FDG PET/CT.
Topics: Carcinosarcoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2021 |
Real-time ultrasound virtual navigation in 3D PET/CT volumes for superficial lymph-node evaluation: innovative fusion examination.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Computer Systems; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Ultrasonography | 2021 |
Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Complete metabolic response with [
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Urinary Bladder Neoplasms | 2022 |
Comparison Between the Maximum Standard Uptake Value and the Ratio of Lymph Node to Primary Tumor Attenuation in Head and Neck Cancers: A Prospective Study.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prospective Studies | 2021 |
F-18 FDG PET-CT for response evaluation in head and neck malignancy: Experience from a tertiary level hospital in south India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; India; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tertiary Care Centers; Treatment Outcome; Young Adult | 2021 |
F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2022 |
Breast cancer preoperative
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2021 |
Follicular Thyroid Carcinoma with Unusual Radioiodine-Refractory Breast Metastasis Mimicking Primary Breast Malignancy.
Topics: Adenocarcinoma, Follicular; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Thyroglobulin; Thyroid Neoplasms | 2021 |
Potential application value of PET/computed tomography in retroperitoneal leiomyosarcoma and a literature review.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Oropharynx; Pharyngectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Tumor Burden | 2021 |
Utility of Routine Preoperative
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2021 |
Utility of Routine Preoperative
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2021 |
Motion-compensated FDG PET/CT for oesophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth; Mouth Neoplasms; Neck; Neck Dissection; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Young Adult | 2021 |
Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography | 2021 |
Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neck Dissection; Pancreatic Neoplasms; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Whole Body Imaging | 2021 |
Intraperitoneal Glucose Transport to Micrometastasis: A Multimodal In Vivo Imaging Investigation in a Mouse Lymphoma Model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Injections, Intraperitoneal; Lymphatic Metastasis; Lymphoma; Mice; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Micrometastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2021 |
FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis.
Topics: Aged; Aged, 80 and over; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies | 2021 |
A new combined index of SUVmax of lymph node in PET / CT by a weighting coefficient plus its maximum minor axis in CECT to evaluate occult lymph node metastasis in clinical N0 patients with tongue cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tongue Neoplasms | 2021 |
Relationship between Lymph Node Metastasis and a Low 18F-FDG PET/CT Axillary SUVmax Value in Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Turkey | 2021 |
The predictive power of artificial intelligence on mediastinal lymphnode metastasis.
Topics: Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2021 |
The additional diagnostic impact of positron emission tomography-computed tomography for lymph node metastasis from colorectal cancer: A prospective lymph node level analysis.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
Topics: Adult; Aged; Biomarkers; Cyclooxygenase 2; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphatic Metastasis; Machine Learning; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; ROC Curve; Tenascin; Uterine Cervical Neoplasms | 2021 |
FDG uptake in axillary lymph nodes after COVID-19 vaccination - a pitfall in a case of highly suspicious lymph node metastases of malignant melanoma.
Topics: Axilla; Breast Neoplasms; COVID-19; COVID-19 Vaccines; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; SARS-CoV-2; Vaccination | 2021 |
Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mutation; Positron Emission Tomography Computed Tomography; Preoperative Care; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tumor Burden; Young Adult | 2017 |
Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.
Topics: Adult; Aged; Chemoradiotherapy; Clavicle; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Palliative Care; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
[18]Fluorodeoxyglucose Positron Emission Tomography for the Textural Features of Cervical Cancer Associated with Lymph Node Metastasis and Histological Type.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms; Young Adult | 2017 |
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients.
Topics: Adult; Aged; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period | 2017 |
FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.
Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Care; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Unnecessary Procedures; Young Adult | 2017 |
Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst.
Topics: Aged; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Thyroglossal Cyst; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2017 |
[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Databases, Factual; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Young Adult | 2017 |
Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
Topics: Adult; Aged; Carcinosarcoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2017 |
Additional value of
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2017 |
The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate | 2017 |
Preoperative
Topics: Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2017 |
Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Triple Negative Breast Neoplasms | 2017 |
Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
An amazing cause of false PET positivity: Diagnosed after a lung cancer surgery.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2017 |
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2017 |
FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Urinary Bladder Neoplasms | 2017 |
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplastic Cells, Circulating; Positron-Emission Tomography; Survival Analysis; Urinary Bladder Neoplasms | 2017 |
Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on
Topics: Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Small Cell Lung Carcinoma; Tumor Burden | 2018 |
Impact of EBUS-TBNA on PET-CT Imaging of Mediastinal Nodes.
Topics: Biopsy, Fine-Needle; Denmark; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography, Interventional | 2017 |
Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
Topics: Aged; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Gastrectomy; Herpesvirus 4, Human; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Role of FDG PET/CT Scan in Head and Neck Cancer Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iran; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2017 |
Groin sentinel node biopsy and
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Pilot Projects; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Vulvar Neoplasms | 2017 |
Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, High-Volume; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Period; Reference Standards; Sensitivity and Specificity; Treatment Outcome; Urinary Bladder Neoplasms | 2019 |
Low Accuracy of Computed Tomography and Positron Emission Tomography to Detect Lung and Lymph Node Metastases of Colorectal Cancer.
Topics: Aged; Colorectal Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Regression Analysis; Retrospective Studies | 2017 |
18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the stage migration and nodal radiation treatment volumes.
Topics: Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2017 |
Pancreatoblastoma With Metastatic Retroperitoneal Lymph Node and PET/CT.
Topics: Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Retroperitoneal Space; Ultrasonography | 2017 |
Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Common Bile Duct; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gallbladder Neoplasms; Humans; Klatskin Tumor; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2018 |
Contrast-enhanced ultrasound for diagnosis of an enlarged cervical lymph node in a patient with oropharyngeal cancer: a case report.
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Phospholipids; Positron-Emission Tomography; Radiopharmaceuticals; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2017 |
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective?
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Vulvar Neoplasms | 2017 |
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Time Factors; Treatment Outcome; Young Adult | 2017 |
Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Ultrasonography | 2018 |
Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought.
Topics: Adult; Aged; Carcinoid Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Pneumonectomy; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2017 |
Clinical Usefulness of
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2018 |
Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2017 |
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Societies, Medical; United States; Uterine Neoplasms | 2018 |
Significant value of
Topics: Adolescent; Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiotherapy, Intensity-Modulated; ROC Curve; Treatment Outcome; Young Adult | 2017 |
Diagnostic accuracy of
Topics: Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
Topics: Aged; Biopsy; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden; Uterine Cervical Neoplasms | 2018 |
Concomitant cutaneous squamous cell carcinoma and chronic lymphocytic leukemia in a patient: The utility of
Topics: Abdominal Pain; Aged; Biopsy; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Ear Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Male; Neck Dissection; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
SUV calculation in breast cancer: which normalization should be applied when using 18F-FDG PET?
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography | 2019 |
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Uterine Cervical Neoplasms | 2018 |
The application of 18F-FDG PET/CT in ovarian immature teratomas when pathological examination results contradict clinical observations: a case report.
Topics: Adolescent; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Teratoma | 2017 |
Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Molecular Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Whole Body Imaging | 2018 |
Metaplastic Squamous Cell Carcinoma of Breast Demonstrated on 18F-FDG PET/CT.
Topics: Adult; Breast Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors | 2018 |
Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2018 |
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Molecular Targeted Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2018 |
The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2018 |
BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET/CT in Patients With Malignant Melanoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Tomography, X-Ray Computed | 2018 |
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Axilla; Axin Protein; Breast Neoplasms; Chemotherapy, Adjuvant; Drosophila Proteins; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Young Adult | 2018 |
An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
Topics: Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms | 2018 |
Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
Topics: Carcinoma, Hepatocellular; Castleman Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Nomograms; Oxaliplatin; Positron Emission Tomography Computed Tomography; Preoperative Period; Radiopharmaceuticals; Radiotherapy Dosage; Risk Assessment; Sex Factors; Survival Rate | 2018 |
Functional visceral fat activity evaluated by preoperative F-18 FDG PET/CT predicts regional lymph node metastasis in differentiated thyroid cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Subcutaneous Fat; Thyroid Neoplasms | 2018 |
Increased Prostate Cancer Glucose Metabolism Detected by
Topics: Aged; Case-Control Studies; Disease-Free Survival; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Risk Assessment; Severity of Illness Index | 2019 |
Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy.
Topics: Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Sensitivity and Specificity | 2018 |
Value of Preoperative PET-CT in the Prediction of Pathological Stage of Gastric Cancer.
Topics: Aged; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2018 |
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted
Topics: Antigens, Surface; Clavicle; Fluorodeoxyglucose F18; Germany; Glutamate Carboxypeptidase II; History, 19th Century; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms; Pathology; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; ROC Curve; Whole Body Imaging | 2018 |
Topics: Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Esophageal Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Ultrasonography, Mammary | 2018 |
Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2018 |
Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Postoperative Period; Thyroid Neoplasms; Thyroid Nodule; Tomography, X-Ray Computed | 2018 |
[Application of (18)F-fluorodeoxyglucose Metabolic Imaging in Diagnosis and Treatment of Cervical Cancer].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Uterine Cervical Neoplasms | 2016 |
Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2019 |
Lymph Node With the Highest FDG Uptake Predicts Distant Metastasis-Free Survival in Patients With Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2018 |
Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes.
Topics: Aged; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Organometallic Compounds; Oropharyngeal Neoplasms; Papillomaviridae; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
[The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Topics: Extremities; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Neoplasms; Torso | 2018 |
18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided; Retrospective Studies; Survival Analysis; Uterine Cervical Neoplasms | 2018 |
Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Topics: Adult; Aged; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2018 |
Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2018 |
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2018 |
Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Databases, Factual; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2018 |
Considerations on 18FDG PET/CT and sentinel lymph node biopsy in AJCC stages I and II of melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2020 |
Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2018 |
Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
Topics: C-Reactive Protein; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Lymphocyte Count; Lymphocytes; Middle Aged; Neoplasm Grading; Neutrophils; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2018 |
Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracic Surgery, Video-Assisted; Treatment Outcome | 2019 |
Prediction of Occult Lymph Node Metastasis Using Tumor-to-Blood Standardized Uptake Ratio and Metabolic Parameters in Clinical N0 Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Topics: Breast; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy | 2019 |
Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Predictive Value of FDG PET/CT to Detect Lymph Node Metastases in Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2018 |
Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; ROC Curve | 2018 |
Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Retrospective Studies; Risk Assessment; Risk Factors; Tertiary Care Centers; Tomography, X-Ray Computed | 2018 |
Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reference Standards; Reproducibility of Results; Retrospective Studies | 2018 |
The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2018 |
2-fluoro-2-deoxy-D-glucose positron emission tomography versus conventional imaging for the diagnosis of breast cancer and lymph node metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Ultrasonography | 2018 |
What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
Topics: Adult; Aged; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Pediatric Esophageal Squamous Cell Carcinoma Staged With 18F-FDG PET/CT.
Topics: Adolescent; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
18F-FDG PET/CT of Internal Mammary Lymph Node Hepatocellular Carcinoma Metastases.
Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mammary Glands, Human; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Non‑invasive monitoring of cisplatin and erlotinib efficacy against lung cancer in orthotopic SCID mouse models by small animal FDG‑PET/CT and CT.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cisplatin; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mice; Mice, SCID; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Models, Statistical; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Survival Analysis | 2019 |
Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cervix Uteri; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intestines; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2018 |
Prognostic significance of supradiaphragmatic lymph node metastasis detected by
Topics: Aged; Carcinoma, Ovarian Epithelial; Diaphragm; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies | 2018 |
Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Topics: Adult; Cytodiagnosis; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2018 |
Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymphatic Metastasis; Middle Aged; Neoplasms; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proof of Concept Study; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2019 |
The Prognostic Value of 18F-FDG Uptake in the Supraclavicular Lymph Node (N3c) on PET/CT in Patients With Locally Advanced Breast Cancer With Clinical N3c.
Topics: Biological Transport; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Preoperative Metabolic Tumor Volume
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Phenotype; Positron-Emission Tomography; Preoperative Period; Prognosis; Transcriptome; Tumor Burden | 2019 |
Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomaviridae; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Routinely staging gastric cancer with
Topics: Adenocarcinoma; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Postoperative Period; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Survival Rate; United Kingdom | 2019 |
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Lymphatic Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Bombesin; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2019 |
FDG-PET/CT for Spontaneous Regression of Metastatic Merkel Cell Carcinoma: Friend or Foe?
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Remission, Spontaneous; Skin Neoplasms | 2019 |
Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
Topics: Adult; Aged; Aorta; Area Under Curve; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
Is FDG maximum standardized uptake value of primary breast cancer a prognostic factor for locoregional axillary lymph node metastasis?
Topics: Adult; Aged; Axilla; Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment | 2019 |
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Topics: Adult; Aged; Aorta; Biomarkers, Tumor; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Detection of distant metastatic disease by positron emission tomography with
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2019 |
Influence of 18F-FDG-PET/CT on staging of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Uterine Cervical Neoplasms | 2019 |
Anal cancer chemoradiotherapy outcome prediction using
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Papillomaviridae; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2019 |
FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2019 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paraneoplastic Syndromes; Positron Emission Tomography Computed Tomography; Sarcoidosis; Whole Body Imaging | 2019 |
Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pelvis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Survival Rate; Uterine Cervical Neoplasms | 2019 |
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2019 |
Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2019 |
FDG PET in Diffuse Spinal Carcinomatous Meningitis.
Topics: Aged; Brain; Fluorodeoxyglucose F18; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skull Base Neoplasms; Spinal Cord Neoplasms | 2019 |
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Combined Modality Therapy; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Netherlands; Palliative Care; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2019 |
Lobectomy for subsegmental lymph node metastasis of unknown origin.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography | 2019 |
Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.
Topics: Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Risk Factors; Survival Analysis; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2019 |
Merkel cell carcinoma: an aggressive cutaneous carcinoma with rare metastasis to the thyroid gland.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Merkel Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Gland; Thyroid Neoplasms | 2019 |
Lymphadenopathy by tuberculosis seemed like metastasis on FDG PET/CT in patients with breast carcinoma.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymphadenopathy; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Paget's Disease, Mammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis; Tuberculosis, Lymph Node | 2019 |
Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
Topics: Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2019 |
Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Topics: Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2019 |
18F-FDG PET/CT Imaging of Trichoblastic Carcinoma With Nodal Metastasis.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Cerebellar Hypermetabolism in a Case of Paraneoplastic Cerebellar Syndrome With the Primary Lymphoepithelial Carcinoma in Tonsil.
Topics: Aged; Cerebellum; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms, Glandular and Epithelial; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Tonsillar Neoplasms | 2019 |
Comment on "Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2".
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2019 |
PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue.
Topics: Adult; Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies; Tomography, X-Ray Computed; Tongue; Tongue Neoplasms; Tumor Burden | 2019 |
[Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
Topics: Adenocarcinoma of Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies | 2019 |
Inflammatory response to the anti PD-L1 drug, atezolizumab, masquerades as breast implant rupture.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Breast; Breast Implants; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Rupture; Urinary Bladder Neoplasms; Urothelium | 2019 |
The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumoconiosis; Positron Emission Tomography Computed Tomography; Pulmonary Fibrosis; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2020 |
Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.
Topics: Biomarkers, Tumor; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2019 |
Diagnostic ability of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography for retropharyngeal lymph node in patients with oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Pharynx; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Metabolic and volume-based parameters of (18F)FDG PET/CT for primary mass and axillary lymph node metastasis in patients with invasive ductal carcinoma: a retrospective analysis in relation to molecular subtype, axillary lymph node metastasis and immunohi
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2019 |
Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: correlation with vascular endothelial growth factor expression.
Topics: Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Keratin-7; Lung Neoplasms; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Micrometastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Receptors, Vascular Endothelial Growth Factor; Statistics, Nonparametric; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2013 |
18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Trastuzumab | 2013 |
Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Pharynx; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Salvage Therapy | 2013 |
Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
Topics: Adult; Aged; Chi-Square Distribution; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Rare axillary metastasis from squamous cell carcinoma of the tonsil.
Topics: Axilla; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Extracapsular spread in hypopharyngeal squamous cell carcinoma: diagnostic value of FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2013 |
A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cisplatin; Disseminated Intravascular Coagulation; Docetaxel; Fatal Outcome; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Taxoids; Tomography, X-Ray Computed; Treatment Failure | 2013 |
Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diffusion Magnetic Resonance Imaging; Drug Monitoring; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes.
Topics: Biological Transport; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Radionuclide Imaging; Retrospective Studies | 2013 |
Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Impact of PET staging in limited-stage small-cell lung cancer.
Topics: Adult; Aged; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Survival Rate | 2013 |
Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
(18)F-FDG PET/CT-positive internal mammary lymph nodes: pathologic correlation by ultrasound-guided fine-needle aspiration and assessment of associated risk factors.
Topics: Breast Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Washington | 2013 |
Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Recurrence, Local; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Prevalence of vocal cord paralysis in patients with incidentally discovered enlarged lymph nodes along the expected course of the recurrent laryngeal nerve.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Diseases; Lymphatic Metastasis; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Recurrent Laryngeal Nerve; Retrospective Studies; Sarcoidosis; Tomography, X-Ray Computed; United States; Vocal Cord Paralysis | 2013 |
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Alphapapillomavirus; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Human papillomavirus 16; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 2014 |
[Prognostic value of PET/CT in lung cancer: retrospective analysis of 47 patients].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2013 |
The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Incidence; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Smoking; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Prognostic factors affecting disease-specific survival in patients with recurrent and/or metastatic differentiated thyroid carcinoma detected by positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Remission Induction; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 2014 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Clinicopathological determinants of positron emission tomography computed tomography fluorodeoxyglucose standardised uptake value in head and neck carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2013 |
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2013 |
Abdominal lymph node metastasis in patients with non-small-cell lung cancer as shown by PET/CT.
Topics: Abdominal Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm applicable to other malignancies--assessment of nodal distribution in gynecological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Aorta; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Guideline Adherence; Humans; Lumbar Vertebrae; Lymph Nodes; Lymphatic Metastasis; Lymphography; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Psoas Muscles; Radiation Oncology; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Renal Artery; Renal Veins; Retrospective Studies; Tomography, X-Ray Computed; Vena Cava, Inferior | 2013 |
Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiography; Stomach Neoplasms; Tomography Scanners, X-Ray Computed | 2014 |
Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiography, Interventional; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Prospective Studies; Radiography; Radionuclide Imaging; Ultrasonography | 2014 |
Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET--guided neck management policy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2014 |
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Sentinel node biopsy and frozen section procedure in signet ring cell carcinoma of the eyelid and orbit.
Topics: Aged; Carcinoma, Signet Ring Cell; Eyelid Neoplasms; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Sodium Pertechnetate Tc 99m | 2014 |
The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Republic of Korea; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Time Factors | 2013 |
Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
Pathology-based validation of FDG PET segmentation tools for volume assessment of lymph node metastases from head and neck cancer.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2013 |
A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Models, Statistical; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2013 |
Aggressive strategy for the treatment of synchronous metastatic anal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Hepatectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mitomycin; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
[Diagnostic values of ultrasound and (18)F-fluoro-2-deoxy-D-glucose-positron emission tomography/computerized tomography for patients with suspected thyroid carcinoma and lymph node metastasis].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2013 |
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Endpoint Determination; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy, Image-Guided; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2013 |
Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
[Clinical target volume delineation for radiotherapy of the esophagus].
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2013 |
Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study.
Topics: Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed | 2013 |
Relationship between extracapsular spread and FDG PET/CT in oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Axilla; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptors, Estrogen; Risk Assessment; ROC Curve; Tomography, X-Ray Computed; Triple Negative Breast Neoplasms; Tumor Burden | 2013 |
Repetition of FDG PET study in the same day after appropriate patient preparation revealed two new cancer localizations: a case report.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasms, Second Primary; Positron-Emission Tomography; Time Factors; Urinary Bladder Neoplasms | 2013 |
Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Utility of 18F-FDG PET/CT in supracricoid partial laryngectomy.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Laryngectomy; Larynx; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Republic of Korea; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Extensive tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18FDG PET/CT in a patient with a history of malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Models, Biological; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Lymph node to primary tumor SUV ratio by 18F-FDG PET/CT and the prediction of axillary lymph node metastases in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2014 |
Hepatic tuberculosis mimics metastasis revealed by 18F-FDG PET/CT.
Topics: Biopsy, Needle; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Hepatic; Ultrasonography | 2014 |
An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vulva | 2014 |
Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Value of F-18 FDG PET/CT in detection and prognostication of isolated extra-axillary lymph node recurrences in postoperative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2014 |
Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Patient Outcome Assessment; Pharynx; Positron-Emission Tomography; Recurrence; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
Prognostic implication of retrocrural lymph node involvement revealed by (18)F-FDG PET/CT in patients with uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2014 |
Preoperative 18F-fluorodeoxyglucose positron emission tomography can predict the tumor malignancy of small peripheral lung cancer.
Topics: Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2014 |
[Comparison of (18)F-FDG PET/CT and enhancement CT in diagnosing regional lymph node metastasis of colorectal cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Enhancement; Tomography, X-Ray Computed; Young Adult | 2013 |
FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
Topics: Aged, 80 and over; Carcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cystectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Selection; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Decision Making; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron-Emission Tomography; Principal Component Analysis; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2013 |
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
[Evaluation of false-negative lymph nodes diagnosed by fludeoxy glucose-positron emission tomography in cases of metastatic esophageal squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography | 2013 |
Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2013 |
Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2013 |
(18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Ganglioneuroblastoma; Humans; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Ipilimumab; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mycophenolic Acid; Platinum Compounds; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Skin Neoplasms; Tacrolimus; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Endoscopy, Gastrointestinal; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Italy; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Rate; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Predictive value of volumetric parameters measured by F-18 FDG PET/CT for lymph node status in patients with surgically resected rectal cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2014 |
Combined measurement of tumor perfusion and glucose metabolism for improved tumor characterization in advanced cervical carcinoma. A PET/CT pilot study using [15O]water and [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Blood Glucose; Cervix Uteri; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Oxygen Radioisotopes; Perfusion Imaging; Pilot Projects; Positron-Emission Tomography; Regional Blood Flow; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2014 |
A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Topics: Algorithms; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Limit of Detection; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Lymphoid metastasis of rat My2/De leukemia.
Topics: Animals; Fluorodeoxyglucose F18; Leukemia, Myeloid; Lymphatic Metastasis; Male; Peroxidase; Positron-Emission Tomography; Rats; Rats, Long-Evans | 2014 |
IMRT with ¹⁸FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
Detection of early esophageal cancer and cervical lymph node metastases by (18)F-FDG PET/CT in a patient with Fanconi anemia.
Topics: Cervical Vertebrae; Child; Child, Preschool; Early Detection of Cancer; Esophageal Neoplasms; Fanconi Anemia; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2014 |
FDG PET in early stage cutaneous malignant melanoma.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2014 |
Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Squamous Cell; Endoscopy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Logistic Models; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate | 2016 |
The role of (18)fluoro-deoxyglucose positron emission tomography/computed tomography in resectable pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
FDG PET/MR for lymph node staging in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck | 2014 |
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2014 |
The role of (18)F-FDG PET/CT for evaluation of metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma or adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2014 |
Nuclear imaging and early breast cancer detection.
Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Molecular Imaging; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?
Topics: Adult; Aged; Aged, 80 and over; Cholecystography; Female; Fluorodeoxyglucose F18; Gallbladder; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mouth Neoplasms; Multidetector Computed Tomography; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tumor Burden | 2014 |
Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2014 |
Comparison of 18F-AIF-NOTA-PRGD2 and 18F-FDG uptake in lymph node metastasis of differentiated thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Biopsy, Fine-Needle; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2014 |
Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2014 |
Prognostic significance of the intratumoral heterogeneity of (18) F-FDG uptake in oral cavity cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed | 2014 |
FDG PET/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities.
Topics: Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET-CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vulva; Vulvar Neoplasms | 2014 |
Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2014 |
Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Cervix Uteri; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2015 |
FDG-PET/CT in staging of clear cell odontogenic carcinoma.
Topics: Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mandibular Neoplasms; Maxillary Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Odontogenic Tumors; Orbital Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Potential performance of dual-time-point 18F-FDG PET/CT compared with single-time-point imaging for differential diagnosis of metastatic lymph nodes: a meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Young Adult | 2014 |
The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer.
Topics: Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Physical Examination; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2015 |
The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours.
Topics: Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm, Residual; Oropharyngeal Neoplasms; Patient Care Planning; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2014 |
Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Topics: Adenocarcinoma; Aged; Biopsy; Esophageal Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Unnecessary Procedures | 2014 |
Efficiency of three-dimensional Doppler ultrasonography in assessing nodal metastasis of head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2015 |
Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2014 |
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2015 |
Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Metabolic Clearance Rate; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2014 |
Comparison of objective criteria and expert visual interpretation to classify benign and malignant hilar and mediastinal nodes on 18-F FDG PET/CT.
Topics: Adult; Aged; Biopsy, Needle; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
Topics: Aged; Algorithms; Artifacts; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Hepatoid adenocarcinoma of the stomach: dual-time-point (18)F-FDG PET/CT findings.
Topics: Adenocarcinoma; Aged; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Stable metabolic disease on FDG-PET provides information on response to endocrine therapy for breast cancer.
Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hormones; Humans; Lymphatic Metastasis; Middle Aged; Mucin-1; Pilot Projects; Positron-Emission Tomography; Retrospective Studies; Treatment Outcome | 2017 |
Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed | 2014 |
Mediastinal sarcoidosis mimicking lymph malignancy recurrence after anti-neoplastic therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Gastrectomy; Granuloma; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Mastectomy, Segmental; Mediastinal Diseases; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stomach Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Tumour 18 F-FDG Uptake on preoperative PET/CT may predict axillary lymph node metastasis in ER-positive/HER2-negative and HER2-positive breast cancer subtypes.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
FDG-PET/CT of schwannomas arising in the brachial plexus mimicking lymph node metastasis: report of two cases.
Topics: Aged; Brachial Plexus; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neurilemmoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imidazoles; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Triazoles | 2014 |
Efficacy of 18F-fluorodeoxyglucose positron emission tomography/CT imaging for extracapsular spread of laryngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hysterectomy; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Chemoradiotherapy; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction; Retreatment; Treatment Outcome | 2014 |
The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
The method and efficacy of support vector machine classifiers based on texture features and multi-resolution histogram from (18)F-FDG PET-CT images for the evaluation of mediastinal lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Support Vector Machine; Tomography, X-Ray Computed | 2015 |
Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Menopause; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals | 2015 |
The clinical value of 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography for predicting regional lymph node metastasis and non-curative surgery in primary gastric carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Peritoneal Neoplasms; Positron-Emission Tomography; Regression Analysis; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Solitary peritoneal lymph node metastasis of head and neck cancer diagnosed with FDG-PET/CT imaging.
Topics: Adult; Carcinoma, Squamous Cell; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Mouth Floor; Mouth Neoplasms; Multimodal Imaging; Peritoneum; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography helpful in the decision-making process for neck dissection in patients with T1-T2 lingual cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tongue Neoplasms | 2015 |
Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed | 2015 |
Long-term results of positron emission tomography-directed management of the neck in node-positive head and neck cancer after organ preservation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRI.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Therapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Risk; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Health Status; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2015 |
18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Molecular Diagnostic Techniques; Multimodal Imaging; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
18F-FDG PET-CT as a supplement to CT/MRI for detection of nodal metastasis in hypopharyngeal SCC with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Squamous cell carcinoma of the tongue with metastasis to the right ventricle.
Topics: Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed; Tongue Neoplasms | 2015 |
Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2015 |
Diffusion-weighted magnetic resonance imaging in preoperative assessment of non-small cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2015 |
The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; China; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2014 |
Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
[A case report of surgical treatment for hepatocellular carcinoma with a Hugely swollen lymph node that showed high FDG uptake].
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2014 |
(18)F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma.
Topics: Adult; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Squamous Cell; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Positron-Emission Tomography; Prognosis; Statistics as Topic; Tongue Neoplasms | 2015 |
Discovery of the primary site of esophageal squamous cell carcinoma based on axillary lymph nodes metastasis detected with fluorodeoxyglucose positron-emission tomography: report of a case.
Topics: Axilla; Carcinoma, Squamous Cell; Endoscopy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography | 2014 |
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
Topics: Adult; Aged; Blood Glucose; Chemoradiotherapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
[Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2015 |
A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Ultrasonography; Young Adult | 2017 |
[Positron emission tomography/computed tomography for lung cancer staging].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Efficacy of 18-FDG PET-CT dual-phase scanning for detection of lymph node metastasis in gynecological cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Patient Positioning; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Supine Position; Tomography, X-Ray Computed | 2015 |
Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Squamous Cell; Cell Proliferation; Cohort Studies; Dideoxynucleosides; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
The prognostic significance of pretreatment [18F]FDG-PET/CT imaging in patients with uterine cervical cancer: preliminary results.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Micrometastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sentinel Lymph Node Biopsy; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Recurrence, Local; Otorhinolaryngologic Surgical Procedures; Plastic Surgery Procedures; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Surgical Flaps; Tomography, X-Ray Computed | 2015 |
Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.
Topics: Adult; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate; Tomography, X-Ray Computed | 2015 |
Extensive Tattoos Mimicking Lymphatic Metastasis on Positron Emission Tomography Scan in a Patient With Cervical Cancer.
Topics: Adult; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tattooing; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
[The role of PET in lung cancer staging].
Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cone-Beam Computed Tomography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Young Adult | 2015 |
Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Papillary; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Diseases; Thyroid Neoplasms | 2016 |
18F-fluorodeoxyglucose positron emission tomography for predicting tumor response to radiochemotherapy in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiotherapy, Intensity-Modulated | 2015 |
Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Neoplasm Regression, Spontaneous; Positron-Emission Tomography; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neck; Oropharyngeal Neoplasms; Palpation; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2016 |
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population.
Topics: Aged; Aged, 80 and over; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2016 |
Herpes Zoster Mimicking Breast Cancer With Axillary Lymph Node Metastasis on PET/CT.
Topics: Adult; Axilla; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires; Urinary Bladder Neoplasms; Urothelium | 2016 |
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Lymph Node Metastasis from Tall-Cell Thyroid Cancer Negative on 18F-FDG PET/CT and Detected by 18F-Choline PET/CT.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
[Multiple enlarged metabolically active lymph nodes in 18F-FDG PET/CT after anti-CTLA-4 antibody therapy in metastatic melanoma - disease progression or immunologically induced side effect?].
Topics: Aged; Antibodies, Monoclonal; Colon; CTLA-4 Antigen; Diagnosis, Differential; Disease Progression; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ipilimumab; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
High metabolic tumor volume and total lesion glycolysis are associated with lateral lymph node metastasis in patients with incidentally detected thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Incidental Findings; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and ¹⁸F-FDG PET/CT.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2015 |
Histogram Analysis of Apparent Diffusion Coefficients for Occult Tonsil Cancer in Patients with Cervical Nodal Metastasis from an Unknown Primary Site at Presentation.
Topics: Adult; Aged; Biopsy; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillar Neoplasms; Tonsillectomy | 2016 |
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2015 |
Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Mutation; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; ras Proteins; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Positron emission tomography-computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Young Adult | 2016 |
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Brain Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Unnecessary Procedures | 2015 |
Ultrasonography-Guided Core Biopsy of Supraclavicular Lymph Nodes for Diagnosis of Metastasis and Identification of Epidermal Growth Factor Receptor (EGFR) Mutation in Advanced Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2015 |
Prognostic Factors and Treatment Outcomes of Parotid Gland Cancer: A 10-Year Single-Center Experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Acinar Cell; Carcinoma, Mucoepidermoid; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Parotid Neoplasms; Prognosis; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2015 |
Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
Topics: Aged; Denmark; False Negative Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy | 2016 |
The value of primary tumor (18)F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Retrospective Studies; ROC Curve | 2016 |
Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Young Adult | 2015 |
Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sigmoid Neoplasms; Tomography, X-Ray Computed | 2015 |
Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Treatment Failure; Uterine Cervical Neoplasms; Young Adult | 2015 |
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2016 |
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2016 |
False-positive finding of retropharyngeal lymph node recurrence in both fluorine (18)FDG PET and MRI in a patient with nasopharyngeal carcinoma.
Topics: Adult; Biopsy; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2016 |
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed | 2015 |
Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
Topics: Blood Vessels; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Lymphatic Vessels; Male; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Receptor, ErbB-2; ROC Curve; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome; Young Adult | 2015 |
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Regression Analysis; Retrospective Studies; ROC Curve; Survival Analysis; Tumor Burden | 2015 |
Use of FDG PET/CT in Patients with Pancoast Tumors: Does It Add Any Contribution to Patient Management?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pancoast Syndrome; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Multimodal Imaging; Pneumoconiosis; Positron-Emission Tomography; Prospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Lack of clinical impact of
Topics: Adult; Aged; Aged, 80 and over; Australia; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2017 |
Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Topics: Adult; Aged; Aged, 80 and over; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Frozen Sections; Glucose; Groin; Humans; Inguinal Canal; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precision Medicine; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Turkey; Vulvar Neoplasms | 2016 |
Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2016 |
(18)F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after Mastectomy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Risk Assessment; Risk Factors; Tumor Burden | 2016 |
Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carci
Topics: Carcinoma; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Viral Load | 2015 |
Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Dexamethasone Suppression FDG PET/CT for Differentiating between True- and False-Positive Pulmonary and Mediastinal Lymph Node Metastases in Non-Small Cell Lung Cancer: A Pilot Study of FDG PET/CT after Oral Administration of Dexamethasone.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Radium-223 dichloride therapy in breast cancer with osseous metastases.
Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Off-Label Use; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radium; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Ammonia; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging | 2016 |
Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
Topics: Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome | 2016 |
Evaluation of 18F-FDG uptake for detecting lymph node metastasis of gastric cancer: a prospective pilot study for one-to-one comparison of radiation dose and pathological findings.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Variations in (18)F-FDG uptake in breast cancer depending on PET/CT acquisition position.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Patient Positioning; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
(18)F FDG PET/CT versus CT/MR Imaging and the Prognostic Value of Contralateral Neck Metastases in Patients with Head and Neck Squamous Cell Carcinoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
[(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Second Primary; Pharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult | 2016 |
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2016 |
Widespread lymph node recurrence of major duodenal papilla cancer following pancreaticoduodenectomy.
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Common Bile Duct Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Organoplatinum Compounds; Oxaliplatin; Pancreaticoduodenectomy; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor.
Topics: Bone Neoplasms; Breast Neoplasms; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ki-67 Antigen; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2016 |
False-Positive Axillary Lymph Nodes Due to Silicone Adenitis on (18)F-FDG PET/CT in an Oncological Setting.
Topics: Axilla; Breast Implants; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphadenitis; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Silicones; Transgender Persons | 2016 |
Comparison of MRI and 18F-FDG PET/CT in the preoperative evaluation of uterine carcinosarcoma.
Topics: Aged; Aorta; Carcinosarcoma; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Neoplasms | 2016 |
Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate | 2016 |
18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.
Topics: Carcinoma; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vaginal Neoplasms; Vulvar Neoplasms | 2016 |
Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer.
Topics: Adenocarcinoma; Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Intra-Abdominal Fat; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Theoretical; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2016 |
18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results; Retrospective Studies; Stomach Neoplasms; Young Adult | 2016 |
Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Aorta; Bile Duct Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Common Bile Duct Neoplasms; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Bronchoscopy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Thoracotomy | 2016 |
F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drainage; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2016 |
Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mouth Neoplasms; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2016 |
Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2016 |
Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms | 2016 |
Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Signal-To-Noise Ratio | 2016 |
PET/CT imaging in diagnosing lymph node metastasis of esophageal carcinoma and its comparison with pathological findings.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Data Accuracy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms | 2016 |
Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2016 |
FDG-PET/CT of Vulvar Adenocarcinoma With Diffuse Metastases.
Topics: Adenocarcinoma; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vulvar Neoplasms | 2016 |
Clinical significance of post-treatment
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neck; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
Topics: Adult; Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Surveys and Questionnaires; Tomography, X-Ray Computed | 2016 |
18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience.
Topics: Biomarkers, Tumor; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Whole Body Imaging | 2016 |
Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
FLT-PET/CT diagnosis of primary and metastatic nodal lesions of gastric cancer: comparison with FDG-PET/CT.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2016 |
Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
Topics: Adenocarcinoma; Antigens, Surface; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2016 |
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Topics: Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2016 |
Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Topics: Aged; Area Under Curve; Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Rate | 2016 |
Intraoperative lymph node evaluation using 18F-FDG and a hand-held gamma probe in endometrial cancer surgery--a pilot study.
Topics: Aged; Cohort Studies; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Virchow's node metastasis: an unusual presentation of ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2016 |
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal-gastric junction.
Topics: Adenocarcinoma; Adult; Aged; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT.
Topics: Aged; Anal Canal; Anus Neoplasms; Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Retrospective Studies; Treatment Outcome | 2016 |
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2016 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |
Should (18)F FDG PET/CT Really Be Indicated in Routine Clinical Practice for Detecting Contralateral Neck Node Metastasis in Head and Neck Squamous Cell Carcinoma?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2017 |
Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2016 |
Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
Topics: Aged; Aged, 80 and over; Breast Neoplasms, Male; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Prognostic value of 18F-FDG PET/CT for identifying high- and low-risk endometrial cancer patients.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Turkey | 2016 |
Relation between primary tumor FDG avidity and site of first distant metastasis in patients with breast cancer.
Topics: Adult; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Survival Rate | 2016 |
Defining risk groups of patients with cancer of unknown primary site and cervical nodal metastases by F-18 fluorodeoxyglucose positron emission tomography and computed tomography imaging.
Topics: Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Risk Assessment; Risk Factors; Survival Analysis | 2016 |
Unusual Presentation of Bone Metastasis from Hepatocellular Carcinoma Mimicking as Breast Lump.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed | 2016 |
Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2017 |
Prognostic value of metabolic parameters on preoperative 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in patients with stage III gastric cancer.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2016 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thyroid Neoplasms | 2016 |
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
Topics: Bone Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Middle Aged; Omentum; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Value of
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Topics: Adenocarcinoma; Contrast Media; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2017 |
Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Topics: Adult; Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Myometrium; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2017 |
18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.
Topics: Aged; Breast Neoplasms, Male; Choline; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
Topics: Bone Neoplasms; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Patient Care Planning; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Survival Rate | 2017 |
Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Reproducibility of Results; Retrospective Studies; Thyroid Neoplasms | 2016 |
Occult breast primary malignancy presenting as isolated axillary lymph node metastasis - early detection of primary site by 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adult; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Whole Body Imaging | 2016 |
Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Topics: Adenocarcinoma; Aged; Bile Ducts, Extrahepatic; Biomarkers, Tumor; Biopsy; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cholangiopancreatography, Magnetic Resonance; Cholecystectomy; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endoscopy, Gastrointestinal; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Immunohistochemistry; Jejunostomy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2016 |
PET/CT with
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult | 2017 |
Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
Unsuspected axillary lymph node metastasis of nasopharyngeal and cervical cancer on 18FDG PET/CT: a case report.
Topics: Axilla; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Nasopharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2016 |
Prognostic significance of venous invasion and maximum standardized uptake value of
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Outcome; Vascular Neoplasms | 2017 |
PET/MR Outperforms PET/CT in Suspected Occult Tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
How we read FCH-PET/CT for prostate cancer.
Topics: Aged; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution | 2016 |
Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; ROC Curve; Time Factors; Treatment Failure; Tumor Burden | 2017 |
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
Topics: Adolescent; Child; Child, Preschool; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Role of
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Outcome Assessment, Health Care; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Comparison of Contrast-Enhanced CT and [
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2017 |
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease.
Topics: Aged; Aged, 80 and over; Axilla; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2017 |
Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
Topics: Adolescent; Adult; Aged; Biological Transport; Carcinoma; Carcinoma, Papillary; Cohort Studies; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Young Adult | 2017 |
Whole-body PET/CT-mammography for staging breast cancer: initial results.
Topics: Algorithms; Axilla; Breast Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2008 |
AEG I and II: is it one tumor entity?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2008 |
Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Time | 2008 |
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
Topics: Adult; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Axilla; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Probability; Prognosis; Prospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Statistics, Nonparametric; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2008 |
Role of ultrasound-guided fine needle aspiration in assessing the impalpable cervical node with increased 18F-fluorodeoxyglucose uptake on positron emission tomography scanning: preliminary communication.
Topics: Adult; Aged; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Interventional; Whole Body Imaging | 2008 |
PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
Topics: Contrast Media; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Practice Guidelines as Topic; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Evaluation of lung lesions using FDG gamma-camera PET equipped with a one-inch crystal.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
18F-FDG uptake in reactive neck lymph nodes of oral cancer: relationship to lymphoid follicles.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2008 |
18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Sensitivity and Specificity | 2009 |
Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thoracic Neoplasms | 2009 |
Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adolescent; Adult; Aged; Carcinoma; Child; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Impact of whole-body 18F-FDG PET on diagnostic and therapeutic management of Medical Oncology patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Whole Body Imaging | 2008 |
Breast cancer staging in a single session: whole-body PET/CT mammography.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2009 |
Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
Topics: Aged, 80 and over; False Negative Reactions; Female; Fibroma, Desmoplastic; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden | 2008 |
Role of PET/CT in the evaluation of cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Uterine Cervical Neoplasms | 2008 |
Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction.
Topics: Algorithms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2008 |
Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
Topics: Adult; Aged; Carbon Radioisotopes; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methionine; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2008 |
Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
[Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors | 2008 |
Lung cancer: new opportunities--changing algorithm in staging.
Topics: Algorithms; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Positron-Emission Tomography | 2008 |
[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2008 |
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Mesothelioma; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Unnecessary Procedures | 2008 |
Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.
Topics: Aged; Axilla; Breast Neoplasms; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome | 2009 |
The role of CT and ¹⁸F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1.
Topics: Adult; Bronchial Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Genetic Markers; Humans; Lymphatic Metastasis; Male; Multiple Endocrine Neoplasia Type 1; Positron-Emission Tomography; Proto-Oncogene Proteins; Sensitivity and Specificity; Thymus Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Performance of 18F-FDG PET/CT in endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Port site and distant metastases of gallbladder cancer after laparoscopic cholecystectomy diagnosed by positron emission tomography.
Topics: Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cholecystectomy, Laparoscopic; Cholecystitis; Cholelithiasis; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Incidental Findings; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Seeding; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Catheter Ablation; Cohort Studies; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Survival Rate; Treatment Outcome; Young Adult | 2009 |
[Role of FDG PET-CT in cutaneous melanoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Carbon; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Skip metastasis to abdominal lymph nodes from lung adenocarcinoma.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study.
Topics: Adult; Aged; alpha-Methyltyrosine; Antigens, CD34; Female; Fluorodeoxyglucose F18; Fusion Regulatory Protein-1; Humans; Immunohistochemistry; Large Neutral Amino Acid-Transporter 1; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2009 |
An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2009 |
Extraosseous myxoid chondrosarcoma with pulmonary and nodal metastases on FDG PET-CT.
Topics: Aged; Chondrosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Topics: Aged; Analysis of Variance; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Forced Expiratory Volume; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Models, Statistical; Nomograms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Severity of Illness Index; Sex Factors; Survival Analysis; Survival Rate; Tumor Burden | 2009 |
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Survival Rate | 2009 |
FDG-positive Warthin's tumors in cervical lymph nodes mimicking metastases in tongue cancer staging with PET/CT.
Topics: Adenolymphoma; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms | 2009 |
Abnormal FDG uptake on 18F-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculous lymphadenitis.
Topics: Antitubercular Agents; Breast Neoplasms; Colonic Neoplasms; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tuberculosis, Lymph Node | 2009 |
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Physical Examination; Positron-Emission Tomography | 2009 |
Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography | 2009 |
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
[Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antigens, CD34; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Microvessels; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2008 |
[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer.
Topics: Adult; Aged; Aorta; Aortography; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed; Uterine Neoplasms | 2009 |
Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.
Topics: Aged; Contrast Media; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Iopamidol; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Systems Integration; Tomography, X-Ray Computed | 2009 |
Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms | 2009 |
[Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference].
Topics: Blood Glucose; Chemotherapy, Adjuvant; Combined Modality Therapy; Consensus; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Otorhinolaryngologic Neoplasms; Patient Care Team; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.
Topics: Dideoxynucleosides; Excitatory Amino Acid Transporter 2; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
[Merkel cell carcinoma: a rare tumor entity in an unusually young patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Combined Modality Therapy; Contrast Media; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Knee; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Skin Neoplasms; Surgical Flaps; Whole Body Imaging | 2009 |
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2010 |
Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Is FDG-PET/CT useful for managing malignant pleural mesothelioma?
Topics: Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma.
Topics: Aged; Aged, 80 and over; Epidemiologic Methods; Fluorodeoxyglucose F18; Groin; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
[Evaluation of the primary lesion detection in colorectal carcinoma with (18)F-FDG PET-CT].
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2009 |
Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2009 |
[The advantage of Positron Emission Tomography combined with Computer Tomography (PET-CT) in the diagnosis of lung cancer (experience with 408 patients)].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, X-Ray Computed | 2009 |
Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2009 |
Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiotherapy, Conformal; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Body Weight; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Blood Vessels; Body Weight; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Databases as Topic; Female; Fluorodeoxyglucose F18; Humans; Keratin-19; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pleura; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thoracotomy | 2009 |
Positron emission tomography-computed tomography in predicting locoregional invasion in esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radioisotopes; Tomography, X-Ray Computed; Video-Assisted Surgery | 2009 |
Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2009 |
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer.
Topics: Aged; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2009 |
Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Belgium; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2009 |
Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Topics: Cystectomy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2010 |
Nodal metastasis from occult thyroid cancer detected by FDG PET-CT in a patient with 2 known malignancies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prostatic Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2009 |
Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2009 |
[The role of preoperative investigation with 18-FDG-PET/CT in primary operable breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
[The role of 18F-FDG SPECT-CT in detecting recurrence and metastases in breast cancer patients with elevated tumor markers].
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2009 |
A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy.
Topics: Axilla; Breast Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Topics: Breast Neoplasms; Carcinoma, Ductal; Diagnosis, Differential; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
[PET/CT based radiotherapy treatment planning in head and neck cancers].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2009 |
Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2009 |
[Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
[18F-FDG PET/CT for the detection of primary tumors metastasizing to lymph nodes of the neck].
Topics: Adolescent; Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Nasopharyngeal Neoplasms; Neck; Positron-Emission Tomography; Pyriform Sinus; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
[Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2009 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2010 |
Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
A different role for FDG PET/CT in axillary lymph node staging in breast cancer.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
S-100B concentrations predict disease-free survival in stage III melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nerve Growth Factors; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Standard uptake value predicts survival in non-small cell lung cancer.
Topics: Aged; Algorithms; Biopsy; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Smoking; Tomography, X-Ray Computed | 2009 |
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT.
Topics: Adolescent; Adult; Aged; Calcinosis; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Leukocytes; Lymph Nodes; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2009 |
A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphography; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET.
Topics: Abdominal Neoplasms; Adult; Aged; Aorta; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies | 2009 |
Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography of breast cancer in detecting axillary lymph node metastasis: comparison with ultrasonography and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2009 |
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
Topics: Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2010 |
Re: Niels M. Graafland, Joost A.P. Leijte, Renato A. Valdes Olmos, et al. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 2009;56:339-45.
Topics: Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Pelvis; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Sensitivity and Specificity; Solitary Pulmonary Nodule; Statistics, Nonparametric; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2010 |
[Correlation between PET-CT 18FDG uptake in primary lesions and clinicopathological parameters in esophageal carcinoma patients].
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
[Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
18F-FDG PET in squamous cell carcinoma of the oral cavity and oropharynx: a study on inter- and intraobserver agreement.
Topics: Carboplatin; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Nuclear Medicine; Observer Variation; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Mutation; Pancreatic Neoplasms; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiotherapy, Adjuvant; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome | 2010 |
Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy: the usefulness of F-18 FDG PET/CT.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Gastric follicular lymphoma with mediastinal lymph node dissemination detected by FDG-PET.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Follicular; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Stomach Neoplasms | 2010 |
(18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Area Under Curve; Carcinoma, Adenosquamous; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2010 |
18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
[Evaluation of fluorodeoxyglucose-position-emission tomography-computer tomography imaging on head and neck squamous cell carcinomas including primary tumors and lymph node metastases].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Prediction of lymph node metastases in NSCLC. Three dimensional anatomical parameters do not substitute FDG-PET-CT.
Topics: Aged; Automation; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2010 |
Usefulness of Positron Emission Tomography for management of ocular sebaceous carcinoma.
Topics: Eye Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography | 2010 |
Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
Topics: Aged; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carney Complex; Chromogranin A; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Gene Transfer Techniques; Humans; Hypertension; Lymphatic Metastasis; Male; Metanephrine; Mutation; Neck; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Succinate Dehydrogenase; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Cervical tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18 FDG PET/CT in a patient with gastric carcinoid tumor.
Topics: Adult; Carcinoid Tumor; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Tuberculosis, Lymph Node | 2009 |
Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.
Topics: Aged; Aged, 80 and over; Cystectomy; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder Neoplasms | 2010 |
High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1).
Topics: Adult; Aged; Axilla; Disease Outbreaks; False Positive Reactions; Female; Fluorodeoxyglucose F18; Greece; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
[Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Spiral Computed | 2009 |
FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
(18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome | 2010 |
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2010 |
Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Japan; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Topics: Adolescent; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Lymphoma; Magnetic Resonance Imaging; Male; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Topics: Chemotherapy, Adjuvant; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Registries; Risk Assessment; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
[Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms | 2010 |
Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2010 |
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases.
Topics: Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Microspheres; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Tumor Cells, Cultured; Yttrium Radioisotopes | 2010 |
[PET scanning for malignant melanoma and positive sentinel node diagnostics].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2010 |
Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.
Topics: Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Regression Analysis; Retrospective Studies; Risk Factors; Thyroid Neoplasms | 2010 |
Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2010 |
Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tumor Burden; Young Adult | 2011 |
Impact of 18-fluorodeoxyglucose positron emission tomography on the management of pancreatic cancer.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk; Sensitivity and Specificity; Serpins; Uterine Cervical Neoplasms; Young Adult | 2011 |
Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2010 |
Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Tomography, X-Ray Computed | 2010 |
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasms, Glandular and Epithelial; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2011 |
Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma; Cell Differentiation; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms | 2011 |
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Topics: Adult; Bone Neoplasms; Brain Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reoperation; Republic of Korea; Time Factors; Tomography, Spiral Computed; Treatment Outcome | 2010 |
[Diffuse subdural recurrence of an esthesioneuroblastoma].
Topics: Adolescent; Biopsy; Combined Modality Therapy; Cranial Fossa, Anterior; Esthesioneuroblastoma, Olfactory; Ethmoid Sinus; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Maxillary Sinus; Necrosis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Orbit; Positron-Emission Tomography; Subdural Space; Tomography, X-Ray Computed | 2010 |
Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thoracotomy | 2010 |
The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Long-term survival of 42 patients with resected N2 non-small-cell lung cancer: the impact of 2-(18)F-fluoro-2-deoxy-D-glucose positron emission tomogram mediastinal staging.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Postoperative Complications; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2011 |
Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Postoperative Period; Prognosis; Recurrence; Retrospective Studies; Risk; Vascular Endothelial Growth Factor D | 2010 |
18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Incidence; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2011 |
FDG-PET staging and importance of lymph node SUV in head and neck cancer.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2010 |
When and how often should PET scans be performed in the management of cervical cancer?
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cost-Benefit Analysis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Time Factors; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
Contrast-enhanced ¹⁸F-FDG-PET/CT for the assessment of necrotic lymph node metastases.
Topics: Aged; Carcinoma, Squamous Cell; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiographic Image Enhancement; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2011 |
The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Mammary | 2010 |
PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2010 |
Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2010 |
Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Oropharyngeal Neoplasms; Polymerase Chain Reaction; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Survival Rate; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate | 2010 |
Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?
Topics: Biological Transport; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The real additional value of FDG-PET in detecting the occult primary tumour in patients with cervical lymph node metastases of unknown primary tumour.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnostic Imaging; Endoscopy; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |
Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Topics: Adult; Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed | 2011 |
Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.
Topics: Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Serpins; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Uveal Neoplasms | 2010 |
Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Splenic Neoplasms; Tomography, X-Ray Computed | 2010 |
[Benefit of PET/CT in the preoperative staging in pancreatic carcinomas].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Evaluation of FDG-PET for detecting lymph node metastasis in uterine corpus cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Uterine Neoplasms | 2010 |
Assessment of therapy response in lung cancer with ¹⁸F-α-methyl tyrosine PET.
Topics: Aged; Aged, 80 and over; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
Topics: Animals; Antibodies, Monoclonal; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Glycoproteins; Humans; Inflammation; Iodine Radioisotopes; Luminescent Measurements; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Melanoma, Experimental; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin; Tissue Distribution; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2010 |
Target delineation of gross tumor volume for radiation therapy planning using fusion images of ¹⁸F-fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2011 |
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2011 |
Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lipoma; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2011 |
Melanoma imaging with highly specific PET probes: ready for prime time?
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2011 |
[18F-fluorodeoxyglucose positron emission tomography (FDG-PET) negative poorly differentiated adenocarcinoma of lung with mediastinal lymph node metastases].
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Latent Tuberculosis; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urothelium | 2011 |
The usefulness of fully three-dimensional OSEM algorithm on lymph node metastases from lung cancer with 18F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Squamous Cell; Chemoradiotherapy; Choline; Cisplatin; Contrast Media; Diagnostic Imaging; Extracellular Space; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Gadolinium DTPA; Glucose; Glycolysis; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Statistics, Nonparametric; Tongue Neoplasms; Tonsillar Neoplasms | 2012 |
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Significance of smoking history and FDG uptake for pathological N2 staging in clinical N2-negative non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Smoking | 2011 |
Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Potential role of combined FDG PET/CT & contrast enhancement MRI in a rectal carcinoma model with nodal metastases characterized by a poor FDG-avidity.
Topics: Adenocarcinoma; Animals; Contrast Media; Fluorodeoxyglucose F18; HT29 Cells; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Mice; Mice, Nude; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Hounsfield units upon PET/CT are useful in evaluating metastatic regional lymph nodes in patients with oesophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2011 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Actinomycosis imitating parotid cancer with metastatic lymph nodes in FDG PET/CT.
Topics: Actinomycosis; Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Parotid Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.
Topics: Adenocarcinoma; Aged; Anthracosis; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Coal; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Mediastinum; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Turkey | 2012 |
[Experience with combined treatment of invasive squamous cell cancer of the penis].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Penile Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed | 2011 |
FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
Topics: Algorithms; Area Under Curve; Artificial Intelligence; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Infusions, Intravenous; Kidney Neoplasms; Kinetics; Lymphatic Metastasis; Magnetic Resonance Imaging; Models, Statistical; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2011 |
Is there any maximum standardized uptake value variation among positron emission tomography scanners for mediastinal staging in non-small cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Equipment Design; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Quality of Health Care; Radiopharmaceuticals; Reproducibility of Results; Thoracotomy; Tomography, X-Ray Computed; Turkey | 2011 |
Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Observer Variation; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tumor Burden | 2011 |
A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2011 |
Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2011 |
False positive lymph node activity on positron emission tomography (PET/CT) due to hemostatic compresses.
Topics: Adenocarcinoma; Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Surgical Sponges; Tomography, X-Ray Computed | 2011 |
[Bifocal lung cancer: the same histology?].
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Bronchoscopy; Carcinoma, Small Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pneumonia; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Tongue Neoplasms; Whole Body Imaging | 2011 |
Usefulness of semi-automatic volumetry compared to established linear measurements in predicting lymph node metastases in MSCT.
Topics: Algorithms; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Iohexol; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Software; Tomography, X-Ray Computed | 2011 |
Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed | 2011 |
Novel handheld PET probes provide intraoperative localization of PET-avid lymph nodes.
Topics: Animals; Fluorodeoxyglucose F18; Lymph Nodes; Lymphatic Metastasis; Mesothelioma; Positron-Emission Tomography; Predictive Value of Tests; Radiography; Radiopharmaceuticals; Rats; Rats, Nude; ROC Curve; Sensitivity and Specificity; Transplantation, Heterologous | 2011 |
Metabolic response of pelvic and para-aortic lymph nodes during radiotherapy for carcinoma of the uterine cervix: using positron emission tomography/computed tomography.
Topics: Aorta; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Pelvis; Positron-Emission Tomography; Prognosis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Endosonography; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Patient Selection; Positron-Emission Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals | 2016 |
Fluorodeoxyglucose-positive Warthin tumor in a neck node mimicking metastasis in primary intraosseous left posterior mandibular cancer staging with positron emission tomography/computed tomography.
Topics: Adenolymphoma; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Neoplasms, Multiple Primary; Parotid Neoplasms; Positron-Emission Tomography; Radiography, Panoramic; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Whole-body FDG PET/CT in diagnosis of internal mammary nodal metastasis of ovarian carcinosarcoma.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography-CT in follow-up of postoperative breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Postoperative Period; Tomography, X-Ray Computed; Young Adult | 2011 |
Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Cohort Studies; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Hepatic macronodular tuberculoma mimics liver metastasis in a patient with locoregional advanced tongue cancer.
Topics: Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mycobacterium tuberculosis; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tongue Neoplasms; Tuberculoma; Tuberculosis, Hepatic; Tuberculosis, Pulmonary | 2011 |
Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2011 |
The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2011 |
18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies | 2011 |
Is positron emission tomography reliable to predict post-chemotherapy retroperitoneal lymph node involvement in advanced germ cell tumors of the testis?
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retroperitoneal Space; Sensitivity and Specificity; Testicular Neoplasms; Young Adult | 2011 |
The standardize uptake value: light and shade of positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Equipment Design; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Quality of Health Care; Radiopharmaceuticals; Reproducibility of Results | 2011 |
PET-CT in the staging and treatment of non-small-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Turkey | 2012 |
Early prediction of local control in head and neck cancer after chemoradiotherapy by FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Time Factors; Treatment Outcome | 2011 |
Lymph node metastasis of squamous cell carcinoma from an unknown primary in the upper and middle neck: Impact of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Thoracic Neoplasms | 2012 |
Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2011 |
Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Iodine; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2012 |
Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nerve Growth Factors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Topics: Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Treatment Outcome; Tumor Burden | 2011 |
Clinical value of integrated [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the preoperative assessment of papillary thyroid carcinoma: comparison with sonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2011 |
The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2011 |
Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Mediastinal teratoma with metastatic lymph node: misleading normal thymic uptake of F-18 FDG.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Radionuclide Imaging; Sternotomy; Teratoma; Thymus Gland | 2011 |
Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; User-Computer Interface | 2011 |
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Topics: Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Rectal Neoplasms; Risk Assessment; Tomography, X-Ray Computed | 2012 |
The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Hungary; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Topics: Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neck; Radionuclide Imaging; Thyroid Cancer, Papillary; Thyroid Neoplasms; Treatment Outcome; Whole Body Imaging | 2011 |
Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Topics: Brachial Plexus; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Esophagus; Fluorodeoxyglucose F18; Heart; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Spinal Cord; Treatment Outcome | 2011 |
The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Peritoneum; Positron-Emission Tomography; Postoperative Period; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
[Usefulness of 18F-FDG PET/CT examination in the diagnosis of head and neck cancer--preliminary results].
Topics: Adult; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.
Topics: Aged; Diagnosis, Differential; Endemic Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinum; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Tuberculosis | 2011 |
Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Tomography, X-Ray Computed | 2012 |
Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.
Topics: Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
[Indications for the use of PET or PET/CT in patients with breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Performance of fluorodeoxyglucose-positron-emission tomography/computed tomography for evaluating tumor response to nonsurgical treatment.
Topics: Adenocarcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neurilemmoma; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy.
Topics: Aged; Aged, 80 and over; Choline; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kinetics; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Recurrence; Time Factors; Tomography, X-Ray Computed | 2012 |
Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Serpins; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Young Adult | 2012 |
The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden | 2012 |
[((18)F)-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2011 |
Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2011 |
Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2012 |
External ultrasonography of the neck does not add diagnostic value to integrated positron emission tomography-computed tomography (PET-CT) scanning in the diagnosis of cervical lymph node metastases in patients with esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
FDG-PET performed concurrently with initial I-131 ablation for differentiated thyroid cancer.
Topics: Ablation Techniques; Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2012 |
Supraclavicular lymph nodes detected by 18F-FDG PET/CT in cancer patients: assessment with 18F-FDG PET/CT and sonography.
Topics: Adult; Aged; Biopsy, Fine-Needle; Clavicle; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2012 |
Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Standard uptake value of positron emission tomography in clinical stage I lung cancer: clinical application and pathological correlation.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
The value of PET/CT to assess clinically negative necks.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Predictive value of positron emission tomography-computed tomography image fusion in the diagnosis of head and neck cancer: does it really improve staging and management?
Topics: Biopsy; Carcinoma; Clinical Competence; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidental Findings; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Whole-body 18F FDG positron emission tomography/computed tomography evaluation of patients with uveal metastasis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma, Amelanotic; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Optical Coherence; Tomography, X-Ray Computed; Uveal Neoplasms; Whole Body Imaging | 2012 |
The method and efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing the lymphatic metastasis of colorectal carcinoma.
Topics: Adult; Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2012 |
Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
To PET or not to PET? That is the question. Staging in anal cancer.
Topics: Anus Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2012 |
FDG PET/CT in diagnosing and staging cutaneous eccrine adenocarcinoma.
Topics: Adenocarcinoma; Aged, 80 and over; Back; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sweat Gland Neoplasms; Tomography, X-Ray Computed | 2012 |
False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Topics: Biopsy; Bone Neoplasms; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Sarcoidosis; Tomography, X-Ray Computed | 2012 |
Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sentinel Lymph Node Biopsy; Taxoids; Tomography, X-Ray Computed | 2013 |
Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Preoperative PET/CT in early-stage breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
[Laparoscopic para-aortic lymphadenectomy in advanced cervical cancer: morbidity and impact on therapy].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Isolated cardiac metastasis from papillary thyroid cancer: prolonged survival with late diagnosis related to inadequate positron emission tomography preparation.
Topics: Carcinoma; Carcinoma, Papillary; Delayed Diagnosis; Female; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Survival; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2012 |
[Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].
Topics: Adult; Aged; Combined Modality Therapy; Confidence Intervals; Disease-Free Survival; Female; Fluorodeoxyglucose F18; France; Humans; Lumbosacral Region; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Uterine Cervical Neoplasms | 2012 |
[¹⁸F]fluorodeoxyglucose positron emission tomography-computed tomography in breast cancer: when... and when not?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Sentinel Lymph Node Biopsy | 2012 |
Correlation between FDG uptake by PET/CT and the expressions of glucose transporter type 1 and hexokinase II in cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Hexokinase; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Topics: Aged; Carcinoma; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intercellular Signaling Peptides and Proteins; Lymphangiogenesis; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Small Cell; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Aortography; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET/CT and ultrasonography.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Ultrasonography | 2012 |
Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2012 |
Lymph node metastases in malignant colonic polyp with favourable histology detected by PET CT.
Topics: Colonic Neoplasms; Colonic Polyps; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiography | 2012 |
Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Unknown Primary; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Urologic Neoplasms | 2012 |
Can we rely on PET in the follow-up of advanced seminoma patients?
Topics: Antineoplastic Agents; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm, Residual; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cystadenoma, Serous; Decision Support Techniques; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Recent progress in positron emission tomography concerning diagnosis and treatment of lung cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection.
Topics: Adult; Aged; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Queensland; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
[Usefulness of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in evaluation of gastric cancer stage].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Stomach Neoplasms; Tomography, X-Ray Computed | 2012 |
[The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Topics: Adult; Aged; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Middle Aged; Multimodal Imaging; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anatomy, Regional; Biopsy; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2012 |
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Extremities; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Topics: Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Whole Body Imaging | 2013 |
The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients.
Topics: Adolescent; Adult; Aged; Biological Transport; Bone Neoplasms; Child; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2012 |
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Positron emission tomography in the detection of occult primary head and neck carcinoma: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck | 2012 |
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2012 |
A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2012 |
The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Topics: Carcinoma, Squamous Cell; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Forecasting; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
The use of intraoperative PET probe to resect metastatic melanoma.
Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Period; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2010 |
A case of isolated paraaortic lymph node recurrence from colon cancer successfully treated with chemoradiotherapy.
Topics: Adenocarcinoma; Carcinoembryonic Antigen; Chemoradiotherapy; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Combined PET/CT-perfusion in patients with head and neck cancers.
Topics: Adult; Aged; Biopsy; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |
Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.
Topics: Adult; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2012 |
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2012 |
Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Young Adult | 2012 |
Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
Topics: Adult; Aged; Brachytherapy; Cervix Uteri; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
FDG-PET guided diagnosis of vaginal intravascular diffuse large B-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillaries; Cyclophosphamide; Fatal Outcome; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Paraproteins; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Vagina; Vascular Neoplasms; Vincristine | 2012 |
Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
PET/CT: Emphasis and current utility in oral cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mouth Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2012 |
Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
Topics: Aged; Choline; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
[Serial (18)F-FDG PET-CT imaging during radiotherapy for nasopharyngeal carcinoma: a prospective clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2012 |
Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Odds Ratio; Patient Selection; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2012 |
Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.
Topics: Adult; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Symporters; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Thorax; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Asymptomatic Diseases; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pneumonectomy; Positron-Emission Tomography; Postoperative Care; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Clinical impact of ¹⁸F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Rhabdomyosarcoma; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Muscle Tissue; Paclitaxel; Positron-Emission Tomography; Radiography; Thoracic Vertebrae; Treatment Outcome | 2012 |
18F-fluorodeoxyglucose-positive Warthin tumor in a contralateral cervical lymph node mimicking metastasis in tongue cancer staging with PET/CT.
Topics: Adenolymphoma; Aged; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Tongue Neoplasms | 2012 |
False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Seminoma | 2013 |
Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2012 |
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2013 |
Comparison of ( 18 ) F-FLT PET and ( 18 ) F-FDG PET for detection of cervical lymph node metastases in head and neck cancers.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed | 2012 |
Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.
Topics: Carcinoma; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2013 |
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Breast Neoplasms, Male; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Sarcoidlike reaction of neoplasia causing hypermetabolic thoracic adenopathy in setting of extrathoracic malignancy: report of two cases and a review of the differential diagnostic considerations.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Sacrum; Sarcoidosis; Thorax; Tomography, X-Ray Computed | 2012 |
Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2012 |
Intramedullary metastasis detected with 18F FDG-PET/CT.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2012 |
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients.
Topics: Aged; Carcinoma; Chemoradiotherapy; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Preoperative Period; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2013 |
Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2013 |
Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cell Proliferation; Choline; Choline Kinase; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2013 |
[A case of hepatocellular carcinoma with multiple lymph node metastases detected by FDG-PET].
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: preoperative planning for necessity and extent of neck dissection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Grading; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Salivary Gland Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
Topics: Carcinoma, Squamous Cell; Case-Control Studies; Chi-Square Distribution; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2013 |
Oesophageal tumour progression between the diagnostic ¹⁸F-FDG-PET and the ¹⁸F-FDG-PET for radiotherapy treatment planning.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2013 |
[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Remission Induction; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Extracapsular spread and FDG PET/CT correlations in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Floor; Mouth Neoplasms; Neck; Neoplasm Invasiveness; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed; Tongue Neoplasms; Young Adult | 2013 |
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence?
Topics: Aged; Biomarkers; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Recurrence; Surgical Procedures, Operative; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Clinical significance of ¹⁸F-fluorodeoxyglucose positron emission tomography in superficial esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Lymphatic Vessels; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2013 |
[Correlation between regional node metastasis and imageological characteristics in non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Multivariate Analysis; Neoplasm Staging; Radiography; Radionuclide Imaging; Risk Factors; Tumor Burden | 2012 |
[Esophageal cancer: outcome according to therapeutic strategy].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N₀ head and neck cancers.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Fluorodeoxyglucose--positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
Topics: Adult; Breast Implants; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Mammaplasty; Mastectomy; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Silicone Gels; Thoracic Surgery, Video-Assisted | 2013 |
Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Multimodal Imaging; Perfusion Imaging; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed | 2013 |
High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, X-Ray Computed | 2013 |
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aorta; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vena Cava, Inferior | 2013 |
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone | 2013 |
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2013 |
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Remission Induction; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The potential of FDG-PET in the detection of occult lymph node metastasis: importance of patient selection and reference standard.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Multimodal Imaging; Patient Selection; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Tomography, X-Ray Computed | 2013 |
Primary tumor PET/CT [¹⁸F]FDG uptake is an independent predictive factor for regional lymph node metastasis in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Tomography, X-Ray Computed | 2013 |
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; Oxygen Radioisotopes; Prognosis; Tomography, Emission-Computed; Water | 2002 |
[The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[F-18 fluorodeoxyglucose positron emission tomography in lung lesions].
Topics: Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
Topics: Blue Cross Blue Shield Insurance Plans; Carcinoma; Device Approval; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Radiopharmaceuticals; Sensitivity and Specificity; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2002 |
Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; Foot; Lymphadenitis; Lymphatic Metastasis; Lymphoma, T-Cell; Male; Methionine; Mice; Mice, Inbred BALB C; Neoplasm Staging; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Tyrosine | 2002 |
Effect of hyperglycemia on tumoral uptake of F-18 FDG.
Topics: Abdomen; Blood Glucose; Diabetes Complications; Diabetes Mellitus; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Solitary Pulmonary Nodule | 2002 |
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2002 |
Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer--Taiwanese experiences.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Positron emission tomography for the preoperative staging of esophageal carcinoma].
Topics: Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
Topics: Adult; Aged; Blood Glucose; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.
Topics: Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
Topics: Abdomen; Back; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2002 |
Incidental detection of primary breast carcinoma with a modified coincident camera in a patient with non-Hodgkin's lymphoma and melanoma.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Melanoma; Neoplasm Staging; Neoplasms, Multiple Primary; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Whole-Body Counting | 2002 |
Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
Evaluation of esophageal cancer by positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Topics: Actuarial Analysis; Bayes Theorem; Carcinoma, Squamous Cell; Cohort Studies; Denmark; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice.
Topics: Adenocarcinoma; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leiomyosarcoma; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color | 2002 |
Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma.
Topics: Aged; Carcinoma, Bronchogenic; Dermatomyositis; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paraneoplastic Syndromes; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
A combined PET/CT scanner: the path to true image fusion.
Topics: Aged; Colonography, Computed Tomographic; Colorectal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2002 |
[Netherlands' experience in positron emission tomography in thoracic oncology].
Topics: Antineoplastic Agents; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mediastinoscopy; Medical Oncology; Netherlands; Patient Selection; Radiation-Protective Agents; Thoracic Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Unnecessary Procedures | 2002 |
A needle free system for cervical lymphatic mapping and sentinel node biopsy in oral squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tongue Neoplasms | 2002 |
Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Child; Clavicle; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle, Skeletal; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Tissue Distribution; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Observer Variation; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Survival Analysis; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Models, Biological; Models, Statistical; Neoplasm Recurrence, Local; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Switzerland; Tomography, Emission-Computed | 2003 |
Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multivariate Analysis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Positron emission tomographic imaging of Merkel cell carcinoma.
Topics: Aged; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
[Diagnostic imaging--recent progress].
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Observer Variation; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Topics: Adult; Aged; Carcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
PET detection of melanoma metastases in lymph nodes.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Coordination Complexes; Copper Radioisotopes; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Life Tables; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Radiation Tolerance; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
[18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Mucin-1; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
Detecting metastatic pelvic lymph nodes by 18F-2-deoxyglucose positron emission tomography in patients with prostate-specific antigen relapse after treatment for localized prostate cancer.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pelvis; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG-PET in paraneoplastic neuropathy.
Topics: Ataxia; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paraneoplastic Syndromes; Radionuclide Imaging; Radiopharmaceuticals; Sensation Disorders | 2003 |
Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Use of FDG-PET in testicular tumours.
Topics: Fluorodeoxyglucose F18; Germinoma; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed | 2003 |
New horizons in oncologic imaging.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetics; Male; Medical Oncology; Nanotechnology; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastitis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed | 2003 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
The role of FDG-PET scan in staging patients with nonsmall cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms | 2003 |
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; Time Factors; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2003 |
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Biopsy; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Esophagus; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Care Planning; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Influenza vaccine and FDG-PET.
Topics: Adult; Animals; Axilla; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Influenza Vaccines; Influenza, Human; Lymph Nodes; Lymphatic Metastasis; Lymphocyte Activation; Mice; Models, Animal; Tomography, Emission-Computed | 2003 |
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG-PET for evaluation of recurrent lymph node metastases in patients with surgically resected breast cancer: adding spot images to whole body images.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
F-18 fluorodeoxyglucose uptake in atherosclerotic plaque in the mediastinum mimicking malignancy: another potential for error.
Topics: Aged; Aorta, Thoracic; Coronary Artery Disease; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphatic Metastasis; Mediastinum; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2004 |
Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck Dissection; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
FDG positron emission tomography for evaluating breast cancer.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Device Approval; Female; Fluorodeoxyglucose F18; Humans; Insurance Coverage; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Outcome Assessment, Health Care; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2003 |
Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Pelvis; Prospective Studies; Radiopharmaceuticals; Statistics as Topic; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Adenosquamous; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carcinosarcoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Penile Neoplasms; Penis; Remission Induction; Survival Analysis; Tomography, Emission-Computed | 2004 |
Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The influence of thyroglobulin on functional imaging in differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Lymph node staging in lung cancer using [18F]FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Carcinoid Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies.
Topics: Adenocarcinoma; Adult; Carcinoembryonic Antigen; Deglutition Disorders; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Muscle Weakness; Neurons; Palliative Care; Paraneoplastic Syndromes, Nervous System; Radionuclide Imaging; Spinal Cord; Stiff-Person Syndrome; Upper Extremity | 2004 |
Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Histiocytosis, Sinus; Humans; Incidental Findings; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
GLUT1 expression in tissue and (18)F-FDG uptake.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germinal Center; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Monosaccharide Transport Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2004 |
Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer?
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Lymph node control in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Radiotherapy Dosage; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
A case of renal pelvic tumor visualized by 18F-FDG-PET imaging.
Topics: Aged; Carcinoma, Transitional Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Software; Tissue Distribution; Treatment Outcome | 2004 |
The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Small cell carcinoma of the parotid gland: evaluation with FDG PET imaging.
Topics: Aged; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Parotid Gland; Parotid Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammary Arteries; Mediastinum; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2004 |
Positron emission tomography in primary thyroid lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2004 |
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Prognosis; Radiopharmaceuticals; Risk Factors; Survival Rate; Tomography, Emission-Computed | 2004 |
[Clinical evaluation of 18-fluorine fluorodeoxyglucose positron emission tomography-CT imaging in head and neck tumors].
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Positron-Emission Tomography; Tomography, X-Ray Computed | 2004 |
Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma.
Topics: Adenocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
Topics: Adenocarcinoma; Aged; Antibodies, Neoplasm; Breast Neoplasms; Carcinoma, Small Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Paraneoplastic Syndromes, Nervous System; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Counting | 2004 |
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2004 |
Virchow's node on F-18 FDG PET/CT.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2004 |
The role of PET scan in the preoperative management of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
Topics: Adenocarcinoma; Aged; Carcinoma, Small Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
[18F-FDG positron emission tomography for mediastinal staging of lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2004 |
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; DNA, Neoplasm; Feasibility Studies; Flow Cytometry; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Cytometry; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Ploidies; Prospective Studies; Radiopharmaceuticals; S Phase; Tomography, Emission-Computed | 2004 |
[PET/CT in radiotherapy].
Topics: Blood Glucose; Carcinoma, Bronchogenic; Equipment Design; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2004 |
FDG PET and gallium scintigraphy for diagnosis of an advanced jejunal adenocarcinoma with distant metastases.
Topics: Adenocarcinoma; Citrates; Fluorodeoxyglucose F18; Gallium; Humans; Image Enhancement; Jejunal Neoplasms; Lymphatic Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2004 |
18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.
Topics: Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
Mediastinal staging (take home messages).
Topics: Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinoscopy; Mediastinum; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography, Interventional | 2004 |
Physiological uptake of [18F]fluorodeoxyglucose in the neck and upper chest region: are there predictive characteristics?
Topics: Adolescent; Adult; Age Distribution; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck; Netherlands; Organ Specificity; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thorax; Thyroid Neoplasms; Tissue Distribution | 2004 |
Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2004 |
Positron emission tomography helps in excluding distant lesions in a case of mesothelioma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage | 2005 |
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Can post-RT FDG PET accurately predict the pathologic status in neck dissection after radiation for locally advanced head and neck cancer? In regard to Rogers et al. (Int J Radiat Oncol Biol Phys 2004;58:694-697).
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Treatment Outcome | 2005 |
FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Increased F-18 FDG uptake in the right auricle of a displaced heart: potential cause of a false-positive pathologic mediastinal node.
Topics: Aged; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals | 2005 |
Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Proportional Hazards Models; Prospective Studies; Radiation-Sensitizing Agents; Radiopharmaceuticals; Registries; Survival Analysis; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease.
Topics: Aged; Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals; Scrotum; Sepsis | 2005 |
18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Japan; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic | 2005 |
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Rate | 2005 |
PET demonstration of left atrial appendage in chronic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Chronic Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lymphatic Metastasis; Male; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
An ovary in luteal phase mimicking common iliac lymph node metastasis from a primary cutaneous peripheral primitive neuroectodermal tumour as revealed by 18-fluoro-2-deoxyglucose positron emission tomography.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Luteal Phase; Lymph Nodes; Lymphatic Metastasis; Neuroectodermal Tumors, Primitive, Peripheral; Ovarian Cysts; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2005 |
18F-FDG PET in malignant lymphoma: significance of positive findings.
Topics: Adolescent; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Role of PET scan in management of oesophageal cancer.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Signet Ring Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms | 2005 |
The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Staging of advanced cervical cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2005 |
Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
FDG-PET evaluation of vaginal carcinoma.
Topics: Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Vaginal Neoplasms | 2005 |
Staging and assessment of lymph node involvement by 18F-fluorodeoxyglucose-positron emission tomography in invasive extramammary Paget's disease.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2005 |
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity | 2005 |
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
FDG-PET in head and neck, and thyroid cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Thyroid Neoplasms | 2005 |
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tongue Neoplasms | 2005 |
[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Uterine Neoplasms | 2005 |
The detection of renal cell carcinoma with adrenal and para-aortic lymph node metastases by FDG-PET.
Topics: Adrenal Gland Neoplasms; Aorta; Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Diseases; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Radiopharmaceuticals; Receptor, ErbB-2; Tomography, Emission-Computed; Trastuzumab; Treatment Outcome; Vinblastine; Vinorelbine | 2005 |
Detection and staging of preinvasive lesions and occult lung cancer in the central airways with 18F-fluorodeoxyglucose positron emission tomography: a pilot study.
Topics: Aged; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Squamous Cell; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Health Care Costs; Humans; Japan; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Mediastinum; Models, Economic; Positron-Emission Tomography; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Whole body PET/CT for initial staging of choroidal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choroid Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Tomography, X-Ray Computed | 2005 |
[Application of 18FDG-PET in the diagnosis of lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Spiral Computed | 2005 |
Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Time Factors | 2006 |
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Reproducibility of Results; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Metastatic lymph node and osteolytic skeletal metastasis detected by FDG-PET in an endoscopy-diagnosed early-stage esophageal cancer.
Topics: Bone Neoplasms; Esophageal Neoplasms; Esophagoscopy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Osteolysis; Radionuclide Imaging; Radiopharmaceuticals; Sternum | 2005 |
Effect of diazepam on the efficacy of dual-phase FDG PET imaging.
Topics: Administration, Oral; Carcinoma; Diazepam; Drug Interactions; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
[Clinical value of computed tomography and fluorine-18 fluorodeoxyglucose positron remission tomography in diagnosis of mediastinal metastasis of non small cell lung cancer].
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2005 |
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon.
Topics: Antiviral Agents; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Interferon alpha-2; Interferon-alpha; Lymphatic Metastasis; Mediastinal Neoplasms; Melanoma; Middle Aged; Polyethylene Glycols; Positron-Emission Tomography; Recombinant Proteins; Sarcoidosis; Sentinel Lymph Node Biopsy | 2005 |
Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2006 |
4th International Cervical Cancer Conference: update on PET and cervical cancer.
Topics: Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2005 |
[Diagnostic value of dual-head 18F-FDG imaging in metastatic lesion with unknown primary tumour].
Topics: Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Positron-Emission Tomography | 2005 |
[Surgical approach for lung cancer with multiple pulmonary nodules].
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography | 2006 |
Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes.
Topics: Aged; Biopsy, Needle; Bronchoscopy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Ultrasonography | 2006 |
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thoracic Neoplasms | 2006 |
Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma?
Topics: Biopsy; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET/CT staging and posttherapeutic assessment of esthesioneuroblastoma.
Topics: Aged; Esthesioneuroblastoma, Olfactory; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Whole-body MRI and PET-CT in the management of cancer patients.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Mass Screening; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2006 |
[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Palpation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2006 |
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
An audit of fusion CT-PET in the management of colorectal liver metastases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Audit; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed at 18F-FDG-PET/CT: an unusual finding.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Adenoma, Oxyphilic; Adult; Aged; Disease Management; Drug Resistance; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
[Significance of PET and integrated PET/CT in the diagnostics of occult primary tumors].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharynx; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Palatine Tonsil; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Tonsillectomy | 2006 |
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2006 |
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Squamous Cell; Cytodiagnosis; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Sensitivity and Specificity | 2006 |
[Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma].
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Diagnostic work-up and outcome of cervical metastases from an unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Combined Modality Therapy; Disease-Free Survival; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Detection of widespread neurolymphomatosis with 18F-FDG PET.
Topics: Adult; Cranial Nerve Diseases; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Diseases; Whole Body Imaging | 2006 |
F-18 FDG PET imaging in gastric neuroendocrine carcinoma.
Topics: Aged; Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2006 |
Asymptomatic familial colon cancer with FDG-PET scanning for recurrent disease.
Topics: Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis | 2005 |
The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2006 |
[Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2006 |
[Mediastinal lymph node metastasis of thyroid cancer occurring 15 years after the initial operation; report of a case].
Topics: Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Nuclear Proteins; Positron-Emission Tomography; Postoperative Period; Thyroid Neoplasms; Thyroid Nuclear Factor 1; Thyroidectomy; Transcription Factors | 2006 |
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
Topics: Abdomen; Acute Disease; Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C; Humans; Lymphatic Diseases; Lymphatic Metastasis; Mastectomy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Spinal Neoplasms; Spleen; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Rate | 2006 |
Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities.
Topics: Child, Preschool; Extremities; Fatal Outcome; Female; Fluorodeoxyglucose F18; Groin; Hand; Humans; Infant; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography; Prognosis; Remission Induction; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Survival Rate; Thigh; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Discordant response to chemotherapy: an unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Time Factors | 2006 |
FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Statistics, Nonparametric | 2006 |
Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Non-Small-Cell Lung; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Prospective Studies; ROC Curve | 2006 |
Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application.
Topics: Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET).
Topics: Aged; Bone and Bones; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Topics: Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2006 |
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Frozen Sections; Humans; Lung Diseases; Lung Diseases, Fungal; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2006 |
18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
Topics: Adenocarcinoma; Aged; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Usefulness of preoperative FDG-PET for detection of gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neck; Neoplasm Metastasis; Positron-Emission Tomography; Preoperative Care; Stomach Neoplasms; Whole Body Imaging | 2006 |
High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Mouth Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Sentinel lymph node biopsy: A new perspective in head and neck mucosal melanoma?
Topics: Adult; Antineoplastic Agents; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Sentinel Lymph Node Biopsy | 2006 |
Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Diabetes Complications; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2006 |
Futility of positron emission tomography and other modalities in the initial radiographic screening of patients with melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Medical Futility; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
Topics: Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
FDG PET/CT demonstrates the effectiveness of isolated limb infusion for malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Fluorodeoxyglucose F18; Infusions, Intra-Arterial; Lymphatic Metastasis; Melanoma; Melphalan; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization.
Topics: Axilla; Diagnosis, Differential; Diagnostic Errors; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Immunization; Lymph Nodes; Lymphatic Metastasis; Lymphoma, B-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Viral Vaccines | 2006 |
Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted | 2007 |
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Survival Analysis | 2006 |
Radioguided detection of lymph node metastasis in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pneumonectomy; Positron-Emission Tomography; Radiopharmaceuticals; Thorax | 2006 |
Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2007 |
The diagnostic role of radioactivity in sentinel nodes in oral and oropharyngeal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2006 |
Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2006 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET: other thoracic malignancies.
Topics: Carcinoma; Cost-Benefit Analysis; Diagnostic Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mesothelioma; Neoplasm Staging; Patient Care Planning; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thymoma; Thymus Neoplasms | 2006 |
Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas?
Topics: Adult; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Ultrasonography | 2006 |
1-[11C]-acetate PET imaging in head and neck cancer--a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning.
Topics: Acetates; Adolescent; Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2007 |
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tomography, X-Ray Computed | 2006 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.
Topics: Carcinoma; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals | 2007 |
Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Whole Body Imaging | 2007 |
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
A case of primary unknown carcinoma with lymphatic spread.
Topics: Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2006 |
[18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
[18F-FDG PET/CT in paraneoplastic osteoarthropathy].
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Osteoarthropathy, Secondary Hypertrophic; Palliative Care; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiography, Thoracic; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2007 |
F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma.
Topics: Adult; Antineoplastic Agents; CA-125 Antigen; Cisplatin; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Reproducibility of Results; Whole Body Imaging | 2007 |
Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Technetium Tc 99m Medronate; Whole Body Imaging; Whole-Body Counting | 2008 |
Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
PET monitoring of clear cell sarcoma of tendons and aponeuroses.
Topics: Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Tendons; Tomography, X-Ray Computed | 2007 |
Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Topics: Abdominal Neoplasms; Adult; Aged; Colonic Neoplasms; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iron; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Oxides; Peritoneal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Topics: Acetic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Hepatocellular; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Thyroid Neoplasms | 2007 |
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2007 |
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neck Dissection; Neoplasm Staging; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2007 |
[18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonia; Preoperative Care; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2006 |
Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment.
Topics: Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2007 |
FDG-PET: an important tool in the diagnosis of lung cancer.
Topics: Abdomen; Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Lung cancer with isolated skip metastasis to an abdominal lymph node.
Topics: Abdomen; Adenocarcinoma; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lung; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2007 |
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle o
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Misonidazole; Oxygen Consumption; Polarography; Positron-Emission Tomography; Prognosis; Ultrasonography, Doppler, Color | 2007 |
[The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Pharynx; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2007 |
Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2007 |
[FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
Topics: Antineoplastic Agents; Blood Glucose; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2008 |
[Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[FDG PET/CT versus PET alone for pre-surgical detection of lymph node metastasis in esophageal carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
[FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2007 |
Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2007 |
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2007 |
[Clinical study of 28 cases of cervical lymph node metastasis from an unknown primary carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis; Survival Rate | 2007 |
[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].
Topics: Adult; Aged; Apoptosis; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
[Analysis of the performance of 18F-fluoro-2-deoxyglucose positron emission tomography in primary tumor detection in metastatic neck cancers].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2007 |
F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Peritonitis; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Tooth Extraction | 2007 |
Metastatic eccrine porocarcinoma detected on FDG PET/CT.
Topics: Carcinoma; Eccrine Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Sweat Gland Neoplasms; Tomography, X-Ray Computed | 2007 |
Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
The contribution of new imaging techniques in staging cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Topics: Carcinoma, Squamous Cell; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Medical Staff, Hospital; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.
Topics: Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiography; Tomography, Emission-Computed | 2007 |
Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2008 |
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Assessment; Survival Rate; Treatment Outcome | 2007 |
STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Positron emission tomography imaging in nonsmall-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2007 |
Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Decision Making; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bronchoscopy; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed | 2007 |
FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Topics: Adult; Aged; Body Burden; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed | 2008 |
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report].
Topics: Carcinoma; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2007 |
Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Esophagoscopy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2007 |
Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer.
Topics: Adult; Aged; Aorta; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Taiwan; Uterine Cervical Neoplasms | 2008 |
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
[Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
[Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2007 |
18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Topics: 3-Iodobenzylguanidine; Aged; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thymus Neoplasms | 2007 |
Primary duodenal lymphoma: successful rituximab treatment and evaluation by FDG-PET.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Duodenal Neoplasms; Endoscopy; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Helicobacter pylori; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Radionuclide Imaging; Rituximab; Time Factors | 2007 |
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Topics: Adult; Aged; Carcinoma; Endoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sensitivity and Specificity | 2008 |
18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Technology Assessment, Biomedical | 2007 |
A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Ink; Lymph Nodes; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tattooing; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2007 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Nonpalpable supraclavicular lymph nodes in lung cancer patients: preoperative characterization with 18F-FDG PET/CT.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Role of FDG-PET in the assessment of survival prognosis in melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Time Factors; Tomography, Spiral Computed | 2007 |
Comparison of 99mtechnetium-pertechnetate and 123iodide SPECT with FDG-PET in patients suspicious for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prone Position; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Supine Position; Thoracic Neoplasms; Tomography, Emission-Computed, Single-Photon | 2007 |
Use of PET probe in surgical oncology.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted | 2008 |
Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Clavicle; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bile Ducts, Intrahepatic; Biopsy; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Angiography; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Diagnosis supporting algorithm for lymph node metastases from colorectal carcinoma on 18F-FDG PET/CT.
Topics: Algorithms; Colorectal Neoplasms; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2008 |
Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Taiwan; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2008 |
Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose po
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Models, Biological; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2008 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
Multimodal virtual bronchoscopy using PET/CT images.
Topics: Bronchoscopes; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lung Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Software; Tomography, X-Ray Computed; User-Computer Interface | 2008 |
Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Survival Rate; Uterine Cervical Neoplasms | 2008 |
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
Topics: Carcinoma, Small Cell; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Statistics, Nonparametric; Tomography, X-Ray Computed | 2008 |
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
Topics: Adult; Aged; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2008 |
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.
Topics: Adult; Chest Pain; Diagnosis, Differential; Dyspnea; Fatal Outcome; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Mesothelioma; Pericardium; Positron-Emission Tomography; Pulmonary Edema; Radiopharmaceuticals; Rare Diseases; Tomography, X-Ray Computed | 2008 |
FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Topics: Aged; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2008 |
Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, X-Ray Computed; Treatment Failure; Tumor Burden | 2008 |
[Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool].
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2008 |
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed | 2008 |
Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colonic Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Rectal Neoplasms; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Assessing the impact of FDG-PET in the management of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
FDG-PET staging of head and neck cancer--can improved imaging lead to improved treatment?
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neck; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Whole Body Imaging | 2009 |
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Para-Aortic Bodies; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
F-18 FDG-PET imaging in adult T-cell leukemia lymphoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Leukemia, T-Cell; Liver Neoplasms; Lymphatic Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Clinical Protocols; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Primary synovial sarcoma of the kidney: use of PET/CT in diagnosis and follow-up.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Tomography, X-Ray Computed | 2008 |
Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Catecholamines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypertension; Lymphatic Metastasis; Mediastinal Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma.
Topics: Adolescent; Adult; Aged; Cicatrix; Costs and Cost Analysis; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 1995 |
Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Sensitivity and Specificity; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Deoxyglucose; Endoscopy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Topics: Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Neck; Sodium Iodide; Sodium Pertechnetate Tc 99m; Thyroid Neoplasms; Tomography, Emission-Computed | 1995 |
Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Neck; Neoplasm Staging; Pharyngeal Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Topics: Aged; Antibodies, Monoclonal; Colorectal Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oligopeptides; Ovarian Neoplasms; Pentetic Acid; Tomography, Emission-Computed | 1995 |
[Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Renal Cell; Combined Modality Therapy; Deoxyglucose; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1995 |
Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Radionuclide Imaging | 1995 |
Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings.
Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mammography; Middle Aged; Tomography, Emission-Computed | 1994 |
Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck.
Topics: Biopsy; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1994 |
Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluorouracil; Glucose; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Oropharyngeal Neoplasms; Tomography, Emission-Computed | 1995 |
The promise FDG in diagnosis and surveillance of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Population Surveillance; Tomography, Emission-Computed | 1994 |
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
Topics: Adenocarcinoma; Cholangiocarcinoma; Contrast Media; Deoxyglucose; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retroperitoneal Fibrosis; ROC Curve; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 1994 |
Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Xeromammography | 1993 |
[Positron emission tomography (PET) in the preoperative evaluation of cervical lymph node metastasis of ORL cancer].
Topics: Aged; Combined Modality Therapy; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neck; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Radiotherapy Dosage; Radiotherapy, High-Energy; Tomography, Emission-Computed | 1993 |
Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Topics: Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pilot Projects; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1993 |
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.
Topics: Adenocarcinoma; Adult; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation.
Topics: Contrast Media; Deoxyglucose; Fluorodeoxyglucose F18; Head; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Mouth Neoplasms; Neck; Nose; Orbit; Parotid Neoplasms; Pharynx; Tomography, Emission-Computed; Tongue Neoplasms | 1993 |
Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxyglucose; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
Topics: Aged; Carcinoma, Small Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Radiography, Thoracic; Tomography, Emission-Computed | 1996 |
Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha.
Topics: Acidosis, Lactic; Aged; Deoxyglucose; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gastrointestinal Hemorrhage; Humans; Hypoglycemia; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Pelvic Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1996 |
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
Topics: Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1996 |
[Positron emission tomography in diagnosis of renal cell carcinoma].
Topics: Blood Glucose; Carcinoma, Renal Cell; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Tomography, Emission-Computed | 1996 |
Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Time Factors; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm, Residual; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography, Mammary | 1996 |
Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Probability; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1996 |
Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
Topics: Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
[Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor].
Topics: Biopsy; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prospective Studies; Tomography, Emission-Computed | 1996 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Quantification of serial tumor glucose metabolism.
Topics: Computer Simulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Models, Biological; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
[Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].
Topics: Blood Glucose; Chronic Disease; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis; Tomography, Emission-Computed | 1996 |
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphatic Metastasis; Mediastinal Cyst; Mediastinal Neoplasms; Tomography, Emission-Computed | 1996 |
Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.
Topics: Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer.
Topics: Carcinoma, Transitional Cell; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 1997 |
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Topics: Adolescent; Adult; Aged; Biopsy; Child; Contrast Media; Deoxyglucose; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1997 |
Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
Topics: Adult; Carcinoma, Papillary; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neck; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 1997 |
A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
[PET scan in general practice for diagnosis of breast carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Breast; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Early changes in fluorine-18-FDG uptake during radiotherapy.
Topics: Aged; Carcinoma, Papillary; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammation; Lymph Nodes; Lymphatic Metastasis; Male; Neck; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
Role of positron emission tomography in staging esophageal cancer.
Topics: Adenocarcinoma; Bone Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Esophageal Neoplasms; False Negative Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Laparoscopy; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Care Planning; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Video Recording | 1997 |
Improvement in staging of esophageal cancer with the addition of positron emission tomography.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Contrast Media; Deoxyglucose; Esophageal Neoplasms; Esophagectomy; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Selection; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Minimally invasive surgical biopsy confirms PET findings in esophageal cancer.
Topics: Adenocarcinoma; Aged; Biopsy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Laparoscopy; Liver Neoplasms; Lumbar Vertebrae; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Sacroiliac Joint; Spinal Neoplasms; Tomography, Emission-Computed | 1997 |
Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer.
Topics: Abdomen; Administration, Intravesical; Artifacts; Catheterization; Colon; Colonic Neoplasms; Diuretics; Fluid Therapy; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Kidney; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Radiopharmaceuticals; Rectal Neoplasms; Sodium Chloride; Therapeutic Irrigation; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract | 1998 |
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Topics: Adult; Aged; Algorithms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Therapy, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Positron emission tomography in the evaluation of the N0 neck.
Topics: Carcinoma, Squamous Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Incidence; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of unknown occult primary tumors using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Urinary Bladder Neoplasms | 1998 |
Injection artifact on FDG PET imaging.
Topics: Adult; Artifacts; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Injections, Subcutaneous; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Topics: Abdomen; Abdominal Neoplasms; Adenocarcinoma; Axilla; Bone Marrow; Bone Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Neck; Observer Variation; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 1998 |
Histological verification of positive fluorine-18 fluorodeoxyglucose findings in patients with differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
[Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 1998 |
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Topics: Carcinoma, Squamous Cell; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cohort Studies; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tongue Neoplasms; Tonsillar Neoplasms | 1998 |
The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Topics: Adolescent; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Phyllodes Tumor; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
[Value of (F18)-2-fluorodeoxyglucose PET scanning in staging mouth cavity carcinoma. Comparative evaluation of PET findings before and after preoperative radiochemotherapy with histological and computerized tomography findings].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Thoracoscopy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
Topics: Esophageal Neoplasms; Esophagectomy; Esophagus; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Patient Selection; Prospective Studies; Radiopharmaceuticals; Stomach; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Uterine Cervical Neoplasms | 1998 |
Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 1998 |
[Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study.
Topics: Axilla; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Phantoms, Imaging; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 1999 |
[Lymph node staging of bladder neck carcinoma with positron emission tomography].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Urinary Bladder Neoplasms | 1999 |
Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Risk; Skin Neoplasms; Tomography, Emission-Computed | 1999 |
Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease.
Topics: Aged; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Topics: Aged; Axilla; Brachial Plexus; Breast Neoplasms; Chemotherapy, Adjuvant; Clavicle; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Peripheral Nervous System Diseases; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Thoracic Neoplasms; Tomography, Emission-Computed | 1999 |
Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
Topics: Adult; Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1998 |
Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography.
Topics: Biopsy, Needle; Carcinoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Pilot Projects; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Neoplasms, Unknown Primary; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Head; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Evaluation of FDG PET in patients with cervical cancer.
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
Role of FDG PET in metastatic thyroid cancer.
Topics: Autoantibodies; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Topics: Adult; Aged; Autoantibodies; Bone Neoplasms; Carcinoma, Papillary; Data Interpretation, Statistical; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
A new look at breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
Topics: Aorta; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Pelvis; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 1999 |
FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 1999 |
Staging non-small cell lung cancer with whole-body PET.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1999 |
[F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tongue Neoplasms; Uterine Cervical Neoplasms | 1999 |
Detection of cancer in augmented breasts by positron emission tomography.
Topics: Axilla; Breast; Breast Implantation; Breast Implants; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
F-18 FDG uptake in benign esophageal disease.
Topics: Adult; Aged; Barrett Esophagus; Diagnosis, Differential; Esophageal Diseases; Esophageal Neoplasms; Esophageal Spasm, Diffuse; Esophageal Stenosis; Esophagitis; Female; Fluorodeoxyglucose F18; Gastroesophageal Reflux; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Observer Variation; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Effect of attenuation correction on lesion detectability in FDG PET of breast cancer.
Topics: Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 1999 |
Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Topics: Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.
Topics: Area Under Curve; Blood Glucose; Cholangiopancreatography, Endoscopic Retrograde; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Pancreatic Diseases; Pancreatic Neoplasms; Preoperative Care; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.
Topics: Aged; Carcinoma, Squamous Cell; Endosonography; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
FDG PET detection of unknown primary tumors.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 2000 |
Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
Topics: Aged; Carbon Radioisotopes; Diagnosis, Differential; Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tissue Distribution; Tomography, Emission-Computed | 2000 |
[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Palpation; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
FDG positron emission tomography in melanoma.
Topics: Blue Cross Blue Shield Insurance Plans; Device Approval; Drug Approval; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Outcome Assessment, Health Care; Radiopharmaceuticals; Technology Assessment, Biomedical; Tomography, Emission-Computed; United States; United States Food and Drug Administration | 2000 |
The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Prospective Studies; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Metabolic staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Topics: Adult; Aged; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Choline; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Phantoms, Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
Topics: Abdomen; Adolescent; Adult; Aged; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mass Screening; Melanoma; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography; Whole-Body Irradiation | 2000 |
How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Local Lymph Node Assay; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Ultrasonography | 2000 |
Lymph node metastasis from breast cancer diagnosed by F-18 FDG whole-body PET (case report).
Topics: Adenocarcinoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Tomography, Emission-Computed | 2000 |
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
Topics: Antibodies, Monoclonal; Bone Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Organotechnetium Compounds; Predictive Value of Tests; Radioimmunodetection; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Clinical PET in oncology.
Topics: Artifacts; Blood Glucose; Cooperative Behavior; Cyclotrons; False Positive Reactions; Female; Fluorodeoxyglucose F18; Germany; Humans; Inflammation; Lymphatic Metastasis; Male; Medical Oncology; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Nuclear Medicine; Organ Specificity; Practice Guidelines as Topic; Private Practice; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Universities | 2000 |
Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Topics: Biopsy, Needle; Cohort Studies; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Germany; Humans; Insurance, Health, Reimbursement; Life Expectancy; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Solitary Pulmonary Nodule; Survival Rate; Tomography, Emission-Computed | 2000 |
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2000 |
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Palliative Care; Probability; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
18F-FDG for the staging of patients with differentiated thyroid cancer: comparison of a dual-head coincidence gamma camera with dedicated PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2000 |
Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma.
Topics: Adult; Aged; Biopsy; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neck; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
[Evaluation of prostate cancer using FDG-PET].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology.
Topics: Adult; Aged; Blood Glucose; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
Staging and managing lung tumors using F-18 FDG coincidence detection.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gamma Cameras; Humans; Lymph Nodes; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Pilot Projects; Proline; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Clinical skills in conducting research studies on clinical applications of oncologic PET.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography detection of metastatic penile squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Penile Neoplasms; Penis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Radiography; Radiopharmaceuticals; Reference Values; ROC Curve; Tomography, Emission-Computed | 2001 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Cervical lymph node sarcoidosis as a pitfall in F-18 FDG positron emission tomography.
Topics: Aged; Diagnosis, Differential; Ear, External; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neck; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
FDG-PET imaging for the staging and follow-up of small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Iodine Radioisotopes; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed | 2001 |
Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Pelvis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2000 |
FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.
Topics: Fluorodeoxyglucose F18; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Radiography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging.
Topics: Carcinoma, Non-Small-Cell Lung; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Carcinoma; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; United States; Uterine Cervical Neoplasms | 2001 |
[Positron emission tomography in head and neck oncology: five cases].
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Re: Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Tomography, Emission-Computed | 2001 |
Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Observer Variation; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Nondetection of sentinel lymph node with lymphoscintigraphy as a result of massive malignant invasion shown by positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
[[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Life Expectancy; Lymphatic Metastasis; Middle Aged; Models, Econometric; Morbidity; Neck Dissection; Neoplasm Staging; Quality-Adjusted Life Years; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
[18F]-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: an unusual pitfall.
Topics: Adenocarcinoma; Adult; Carcinoembryonic Antigen; Colonic Neoplasms; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Herpes Zoster; Humans; Lumbosacral Region; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
Topics: Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endoscopy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pilot Projects; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed | 2002 |
The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Carcinoma, Verrucous; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2001 |
Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 2002 |
Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Topics: Aged; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, Emission-Computed | 2002 |
FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[A case report. FDG-PET in occult breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2002 |
Therapy monitoring using FDG-PET in metastatic cervical cancer.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2000 |
Improved image interpretation with registered thoracic CT and positron emission tomography data sets.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Radiography, Thoracic; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Citrates; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Topics: Adult; Aged; Carcinoma; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed | 2002 |
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Testicular Neoplasms; Tomography, Emission-Computed | 2002 |
[Diagnosis of esophageal cancer using positron emission tomography].
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Remission Induction; Risk Factors; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed | 2002 |
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2002 |
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Otorhinolaryngologic Neoplasms; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Current status of nuclear medicine clinical application of FDG-PET for cancer diagnosis. Lung cancer].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphatic Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Esophageal cancer].
Topics: Aged; Aged, 80 and over; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
[The role of PET scan in the investigation of the lymphatic spreading of Hodgkin's disease].
Topics: Adult; Aged; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
[PET scan in patients with epipharyngeal tumors].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Pharyngeal Neoplasms; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2002 |
[FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.
Topics: Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Tomography, Emission-Computed | 1992 |
[Diagnosis of energy metabolism in ENT tumors--a PET study].
Topics: Blood Glucose; Carcinoma, Squamous Cell; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Follow-Up Studies; Hemangiopericytoma; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Staging; Otorhinolaryngologic Neoplasms; Survival Rate; Tomography, Emission-Computed | 1992 |
The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.
Topics: Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Lymph Nodes; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; Rats; Rats, Inbred Strains; Reference Values; Tomography, Emission-Computed | 1990 |
Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma.
Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Drug Evaluation; Female; Fluorine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Retroperitoneal Neoplasms | 1987 |